thursday, 3 october 20132013.cardiorhythm.com/download/detail-program-26-sep.pdf · mohit singla...

Thursday, 3 October 2013

08:30-10:10 Main Sessions on Atrial Fibrillation (Ablation), Bradycardia Pacing, Tachycardia Therapy Device, Sudden Cardiac Death

Certificate CRM Course Basic Research Focus Session Workshop Oral Abstract Session Joint Session with WSA

10:10-10:40 Coffee Break & Poster Sessions (Best Poster Award)

10:40-12:20 Main Sessions on Atrial Fibrillation (Drug), Heart Failure & Remote Patient Monitoring, VT Ablation

Certificate CRM Course Basic Research Debate Workshop Oral Abstract Session Joint Session with EHRA

12:20-13:50 Luncheon Symposium (Medtronic) Luncheon Symposium (Biosense Webster) Luncheon Symposium (St. Jude Medical)

13:50-15:30 Main Sessions on Atrial Fibrillation (Ablation), Syncope, Sudden Cardiac Death, Arrhythmias in Pediatric & Adult Congenital Heart Disease

Certificate CRM Course Basic Research Debate Live Transmission (Biosense Webster) Workshop Oral Abstract Session Joint Session with ISHNE

15:30-16:00 Coffee Break & Poster Sessions (Young Investigator Award)

16:00-17:40 Main Sessions on Atrial Fibrillation (Device), Heart Failure & Remote Patient Monitoring, SVT Ablation

Certificate CRM Course Basic Research Live Transmission (St. Jude Medical) Workshop Oral Abstract Session Joint Session with Australia-New Zealand

17:00-18:00 Cocktail Reception Symposia (Sponsored by Medtronic)

18:00-19:00 Opening Ceremony

19:00-19:30 Hong Kong Heart Foundation Lecture In memory of Sir QW Lee Speaker: Professor John Camm

16

TH

UR

SD

AY


Hall 5G, Room A

[001] Atrial Fibrillation (Ablation) 1 - New Technologies08:30 – 10:10 Chairs: Christian de Chillou (France) Akira Fujiki (Japan) Sum-Kin Leung (Hong Kong)

08:30 Multi-electrode Ablation Andrea Natale (USA)

08:50 Balloon Based Technologies Gerhard Hindricks (Germany)

09:10 Contact Force Technologies Karl-Heinz Kuck (Germany)

09:30 Imaging Technologies (3D, ICE, MRI) Douglas Packer (USA)

09:50 Novel Electrogram Mapping Meleze Hocini (France)

Hall 5G, Room B

[002] Bradycardia Pacing 1 - Implant Related Issues08:30 – 10:10 Chairs: Kai-Fat Tse (Hong Kong) Moon-Hyoung Lee (Korea)

08:30 Managing Anticoagulation for New Device Implants: Is there a Consensus?

Kazuo Matsumoto (Japan)

08:50 Non-apical RV Lead Placement for Bradycardia Support: Evidence-base and Ideal Location?

Harry Mond (Australia)

09:10 Managing Advisories: What Should the Clinician Know About Managing Patients with Hardware Under “Advisory”?

Russell Denman (Australia)

09:30 Leadless Pacing: Who, What, When, Why, How? L Bing Liem (USA)

09:50 How to Manage Tricuspid Regurgitation in the Device Patient with 1 or More Leads Across the Tricuspid Valve?

Ke-Ping Chen (China)

16 17

TH

UR

SD

AY


Hall 5G, Room C

[003] Tachycardia Therapy Device 1 - ICD Selected Topics08:30 – 10:10 Chair: Chi-Woon Kong (Taiwan) Boon-Yew Tan (Singapore) Yan-Hong Tang (China)

08:30 Problems and Solutions with Device Sensed Arrhythmias: Case Studies

Margaret Hood (New Zealand)

08:50 Solutions to High DFTs in 2013 Toon-Wei Lim (Singapore)

09:10 When to Extract Leads Beyond the Obvious Reasons: How to Manage Recall Leads?

Peter Belott (USA)

09:30 ICDs in Young Patients: Indications, Challenges and Follow-up

Andrew Davis (Australia)

09:50 Subcutaneous ICD Gust Bardy (USA)

Room S421

[004] Focus Session 1 - Heart Failure08:30 – 10:10 Chair: Herwig Schmidinger (Austria)

08:30 Case Based: Prevention of Effective CRT by Frequent PVC

Kuo-Hung Lin (Taiwan)

09:03 Case Based: A Difficult Case to Manage Phrenic Nerve Stimulation

Jin-Long Huang (Taiwan)

09:36 Case Based: Converting a CRT Non-responder into a Responder

Bernard Thibault (Canada)

18

TH

UR

SD

AY


Room S423

[005] VT Ablation Workshop 08:30 – 10:10 Chairs: Stephen KM Tam (Hong Kong) Anees Thajudeen (India)

08:30 Mapping of Ablation and Unstable VT Jo Jo Hai (Hong Kong)

08:50 Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia with Mechanical Circulatory Support

Fei Lü (USA)

09:10 PVC and LV Diastolic Dysfunction Venkat Tholakanahalli (USA)

09:30 Idiopathic VT Originating from the Noncoronary Sinus of Valsalva

Takumi Yamada (USA)

09:50 Intacardiac Echocardiography for the Ablation VT

Bernard Abi-Saleh (Lebanon)

Room S424

[006] Pediatric Workshop 1 - Management of Pediatric Arrhythmias I08:30 – 10:10 Chairs: Shuk-Han Lee (Hong Kong) Mei-Hwan Wu (Taiwan)

08:30 Arrhythmias in the Failing Pediatric Heart - How to Intervene When Transplantation is Around the Corner

Sabrina Tsao (USA)

08:50 The Device Based Therapy for Pediatric Cardiology Population – Japanese Single Centre Experience

Aya Miyazaki (Japan)

09:10 How to Ablate Ventricular Tachyarrhythmias in Children without Structural Heart Disease?

Naokata Sumitomo (Japan)

09:30 How to Manage VT in Adult with Repaired TOF?

June Huh (Korea)

09:50 How to Avoid the Risk of AV Block in Children with AVNRT Ablation?

Pi-Chang Lee (Taiwan)

18 19

TH

UR

SD

AY


Room S425

[007] SVT Workshop 1 - Getting Start08:30 – 10:10 Chairs: Hasri Samion (Malaysia) Chi-Ming Tam (Hong Kong)

08:30 Differential Diagnosis of SVT Bradley Knight (USA)

08:50 Ablation of Septal AP Sunny Po (USA)

09:10 Ablation of Mahaim AP Soot-Keng Ma (Malaysia)

09:30 Ablation of Difficult AVNRT Mark McGuire (Australia)

09:50 Ablation of Atypical AVNRT Eun-Sun Jin (Korea)

Room S426

[008] Sudden Cardiac Death (Global) - Global Burden and Stand Against Out-Of-Hospital SCD08:30 – 10:10 Chairs: Young-Hoon Kim (Korea) Sumeet Chugh (USA)

08:30 SCD in Korea Young-Hoon Kim (Korea)

08:50 SCD in Mid-Taiwan: Insights From the THUNDER Project

Kuan-Cheng Chang (Taiwan)

09:10 SCD in Hong Kong Chu-Pak Lau (Hong Kong)

09:30 North American Experience and Lessons from the Oregon Sudden Death Study

Sumeet Chugh (USA)

09:50 SCD in India Hygriv Rao (India)

20

TH

UR

SD

AY


Room S427

[009] Basic Research 1: Stem Cell Therapy of Cardiac Arrhythmia08:30 – 10:10 Chairs: Beny Hartono (Indonesia) Huey-Ming Lo (Taiwan)

08:30 Cell-based Therapy for Treatment of Ventricular Tachyarrhythmias

Douglas Packer (USA)

08:50 iPSC Platform for Modeling of Inherited Dilated Cardiomyopathy

David CW Siu (Hong Kong)

09:10 Modeling of Inherited Channalopathy with iPSC Platform

Silvia Priori (Italy)

09:30 The Past and Future of Stem Cell Therapy: Toward Overcoming Arrhythmia

Hye-Jin Hwang (Korea)

09:50 Stem Cell Therapy for Heart Diseases: Anti-arrhythmic or Proarrhythmic

Dao-Wu Wang (China)

Room S429

[010] Oral Abstract Session08:30 – 10:10 Oral Presentation - CRT 1 Chairs: Ka-Chun Chan (Hong Kong) Xiao-Shu Cheng (China) Yuen-Wai Tang (Hong Kong)

08:30 OP 01-1 Electrogram characteristics of quadripolar leads - implications for multipoint pacing

David O'DONNELL (Australia)

08:46 OP 01-2 Cardiac resynchronization therapy (CRT) - does multiple pacing configurations with the quadripolar LV lead overcome suboptimal lead positioning

Veeresh PATIL (India)

09:02 OP 01-3 Impact of steroid eluting on performance of multiple electrode left ventricular cardiac vein leads in CRT

Ping YANG (USA)

09:18 OP 01-4 Is the most delayed site the best site for LV lead pacing? insights from optimal LV lead positions

Darragh FLANNERY (Australia)

20 21

TH

UR

SD

AY


09:34 OP 01-5 Is left sided single lead DDD pacing feasible? Vinayakrishnan RAJAN (The Netherlands)

09:50 OP 01-6 Targeted lead implantation using a novel left ventricular active fixation lead

Azlan HUSSIN (Malaysia)

Room S430

[011] Oral Abstract Session08:30 – 10:10 Oral Presentation: Biomarkers Chairs: Kelvin KW Chan (Hong Kong) Pi-Hua Fang (China) Hong Jiang (China)

08:30 OP 02-1 Predictive potency of big endothelin-1 on response and long-term survival following cardiac resynchronization therapy

Xinwei YANG (China)

08:46 OP 02-2 Decreased endothelial nitric oxide production is more closely related with framigham risk than CHA2DS2-VASc scores in paroxysmal atrial fibrillation

Bonpei TAKASE (Japan)

09:02 OP 02-3 Predictive value of plasma N-terminal pro brain natriuretic peptide levels in left atrial spontaneous echo contrast in patients with atrial fibrillation

Kyoung Im CHO (Korea)

09:18 OP 02-4 Plasma level of galectin-3 has inverse relationship with transforming growth factor-b and predictive value for clinical recurrence of atrial fibrillation after catheter ablation

Jae Hyung PARK (Korea)

09:34 OP 02-5 QT dispersion: a marker of coronary artery disease and microvascular dysfunction

Betty RAMAN (Australia)

09:50 OP 02-6 The relationship between the secretion of B-type natriuretic peptide and the effects of several factors in patients with atrial fibrillation

Yukiko HAYAMA (Japan)

22

TH

UR

SD

AY


Room S221

[012] Certificate CRM Course - Introduction to Cellular Electrophysiology*For CRM Course Registrants

08:30 – 10:10 Chairs: Christine Chiu-Man (Canada) Kathy LF Lee (Hong Kong)

08:30 Effects of Ion Channels on Electrocardiographic Findings

Gil Gross (Canada)

09:03 Arrhythmogenesis: Reentry, Automaticity and Triggered Activity

Peng-Sheng Chen (USA)

09:36 Workshop: Early repolarization - Is it Good or Bad?

Mohit Singla (India)

Room S226

[013] Joint Session with WSA - Advances in Cardiac Pacing08:30 – 10:10 Chairs: Massimo Santini (Italy) Shu Zhang (China)

08:30 The Challenges to Instituting Remote Monitoring of CIED Patients in Clinical Practice

Suneet Mittal (USA)

08:55 The Leadless Pacemaker: Where are We? Reinoud Knops (The Netherlands)

09:20 Device Remote Control in Patients with Paroxysmal Atrial Fibrillation: Does it Reduce Hospitalization and Stroke?

Luca Santini (Italy)

09:45 Multisite and Multipoint Pacing to Optimize Cardiac Resynchronization Therapy

Antonio Curnis (Italy)

22 23

TH

UR

SD

AY


Hall 5G, Level 5

[014] Poster Session 1 10:10 – 10:40 Best Poster Award Judge: David Benditt (USA)

P1-001 Ventricular pre-excitation manifested in the course of Aortic valve endocarditis resulted in multiple VFs and sever left ventricular dysfunction

Aliasghar KHADEM (Canada)

P1-002 The prognostic implication of seasonal and meteorological parameters on malignant events in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC)

Fa-Po CHUNG (Taiwan)

P1-003 Permanent pacemaker and implantable cardioverter-defibrillator implantation worsens tricuspid regurgitation and may be associated with more heart failure admissions

Michael-Joseph AGBAYANI (Singapore)

P1-004 The impact of pharmacological activation of small-conductance calcium-activated potassium channels with SKA-31 on atrial fibrillation

Shu-Hsuan CHANG (Taiwan)

P1-005 PR prolongation strongly predicts new-onset myocardial infarction, ischemic stroke, heart failure and cardiovascular death in coronary patients or risk equivalent: a 5-year clinical-pathophysiological study

Yap-Hang CHAN (Hong Kong)

P1-006 Effect of renal sympathetic denervation on the inducibility of atrial fibrillation and atrial remodeling in ambulatory canines with prolonged atrial pacing

Xule WANG (China)

24

TH

UR

SD

AY


Hall 5G, Room A

[015] Atrial Fibrillation (Drug) 1 - Practical Aspects on Stroke Prevention in Atrial Fibrillation - What to Do?10:40 – 12:20 Chairs: Rungroj Krittayaphong (Thailand) Ton-That Minh (Vietnam) Marcellus Francis Ramirez (Philippines)

10:40 My Patient Gets a Thromboembolic Event Despite Well Controlled Warfarin

Tatjana Potpara (Serbia)

11:00 My Patient with AF Presents with An Acute Coronary Syndrome and Needs a Stent

Razali Omar (Malaysia)

11:20 My Patient with New-Onset AF and CHA2DS2-VASc

Eric Prystowsky (USA)

11:40 My Patient With AF Has a Previous History of Intracranial Bleeding 5 Years Ago


12:00 My Patient on Oral Anticoagulation Needs an Ablation

Jeff Healey (Canada)

Hall 5G, Room B

[016] Heart Failure & Remote Patient Monitoring 1 - Neuromodulation & Cardiac Arrhythmia10:40 – 12:20 Chair: Arun Chopra (India)

10:40 Vagal Stimulation in Man: Evidence in Heart Failure and Rationale to Prevent Lethal Arrhythmias

Peter J. Schwartz (Italy)

11:00 Renal Denervation to Prevent AF Jonathan S. Steinberg (USA)

11:20 Spinal Cord Stimulation for Heart Failure Hung-Fat Tse (Hong Kong)

11:40 Cardiac Contractility Modulation for Heart Failure

Herwig Schmidinger (Austria)

12:00 Neural Innervation of Cardiovascular System: Implications for Therapy

Sunny Po (USA)

24 25

TH

UR

SD

AY


Hall 5G, Room C

[017] VT Ablation 1 - Non-infundibular Outflow Tract VT Ablation: Right and Left10:40 – 12:20 Chairs: Bo-Young Joung (Korea)

10:40 Idiopathic Ventricular Arrhythmias Arising From the Pulmonary Artery: Mapping and Ablation

Ke-Jiang Cao (China)

11:00 Safe and Successful Ablation of Parahisian Idiopathic Ventricular Arrhythmias

Akihiko Nogami (Japan)

11:20 Idiopathic Ventricular Arrhythmias Arising from the Aortic Sinuses of Valsalva: Tips and Tricks

Koji Kumagai (Japan)

11:40 Outflow Tract Ventricular Arrhythmia Ablation via the Coronary Venous System: Electrical and Plumbing Challenges

Haris Haqqani (Australia)

12:00 Epicardial Outflow Tract Arrhythmias: Percutaneous Epicardial Mapping/Ablation and Alternative Routes/Strategies

Francis E. Marchlinski (USA)

26

TH

UR

SD

AY


Room S421

[018] Pediatric Workshop 2 - Management of Pediatric Arrhythmias II10:40 – 12:20 Chairs: Pi-Chang Lee (Taiwan) Maurice Leung (Hong Kong) Mohit Singla (India)

10:40 Ventricular Tachycardia in Children with Structurally Normal Hearts: Role of Ablation

Thomas Kriebel (Germany)

11:00 Management of Junctional Ectopic Tachycardia before and during TCPC Procedure in Asplenic Heart

Shigeru Tateno (Japan)

11:20 Radiofrequency Ablation in a Patient with WPW Syndrome with Congenital Corrected Transposition of Great Artery

Shuenn-Nan Chiu (Taiwan)

11:40 Electrical Storm in Pediatric Patients Andrew Davis (Australia)

12:00 CRT in Patients with Congenital Heart Disease Cesar Khazen (Austria)

Room S423

[019] Pacing Workshop 1 - The CIED Lead: Principles, Progress and Promises10:40 – 12:20 Chair: Piya Kasemsuwan (Thailand)

10:40 The Early Pacemaker Lead: Memories from a Bygone Era

Harry Mond (Australia)

11:00 How to Make the Pacing Lead Safe for MRI Wee-Siong Teo (Singapore)

11:20 The Electrode Tissue Interface: The Value of Steroid Elution

Toshiyuki Ishikawa (Japan)

11:40 Pacemaker Lead Fixation: Active or Passive Giselle Gervacio (Philippines)

12:00 Controversies in Choice of High Voltage Lead Implantation - Small versus Large Diameter Leads

Edmund Keung (USA)

26 27

TH

UR

SD

AY


Room S424

[020] CSPE Basic Research 1 - Female and Cardiac Arrhythmia10:40 – 12:20 Chairs: Ke-Ping Chen (China) Bing Liu (China) Xiu-Fen Qu (China)

10:40 Gender Differences in Cardiac Arrhythmias An-Li Tang (China)

11:00 Gender Differences in Device Therapy Ke-Ping Chen (China)

11:20 Effect of Sex on Iron Channels Kui Hong (China)

11:40 Pregnancy and Cardiac Arrhythmias Jing Xu (China)

12:00 Management of Anxiety or Depression in Female Patients of Arrhythmias

Xiao-Lin Xue (China)

Room S425

[021] Atrial Fibrillation (Ablation) Debate10:40 – 12:20 Chair: Ulhas M. Pandurangi (India)

10:40 RF Ablation is Safer and More Effective that Cryoballoon Ablation for Treatment of Paroxysmal AF

Pro: Robert Lemery (Canada) Con: Douglas Packer (USA)

11:13 The Left Atrial Appendage Should Never Be Isolated

Pro: Karl-Heinz Kuck (Germany) Con: Andrea Natale (USA)

11:46 Catheter Ablation of Atrial Fibrillation Should Be Recommended as a First Line Treatment Strategy Prior to Antiarrhythmic Drug Therapy for Patients with Paroxysmal Atrial Fibrillation

Pro: Hugh Calkins (USA) Con: John Camm (USA)

28

TH

UR

SD

AY


Room S426

[022] Atrial Fibrillation (Ablation) Workshop 1 - Long Term Follow-up10:40 – 12:20 Chairs: Christian de Chillou (France) Lousia Poon (Hong Kong)

10:40 Long Term Follow-up of Non Paroxysmal AF Jonathan Kalman (Australia)

11:00 Ablation of AF without PV Isolation. What is the Long Term Follow-up?

Xue Zhao (China)

11:20 What to Do if PVs are Isolated at Redo Procedures?

Toshiya Kurotobi (Japan)

11:40 Termination of AF during Ablation of Long Standing Persistent AF. Should it be the End Point?

Hui-Nam Pak (Korea)

12:00 Long Term Follow-up of Paroxysmal AF Shih-Ann Chen (Taiwan)

Room S427

[023] Basic Research 2 - Hot Topic on Basic Research in AF10:40 – 12:20 Chairs: Ji-Yun Wang (China) Dong-Gu Shin (Korea)

10:40 Tachycardia of Atrial Myocytes Induces Collagen Expression in Atrial Fibroblasts through TGF B1

Chia-Ti Tsai (Taiwan)

11:00 Calcium Handling and Atrial Fibrillation Dobromir Dobrev (Germany)

11:20 Micro-RNA and Atrial Fibrillation Andreas Goette (Germany)

11:40 Inflammation, Fibrosis and Atrial Fibrillation Mohammad Shenasa (USA)

12:00 Nervous System and Atrial Fibrillation Shien-Fong Lin (USA)

28 29

TH

UR

SD

AY


Room S429

[024] Oral Abstract Session10:40 – 12:20 Oral Presentation - CRT 2 Chairs: Kwok-Lap Chan (Hong Kong) Michael PH Chan (Hong Kong) Kin-Keung Tsang (Hong Kong)

10:40 OP 03-1 Influence of intra-atrial block on the effect of cardiac resynchronization therapy

Qi SUN (China)

10:56 OP 03-2 Effects of atrioventricular conduction delay on the outcome of cardiac resynchronization therapy

Ying-Hsiang LEE (Taiwan)

11:12 OP 03-3 Cardiac resynchronization therapy (CRT) response and clinical outcomes in NYHA class IV patients: a real world experience

Avinash VERMA (India)

11:28 OP 03-4 Effect of cardiac resynchronization therapy in heart failure patients with right branch bundle block after ultrasound assessment by tissue doppler imaging

Yi FU (China)

11:44 OP 03-5 Characterization of mechanical and electrical activation patterns in patients with systolic dysfunction evaluated using a novel non-fluoroscopic 4D navigation system

Gerhard HINDRICKS (USA)

12:00 OP 03-6 Comparison between CRT-D and CRT-P of the elderly patients in saitama medical school international medical center

Yoshifumi IKEDA (Japan)

30

TH

UR

SD

AY


Room S430

[025] Oral Abstract Session10:40 – 12:20 Oral Presentation - Atrial Fibrillation

(Ablation) 1 Chairs: Tsan-Fai Chan (Hong Kong) On-Hing Kwok (Hong Kong) Chi-Wing Lo (Hong Kong)

10:40 OP 04-1 Ganglionated plexi ablation directed by high-frequency stimulation and complex fractionated atrial electrograms for paroxysmal atrial fibrillation

Artem STRELNIKOV (Russia)

10:56 OP 04-2 Ganglionated plexi ablation combined with pulmonary vein isolation improves outcome of catheter ablation in patients with longstanding persistent atrial fibrillation: a prospective randomized comparison

Sevda BAYRAMOVA (Russia)

11:12 OP 04-3 Fractionated atrial potential at anatomical ganglionated plexi sites in atrial fibrillation – investigation by electrical anatomical mapping system

Daisuke ISHIGAKI (Japan)

11:28 OP 04-4 Surgical ablation by unilateral approach (left chest) for lone atrial fibrillation: a single center experience in 100 consecutive patients

Ju MEI (China)

11:44 OP 04-5 Efficacy of catheter ablation of atrial fibrillation using robotic navigation

Fahd CHAHADI (Australia)

12:00 OP 04-6 Surrogates markers have limited ability for predicting pre-ablation contact force and lesion efficacy during catheter ablation of atrial arrhythmias in humans

Saurabh KUMAR (Australia)

30 31

TH

UR

SD

AY


Room S221

[026] Certificate CRM Course - EP Studies: Anatomy, EGM Interpretation, Stimulation Protocols*For CRM Course Registrants

10:40 – 12:20 Chairs: Steve Lai (Hong Kong) Craig Swygman (USA)

10:40 Cardiac Anatomy and Fluoroscopic Imaging in EP

Craig Swygman (USA)

11:05 Fundamentals of EGM Interpretation and Rhythm Analysis

Chang-Hee Lee (Korea)

11:30 Basic Stimulation Protocols and Electrophysiologic Evaluation

Ricardo Bernardo (Portugal)

11:55 Principles of Entrainment Hans Henrik Odland (Norway)

32

TH

UR

SD

AY


Room S226

[027] Joint Session with EHRA - New Strategies for AF Catheter Ablation: Moving Towards Personalized Ablation?10:40 – 12:20 Chair: Cathy Lam (Hong Kong)

10:40 Individualized Ablation versus Standard Lesion Deployment: What´s the Future?

Shih-Ann Chen (Taiwan)

11:00 What´s the Substrate of AF and What are the Drivers?

Hans Kottkamp (Switzerland)

11:20 Mapping of AF and Detection of Ablation Targets I: Insights from Intraoperative Mapping

Jonathan Kalman (Australia)

11:40 Mapping of AF and Detection of Ablation Targets II: Insights from Catheter-Based Mapping

Feifan Ouyang (Germany)

12:00 Mapping of AF and Detection of Ablation Targets III: Insights from Body Surface Mapping

Yoshito Iesaka (Japan)

32 33

TH

UR

SD

AY


Hall 5G, Level 5

Poster Session 108:30 – 12:20 Poster Display - Atrial Fibrillation (Ablation) I

*Presenters will standby from 10:10 – 10:40 to answer questions.

P1-007 Benefit of ablation of first diagnosed atrial fibrillation in patients submitted to coronary artery bypass grafting

Artem STRELNIKOV (Russia)

P1-008 Does AF burden measured by implantable loop recorder during post-ablation blanking period predict response at 12 month follow-up?

Denis LOSIK (Russia)

P1-009 Ablation of paroxysmal and persistent atrial fibrillation: long-term recurrence rates via continuous subcutaneous monitoring

Sevda BAYRAMOVA (Russia)

P1-010 Clinical implications of and factors influencing spontaneous activities in dissociated pulmonary veins

Songwen CHEN (China)

P1-011 Echocardiographic and ECG can predict of arrhythmia recurrence after RFA of AFib

Evgeny ZHELYAKOV (Russia)

P1-012 Fibrillatory pattern of dissociated pulmonary vein activity following pulmonary vein isolation is the property of the triggering ectopy for atrial fibrillation

Masato OKADA (Japan)

P1-013 Adenosine facilitates dormant conduction across left atrial lines in patients with atrial fibrillation who underwent catheter ablation

Yoshiyuki HAMA (Japan)

P1-014 Experience using contact force sensing catheter in atrial fibrillation ablation

Daisuke SATO (Japan)

P1-015 Effect of the administration of adenosine directly into the left atrium to provoke dormant conduction after pulmonary vein isolation

Hanako YAMANOUCHI (Japan)

34

TH

UR

SD

AY


P1-016 Crocodile clips and a non-sterile ablation catheter to deliver radiofrequency energy through a brockenbrough needle: a simple, low cost method to facilitate difficult transseptal puncture

Guy FURNISS (New Zealand)

P1-017 Distribution of left atrium degeneration evaluated by integrated backscatter values: a difference with the distribution of complex fractionated electrograms

Tomoki KUBOTA (Japan)

P1-018 Disease duration of paroxysmal atrial fibrillation as a predictive factor for a successful primary catheter ablation

Takehiro KIMURA (Japan)

P1-019 Characteristics of recurrence in paroxysmal and persistent atrial fibrillation after primary catheter ablation

Takehiro KIMURA (Japan)

P1-020 Effect of single bolus injection of low- and moderate-dose steroid for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation

Darae KIM (Korea)

P1-021 Efficacy of repeat circumferential pulmonary vein isolation without empiric linear ablation in patients with recurrent atrial fibrillation

Koichiro EJIMA (Japan)

P1-023 Clinical efficacy of epicardial adipose tissue based linear left atrial ablation of persistent AF

Shiro NAKAHARA (Japan)

P1-024 Analysis of the incidence and arrhythmogenicity of recurrent conduction in pulmonary vein isolation and linear ablations in 84 consecutive patients underwent re-do ablation for atrial fibrillation

Nobuhiro NISHIYAMA (Japan)

P1-025 Exercise tolerance can improve with sinus rhythm restoration by the catheter ablation for persistent atrial fibrillation

Yoshinori KATSUMATA (Japan)

P1-026 A novel method of evaluating the role of pulmonary veins in maintaining persistent atrial fibrillation: adenosine triphosphate test

Liang SHI (China)

34 35

TH

UR

SD

AY


P1-027 Catheter ablation of atrial arrhythmias in patients with prior maze operation

Jin Hee CHOI (Korea)

P1-028 Atrial fibrillation ablation – partial success is a failure

David O'DONNELL (Australia)

P1-029 Assessment of clinical factors associated with a successful catheter ablation outcome in younger patients with atrial fibrillation

Tadashi FUJINO (Japan)

P1-030 Elevated atrial TGF-ß1 in obesity predicts atrial structural and electrophysiological remodeling in an obese ovine model

Rajiv MAHAJAN (Australia)

P1-031 Comparison of a irrigated porous flexible catheter tip design with a conventional tip design at atrial fibrillation ablation – a prospective randomized trial

Thomas GASPAR (Germany)

P1-032 Additional linear ablation after circumferential pulmonary vein isolation does not reduce clinical recurrence in patients with paroxysmal atrial fibrillation: prospective randomized study

Tae-Hoon KIM (Korea)

P1-033 Distance between the his bundle and the non-coronary aortic cusp

Tatsuya HAYASHI (Japan)

P1-034 Clinical outcome of catheter ablation of atrial fibrillation in patients with structural heart disease: a single centre study

Lily CHEUNG (Hong Kong)

P1-035 Detecting ablation transmurality by using mini electrodes placed within an ablation catheter

Li-Wei LO (Taiwan)

P1-036 Direct access to expert health allied professionals reduces re-hospitalization after c atheter ablation for atrial fibrillation

Luigi DI BIASE (USA)

P1-037 De novo non-pulmonary vein foci are the major cause of atrial fibrillation recurrence following multiple catheter ablation procedures

Keiichi INADA (Japan)

36

TH

UR

SD

AY


P1-038 Evaluation of left atrial appendage flow velocity during intracardiac echocardiography during atrial fibrillation ablation

Kohei INAGAWA (Japan)

P1-039 Characterization of symptoms and quality of life in patients with recurrent atrial arrhythmia following catheter ablation

Chrishan NALLIAH (Australia)

P1-040 Echocardiographic new predictor of successful clinical outcome and time-course of left atrial structure and function after atrial fibrillation ablation assessed by speckle tracking echocardiography

Shunichiro WARITA (Japan)

P1-041 Additional linear ablation on superior vena cava to right atrial septum after circumferential pulmonary vein isolation improves clinical outcome in patients with paroxysmal atrial fibrillation: prospective randomized study

Ki-Woon KANG (Korea)

P1-042 Atrial septal thickness influences right pulmonary vein isolation and a right septum approach can successfully overcome right pulmonary vein isolation

Mizutani YOSHIAKI (Japan)

P1-043 Dose digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation?

Tze-Fan CHAO (Taiwan)

P1-044 A functional variant in the KCNN3 gene predicts isoproterenol inducible triggers from pulmonary vein in patients with paroxysmal atrial fibrillation

Fuchun CHIU (Taiwan)

P1-045 Characteristics of dormant pulmonary vein conduction induced by adenosine after circumferential pulmonary vein isolation and subsequent reconnection

Ken KATO (Japan)

P1-046 Acute complications related to remote controlled magnetic navigation for arrhythmia ablation: a single centre experience

Paul Chun Yih LIM (Singapore)

36 37

TH

UR

SD

AY


P1-047 CFAE vs. PVI ablation for Long-Lasting Persistent Atrial Fibrillation Results from Chronic Period

Taku ASANO (Japan)

P1-048 Comparison of long-term effect of linear ablation versus complex fractionated atrial electrograms guided left atrial ablation in patients with atrial fibrillation

Ji-Eun BAN (Korea)

P1-049 Catheter ablation of atrial fibrillation in patients with autoimmune rheumatic diseases

Songnan WEN (China)

P1-050 Early recurrence may associate with late recurrence of atrial tachyarrhythmias after catheter ablation of atrial fibrillation

Yoko ITO (Japan)

P1-051 Comparison of ablation-parameters between 6 and 56 holes irrigation catheters

Ritsushi KATO (Japan)

P1-052 A sedative drug can change the position of the heart: a pitfall of the “CARTOMERGE ”procedure

Satoru SAKAGAMI (Japan)

P1-053 Effect of anterior wall ablation on left atrium and left atrial appendage function assessed by LA angiogram immediate after right ventricular pacing

Hwan-Cheol PARK (Korea)

P1-054 Adenosine-5'-triphosphate (ATP) induced atrial fibrillation cases

Hwna-Cheol PARK (Korea)

P1-055 Electrocardiographic P wave characteristics reflecting the degree of electroanatomical remodeling of left atrium in patients with atrial fibrillation

Jin-Kyu PARK (Korea)

P1-056 Apical type hypertrophic cardiomyopathy is associated with favorable outcome after catheter ablation for atrial fibrillation

Yae Min PARK (Korea)

P1-057 Catheter ablation for persistent atrial fibrillation patients with mitral valve disease

Hailong TAO (China)

38

TH

UR

SD

AY


P1-058 Catheter ablation of atrial fibrillation: conventional manual ablation vs initial experience with remote magnetic navigation and ablation

Edward LEE (Singapore)

P1-059 Electrophysiologic characteristics and results of radiofrequency catheter ablation in patients with previous maze procedure

Ki Won HWANG (Korea)

P1-060 Effects of gender differences in catheter ablation for atrial fibrillation

Grace NAM (USA)

P1-061 Catheter ablation for the atrial fibrillation patients with common trunk of pulmonary vein

Kenichi TOKUTAKE (Japan)

08:30 - 12:20 Poster Display - Heart Failure & Remote Patient Monitoring


P1-062 Long-term results after cardiac resynchronization therapy with or without surgical revascularization in patients with ischemic heart failure and left ventricle dyssynchrony


P1-063 Effect of milrinone on short term outcome of patients with myocardial dysfunction undergoing off-pump coronary artery bypass graft: a randomized clinical trial

Seyed Mohammad Yousof MOSTAFAV I POUR MANSHADI (Iran)

P1-064 Electromechanical interplay in diabetic cardiomyopathy: relationship between diastolic dysfunction and T-wave alternans

Kai Hang YIU (Hong Kong)

P1-065 Predictive value of plasma NT-proBNP to long-term response to cardiac resynchronization therapy

Xinwei YANG (China)

P1-066 Myocardial gap junction remodeling and sodium channel dysfunction in alcoholic cardiomyopathy: mechanistic insights into the cardiac electrical conduction disturbances

Yu-Jun LAI (Taiwan)

38 39

TH

UR

SD

AY


P1-067 Long term performance of active fixation leads in the coronary sinus for left ventricular pacing : a three year follow-up

Ahmad Fazli ABDUL AZIZ (Malaysia)

P1-068 Robust automated assessment of myocardial iron loading

Defeng WANG (Hong Kong)

P1-069 Acute beta-adrenoceptor blockade fails to bring down repolarization instability in patients with ischemic cardiomyopathy prone to ventricular tachycardia

Sachin NAYYAR (Australia)

P1-070 Ethnic disparities in hospitalized patients with chronic heart failure in Xinjiang, China

Hua JIANG (China)

P1-071 The evaluation of efficacy to use quadripolar left ventricular lead compared with existed bipolar lead in CRT-D patients

Taishi HIRAHARA (Japan)

P1-072 Automatic detection and analyses of uneven membrane electrical activity for high incidence localization on the murine heart by using optical mapping

Yu-Jun LAI (Taiwan)

P1-073 The effectiveness of OptiVol monitoring as a predictor of heart failure hospitalization

Kei MABUCHI (Japan)

P1-074 RV lead migration in CRT-P device, turning complication in to opportunity- a case report

Sanjib PATRA (India)

P1-075 Effects of cardiac resynchronization therapy on MTWA

Zhen CHEN (China)

P1-076 The clinical characteristics and predictors of delayed responders to cardiac resynchronization therapy

Xiaofeng HOU (China)

P1-077 Evaluation of cardiac synchronization in CRT super-responders

Xiaofeng HOU (China)

P1-078 Remote PHM cloud cluster for heart failure prognosis and drug therapy optimization

Sergey KIRILLOV (Russia)

40

TH

UR

SD

AY


P1-079 Novel non-invasive mapping reveals variable electrical synchrony during multipolar pacing - potential new tool for vector optimization

Johannes SPERZEL (Germany)

P1-080 Antidromic snare technique for when the LV lead cannot be advanced in the target vein: results, safety and feasibility in 13 patients

Seth WORLEY (USA)

P1-081 Carelink: to evaluate the amount of time a patient saves by using a remote monitoring as compared to an in-office check

Su Yi HO (Singapore)

P1-082 Does remote monitoring reduce actionable implantable device checks compared to in-office evaluation?

Hui Min CHONG (Singapore)

P1-083 Nonpharmacological treatments compliance among heart failure patients

Sui-Yu YAU (Hong Kong)

P1-084 A pilot study for new wireless smartphone-based ECG recording for detecting arrhythmias

Yen-Chang HUANG (Taiwan)

P1-085 Multipoint left ventricular pacing provides similar acute hemodynamic improvement in both ischemic and non-ischemic cardiac resynchronization therapy patients

Luke MCSPADDEN (USA)

P1-086 Improvement in 3-month echocardiographic and clinical response to cardiac resynchronization therapy with multipoint left ventricular pacing in a single coronary sinus branch

Luke MCSPADDEN (USA)

P1-087 Rapid increasing of left ventricular lead impedance immediately after CRT-D implantation: report of a case

Susumu NAKAMOTO (Japan)

P1-088 Review of remote device transmission report is less time consuming than in-office device check


40 41

TH

UR

SD

AY


P1-089 The electrocardiogram predicts super-responders in patients receiving cardiac resynchronization therapy

Miwa KIKUCHI (Japan)

P1-090 Electrocardiographic parameters associated with mortality in patients with heart failure with preserved left ventricular ejection fraction

Chee Yang CHIN (Singapore)

P1-091 Effects of ventricular conduction block patterns and pulmonary hypertension on mortality in hospitalized patients with dilated cardiomyopathy

Xiaoping LI (China)

P1-092 SCN5A mutations associated with dilated cardiomyopathy

Mamoru HAYANO (Japan)

P1-093 Diastolic LV dysfunction with left atrial dilatation: is there further value of multiple doppler indices for complete evaluation of LV dysfunction?

Marleen IRWIN (Canada)

P1-094 LV dysfunction responders: is there value in endothelium-independent dilation using peripheral arterial tonometry for evaluation of LV dysfunction?

Marleen IRWIN (Canada)

P1-095 Winding without twiddling of the left ventricular lead in a patient of biventricular pacemaker

Manoj KUMAR (India)

P1-096 The long-term prognosis of different Left ventricular lead location with cardiac resynchronization therapy in patients with chronic heart failure

Yaodong LI (China)

P1-097 Cardiac resynchronisation therapy (CRT) for the treatment of heart failure: our experience in a UK tertiary centre

Deacon Zhao Jun LEE (UK)

P1-098 Implications for cardiac resynchronization therapy; an ECG algorithm to predict the latest site of left ventricular activation in cardiomyopathy patients with left bundle branch block

Ben PANG (Australia)

42

TH

UR

SD

AY


P1-099 Improvement of left ventricular mechanical function by delivering electrical cardiac contractility modulation via the CRT lead configuration

Farong SHEN (China)

P1-100 Predicting score system for mid-term responder of cardiac resynchronization therapy in patients severe heart failure

Fang FANG (Hong Kong)

P1-101 EXTRACT: medtronic carelink express - reducing patient transfer across the state

James MARANGOU (Australia)

P1-102 The efficacy of cardiac resynchronization therapy on patients over 80 years-old

Noriko MATSUSHITA (Japan)

P1-103 Predictive Factors and Clinical Effect of Optimized Cardiac Resynchronization Therapy

Guo-Jun XU (China)

P1-104 Combination of low EF and long QRS but not EF nor long QRS alone as predictor of pure prognosis in CHF patients

Yura MAREEV (Russia)

P1-105 Heart failure monitoring using remote monitoring system

Maki ONO (Japan)

P1-106 Patients with systolic heart failure and permanent atrial fibrillation with heart rate more than 70 bpm at discharge from hospital have better long-term survival then patients with slower heart rate


P1-107 The achievement of 60-80% max heart rate in activity trend is correlated inversely with NYHA class and BNP in patients with implanted cardiac resynchronization therapy device.

Yusuke TOKUDA (Japan)

P1-108 Catheter-based renal denervation improves cardiac function in porcine model of ischemic heart failure

Yuan LIU (Hong Kong)

P1-109 Improved response to cardiac resynchronization therapy utilizing more basal pacing with quadripolar left ventricular lead

L. Bing LIEM (USA)

42 43

TH

UR

SD

AY


P1-110 Hydralazine inhibits ventricular tachyarrhythmias in an acquired long QT rabbit model

Kenta TSUTSUI (Japan)

P1-111 Does atrial fibrillation impact long-term outcomes in patients hospitalized with heart failure?

Ahmad HERSI (Saudi Arabia)

Hall 5G, Level 508:30 – 12:20 Poster Display - Late Technology Innovation


P1-112 Relation between the uenous ostium imdex(VOI) of the pulmonary vein and recurrences of atrial fibrillation after catheter ablation

Cheng HUI (China)

P1-113 Relationship between right ventricular systolic pressure (RVSP) and repeated atrial fibrillation ablation

Nongnooch POOWANAWITTAYAKOM (USA)

P1-114 Clinical outcomes of arrhythomgenic right ventricular dysplasia/cardiomyopathy patients in taiwan - a large cohort observational study

Yun-Yu CHEN (Taiwan)

P1-115 Contact force and voltage thresholds during high frequency stimulation mapping of human cardiac ganglionnated plexuses

Robert LEMERY (Canada)

44

TH

UR

SD

AY


Hall 5G, Room A

[028] Medtronic Luncheon Symposium - Advances in Post-Implant Patient Management12:20 – 13:50 Chairs: Anoop Kumar Gupta (India) Hiroshi Tada (Japan)

12:20 Staying Connected to Your Patients David Hayes (USA)

12:50 Programming CRT to Maximize Pacing Kathy Lee (Hong Kong)

13:20 The Need for MRI Safe Devices Massimo Santini (Italy)

Hall 5G, Room B

[029] Biosense Webster Luncheon Symposium - Smart Touch12:20 – 13:50 Chairs: Kyoko Soejima (Japan) Shu Zhang (China)

12:20 The Importance of Contact Pressure Andrea Natale (USA)

13:10 Clinical Use of Contact Force: Hamburg Experience

Feifan Ouyang (Germany)

44 45

TH

UR

SD

AY


Hall 5G, Room C

[030] St. Jude Medical Luncheon Symposium - Heart Failure Management12:20 – 13:50 Chairs: Morio Shoda (Japan) Bruce Wilkoff (USA)

12:20 New Technologies to Improve CRT Outcomes Karlheinz Seidl (Germany)

12:50 CRT MultiPoint Pacing - Managing the Non-Responder?

Luca Santini (Italy)

13:20 Remote Disease Management for the Heart Failure Patient

Katherine Fan (Hong Kong)

Hall 5G, Room A

[031] Atrial Fibrillation (Ablation) 2 - Ablation Strategies13:50 – 15:30 Chairs: Mauricio Abello (Argentina) Kuan-Cheng Chang (Taiwan) Dong-Gu Shin (Korea)

13:50 Pulmonary Vein Isolation Alone Versus Expanded Ablation

David Burkhardt (USA)

14:10 Fractionated Electrogram Ablation Shih-Ann Chen (Taiwan)

14:30 Linear Ablation Yoshito Iesaka (Japan)

14:50 FIRM Ablation Sanjiv Narayan (USA)

15:10 Hybrid Procedures Chang-Sheng Ma (China)

46

TH

UR

SD

AY


Hall 5G, Room B

[032] Syncope 1 - Management of Syncope13:50 – 15:30 Chairs: Marcellus Francis Ramirez (Philippines) Xiu-Fen Qu (China)

13:50 Pediatric Syncope: When to Worry? Andrew Davis (Australia)

14:10 What is the Evidence that Drugs May Be Effective for Prevention of Vasovagal Syncope?

Andy WK Chan (Hong Kong)

14:30 Can We Reliably Distinguish Seizures from Syncope in the Evaluation of the “Collapse” Patient?

Haruhiko Abe (Japan)

14:50 Syncope Management Units: Do They Improve Outcomes and How Should They be Organized?

Michele Brignole (Italy)

15:10 New Insights Into the Role of Cardiac Pacing in Vasovagal Syncope and Is There a Best Pacing Method?

Richard Sutton (Monaco)

Hall 5G, Room C

[033] Sudden Cardiac Death 1 - Reduction of SCD with Device Therapy13:50 – 15:30 Chair: Chee-Wan Lee (Singapore)

13:50 Subcutaneous ICD Gust Bardy (USA)

14:10 CRT-D in NYHA Class I and II David Cannom (USA)

14:30 CRT-D in NYHA Class III and Ambulatory IV Wanwarang Wongcharoen (Thailand)

14:50 Improved ICD Programming Peter Larsen (New Zealand)

15:10 Wearable Defibrillator Morio Shoda (Japan)

46 47

TH

UR

SD

AY


Room S421

[034] Biosense Webster Live Transmission13:50 – 15:30 VT Ablation with Carto 3 System and PaSo

Module

Chairs: Ming-Hsiung Hsieh (Taiwan) Kyoko Soejima (Japan) Chu-Pak Lau (Hong Kong) Panelists: Andrea Natale (USA) Feifan Ouyang (Germany)

Room S423

[035] ICD Workshop 1 - New Trends in ICD Management13:50 – 15:30 Chair: Kam-Sang Woo (Hong Kong)

13:50 The Subcutaneous Defibrillator Bradley Knight (USA)

14:10 Trends in ICD Programming or “Minimizing Inappropriate Shocks”

David Hayes (USA)

14:30 High DFT Prediction and Management Peter Lercher (Austria)

14:50 ICD Lead Extraction Bruce Wilkoff (USA)

15:10 VT Storm Spencer Heald (New Zealand)

48

TH

UR

SD

AY


Room S424

[036] VT Workshop 1 - Hot Topics on Ventricular Arrhythmia13:50 – 15:30 Chairs: Bernard Abi-Saleh (Lebanon) Tak-Sun Tse (Hong Kong)

13:50 Genetic Testing for Inherited Cardiac Disease Arthur Wilde (The Netherlands)

14:10 Novel ECG Based Risk Stratification of VT & SCD

André Ng (UK)

14:30 Mechanisms of Ventricular Arrhythmias and Autonomic Modulation

Kalyanam Shivkumar (USA)

14:50 New Technology for VT Mapping Edward P. Gerstenfeld (USA)

15:10 Low Energy Defibrillation for VT/VF Jian Huang (USA)

Room S425

[037] CRT Debate13:50 – 15:30 Chair: Katherine Fan (Hong Kong)

13:50 Implantation of CRT in a Patient with Complete AV-Block?

Pro: Cheuk-man Yu (Hong Kong) Con: Anne Gillis (Canada)

14:40 CRT-P is the Right Device for a 75 Years Old Female Presenting with Idiopathic Dilated Cardiomyopathy and QRS >160 ms.

Pro: Seth Worley (USA) Con: Bradley Knight (USA)

48 49

TH

UR

SD

AY


Room S426

[038] Arrhythmias in Pediatric and Adult Congenital Heart Disease13:50 – 15:30 Chairs: Aldophus KT Chau (Hong Kong) Shigeru Tateno (Japan)

13:50 ICDs in Adult Congenital Heart Disease: Who When and How?

Tak-Cheung Yung (Hong Kong)

14:15 Catheter Ablation of "No Entry Heart" in Congenital Heart Disease

Morio Shoda (Japan)

14:40 Atypical Device Configurations in Congenital Heart Disease: Epicardial and Endocardial Systems

Sabrina Tsao (USA)

15:05 Radiofrequency Catheter Ablation of Supraventricular Tachyarrhythmia in Children with Congenital Heart Disease

Shuenn-Nan Chiu (Taiwan)

Room S427

[039] Basic Research 3 - New Insights into the Mechanism of AF I13:50 – 15:30 Chair: Rungroj Krittayaphong (Thailand)

13:50 Latest Insight on the Mechanism of AF: Implication on Management

Eric Prystowsky (USA)

14:10 Systems Biology of Atrial Fibrillation Andrew Grace (UK)

14:30 Therapeutic Potential of Ryanodine Receptor Channels in Atrial Arrhythmias

Haruo Honjo (Japan)

14:50 Roles of Potassium Channels in Atrial Fibrillation

Tae-Joon Cha (Korea)

15:10 Neural Mechanism of Atrial Fibrillation Peng-Sheng Chen (USA)

50

TH

UR

SD

AY


Room S429

[040] Oral Abstract Session13:50 – 15:30 Oral Presentation - CRT 3 Chairs: Arun Chopra (India) Alex SK Kwong (Hong Kong) Edward SL Lo (Hong Kong)

13:50 OP 05-1 Simple protocol of follow-up patients on CRT and its results


14:06 OP 05-2 A cost analysis of cardiac resynchronization therapy in patients with atrioventricular nodal disease and reduced ejection fraction

Bhupesh PATHIK (Australia)

14:22 OP 05-3 Real world assessment of left ventricular lead implant success and complication rates: results from asia-pacific region in the attain success clinical trial

Balbir SINGH (India)

14:38 OP 05-4 Effect of baseline QRS interval on cardiac resynchronization therapy (CRT) response: is wider always better?

Avinash VERMA (India)

14:54 OP 05-5 CIED-infections: is the implantation of CIED in the cath lab safe?

Karlheinz SEIDL (Germany)

15:10 OP 05-6 Risk factor associated device infection, pneumothorax and perforation of heart in 46,506 device implantations: a national population-based study

Tien-Hsing CHEN (Taiwan)

50 51

TH

UR

SD

AY


Room S430


(Ablation) 2 Chairs: Lik-Cheung Cheng (Hong Kong) Jian Jiang (China) Albert WS Leung (Hong Kong)

13:50 OP 06-1 Directed ablation of regions of high shannon entropy as potential marker of AF rotors: initial clinical experience

Anand GANESAN (Australia)

14:06 OP 06-2 Cryoablation of pulmonary veins for paroxysmal atrial fibrillation: comparison of acute and mid-term outcome between first and second generation balloon

Massimo MOLTRASIO (Italy)

14:22 OP 06-3 Contact force values during ablation for pulmonary vein isolation: analysis according to anatomy and operators

Roberto DE PONTI (Italy)

14:38 OP 06-4 Clinical impact of anatomical variation of vein of marshall (VOM) on creating bi-directional conduction block at mitral isthmus after ethanol infusion into VOM

Naohiko KAWAGUCHI (Japan)

14:54 OP 06-5 Marked variation in catheter-tissue contact force during cavotricuspid isthmus ablation using traditional markers of good contact


15:10 OP 06-6 Remote magnetic navigation for mapping and ablation of atrial fibrillation

Wee Siong TEO (Singapore)

52

TH

UR

SD

AY


Room S221

[042] Certificate CRM Course - Basics of Cardiac Pacing*For CRM Course Registrants

13:50 – 15:30 Chairs: Wai-Sum Luk (Hong Kong) Dulce Obias-Manno (USA)

13:50 Electrical Concepts in Pacing: Ohms Law, Threshold, Sensing, Polarity

Susan Song (USA)

14:23 Basics of Pacemaker Timing Cycles: From VVI to DDDR

Christine Chiu-Man (Canada)

14:56 Hemodynamics of Cardiac Pacing Carsten Israel (Germany)

Room S226

[043] Joint Session with ISHNE - Atrial Fibrillation13:50 – 15:30 Chairs: Claudio Hadid (Argentina) Teruhisa Tanabe (Japan)

13:50 AF Clinical Overview Chang-Sheng Ma (China)

14:10 New Oral Anticoagulants Luis Aguinaga (Argentina)

14:30 Antiarrhythmic Drugs Haris Haqqani (Australia)

14:50 Radiofrequency Catheter Ablation of Paroxysmal Atrial Fibrillation

Claudio Hadid (Argentina)

15:10 Antiarrhythmic Drugs or Radiofrequency Ablation

Gustavo Maid (Argentina)

52 53

TH

UR

SD

AY


Hall 5G, Level 5

[044] Poster Session 215:30 – 16:00 Young Investigator Award Judge: Carsten Israel (Germany)

P2-001 Prevalence and significance of early repolarization variant in children with syncope: a case control study

Mohit SINGLA (Canada)

P2-002 Diffuse atrial fibrosis measured by T1 mapping on cardiac MRI predicts success of atrial fibrillation ablation

Alex MCLELLAN (Australia)

P2-003 Pericardial fat volume is an independent predictor for clinical recurrence of atrial fibrillation and obstructive sleep apnea in patients who underwent catheter ablation: over 600 case study

Tae-Hoon KIM (Korea)

P2-004 Correlation between complex fractionated atrial electrograms and underlying dynamic substrate mapping in patients with persistent atrial fibrillation


P2-005 Predictors of difficult cardiac resynchronization therapy implantation

Darragh FLANNERY (Australia)

P2-006 Long QT and Brugada overlap syndrome - dilemma in treatment

Jo Jo Siu-han HAI (Hong Kong)

54

TH

UR

SD

AY


Hall 5G, Room B

[045] Heart Failure & Remote Patient Monitoring 2 - Management of Heart Failure Patients16:00 – 17:40 Chair: Ming-Hsing Hsieh (Taiwan)

16:00 Predicting Factors of LV Dysfunction in Patients with Pacemaker

Seil Oh (Korea)

16:20 MicroRNAs in the Diagnosis and Prognosis of Heart Failure

Hon-Chi Lee (USA)

16:40 Does Remote Monitoring Reduce AF Burden and Stroke Risk in Heart Failure Patients?

Niraj Varma (USA)

17:00 Non-Pharmacological Approaches in Heart Failure Patients with AF

Mohammad Shenasa (USA)

17:20 Fundamental Approach to Arrhythmia Management in Heart Failure

Ruey Sung (Taiwan)

Hall 5G, Room C

[046] SVT Ablation 1 - Challenges in Bypass Tract Ablation16:00 – 17:40 Chairs: Kengo Kusano (Japan) Muhammad Yamin (Indonesia)

16:00 Diagnosis and Ablation of Atriofascicular Bypass Tracts: Tips and Tricks


16:20 Catheter Ablation of Anteroseptal and Midseptal Bypass Tracts: To Burn or to Freeze?

Ngai-Yin Chan (Hong Kong)

16:40 Ablation of Difficult Posteroseptal Bypass Tracts: Ins and Outs

Sunny Po (USA)

17:00 My Most Memorable Bypass Tract Ablation Cases

Henry Hsia (USA)

17:20 Arrhythmic Risk in Asymptomatic WPW George Klein (Canada)

54 55

TH

UR

SD

AY


Room S421

[047] St. Jude Medical Live Transmission16:00 – 18:00 Live Transmission of Persistent AF Ablation &

Renal Denervation Case Review Moderator: Steve Worthley (Australia) Chairs: Joseph YS Chan (Hong Kong) Ming-Hsiung Hsieh (Taiwan) Panelists: Young-Hoon Kim (Korea) Siu-Lung Li (Hong Kong)

16:00 AF Ablation (Transeptal Puncture)

16:15 Renal D Procedure & Presentation

17:00 AF Ablation (Catheter Ablation)

Room S423

[048] Lead Extraction Workshop 1: Making Decisions About Lead Failures & Vascular Occlusions – Use Cases to Illustrate Principles16:00 – 17:40 Chair: Giselle Gervacio (Philippines)

16:00 Vascular Access (Subclavian, Cephalic, Axillary, Iliac, Surgical)

Chi-Keong Ching (Singapore)

16:20 Reflections on Fidelis, Riata, Accufix & Coaxial Polyurethane Leads

Charles Love (USA)

16:40 Balancing Risks, Timing Interventions, When to Wait?

Bruce Wilkoff (USA)

17:00 Management of Venous Occlusion (Acute, Chronic, At Time of Upgrade)

Russell Denman (Australia)

17:20 Cardiac Venous Lead Problems & Solutions Robert Giles (Australia)

56

TH

UR

SD

AY


Room S424

[049] VT Workshop 2 - ARVC Session16:00 – 17:40 Chair: Jason KC Ko (Hong Kong)

16:00 Catheter Ablation of Arrhythmias by Magnetic Navigation System in China

Ke-Jiang Cao (China)

16:20 Genetic and Molecular Basis of ARVC Minoru Horie (Japan)

16:40 Updated Criteria for ARVC Diagnosis Hugh Calkins (USA)

17:00 Current Therapies for ARVC Kyoung-Min Park (Korea)

17:20 Catheter Ablation of ARVC: Updated Results Yan Yao (China)

Room S425

[050] Atrial Fibrillation (Ablation) Workshop 2 - Technologies and Tools for AF Ablation; Where DO We Stand in 201316:00 – 17:40 Chair: Jacob Benjamin (India) Young-Keun On (Korea)

16:00 Point by Point RF Ablation with Irrigated Ablation Catheters

Wing-Hong Fung (Hong Kong)

16:20 Contact Sensing RF Ablation Catheters Gerhard Hindricks (Germany)

16:40 Balloon Based Ablation Systems Wyn Davies (UK)

17:00 Future Perspectives Andrea Natale (USA)

17:20 Remote Controlled Ablation Systems Chi-Keong Ching (Singapore)

56 57

TH

UR

SD

AY


Room S426

[051] Atrial Fibrillation (Device) 1: Monitoring AF by Implantable Devices – Why and How?16:00 – 17:40 Chairs: Man-Chun Choi (Hong Kong) Piya Kasemsuwan (Thailand)

16:00 Ongoing and Future Trials on AF Monitoring by Implantable Devices


16:20 AF Monitoring after Pulmonary Vein Isolation: Why, How, and Which Study Results?

Shashidhar (India)

16:40 AF Monitoring for Stroke Prevention: Who, How, and Which Study Results?

Chu-Pak Lau (Hong Kong)

17:00 Remote AF Monitoring: Implications for Oral Anticoagulation

Gregory Lip (UK)

17:20 Trouble-Shooting: Appropriate or Inappropriate AF Detection?

Carsten Israel (Germany)

Room S427

[052] Basic Research 4 - New Insights into the Mechanism of AF II16:00 – 17:40 Chair: Erika Maharani (Indonesia)

16:00 Rotational Activation in AF: Insights from Direct Contact Mapping

Dennis Lau (Australia)

16:20 Molecular Basis for Tachycardia-Bradycardia Syndrome

Yung-Hsin Yeh (Taiwan)

16:40 Intercellular Communication and Atrioventricular Conduction

Yu-Shien Ko (Taiwan)

17:00 Connexin and AF Hung-I Yeh (Taiwan)

17:20 Mechanistic Insights into Atrial Thrombogenesis in AF


58

TH

UR

SD

AY


Room S429

[053] Oral Abstract Session16:00 – 17:40 Oral Presentation - Pediatric & Inherited

Arrhythmia Chairs: Pi-Chang Lee (Taiwan) Xv Liu (China) Mei-Hwan Wu (Taiwan) 16:00 OP 07-1 Three-dimensional electroanatomical mapping

for scar-related atrial tachycardias in patients with congenital heart disease

Xianhui ZHOU (China)

16:16 OP 07-2 Multicentre long term follow-up of pediatric primary prevention ICD shocks

Hiroko ASAKAI (Australia)

16:32 OP 07-3 A decade of RF ablation in children – a single centre experience

Mandar SHAH (India)

16:48 OP 07-4 Single-centre experience in permanent pacemaker implantation in pediatric population with a five-year follow-up

Niti CHADHA (India)

17:04 OP 07-5 Mutation of desmoplakin gene and assessment of right ventricle function in patients with arrhythmogenic right ventricular cardiomyopathy

Qianhuan ZHANG (China)

17:20 OP 07-6 Utility of modified moving average analysis of microvolt T-wave alternans to predict ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy

Xue SHELIANG (China)

58 59

TH

UR

SD

AY


Room S430

[054] Atrial Fibrillation (Ablation) Workshop 3 - Antithrombotic Therapy for Stroke Prevention16:00 – 17:40 Chairs: Louisa Poon (Hong Kong) Michael Wan (Australia)

16:00 Antithrombotic Therapy for Stroke Prevention in AF Around Asian-Pacific Region: Have the Needs been Met?

Li-Jen Lin (Taiwan)

16:20 Are Anti-Platelets Obsolete in Stroke Prevention?

To be announced

16:40 Effectiveness of Low Intensity Anticoagulation in Asian People

Chun-Yu Zeng (China)

17:00 Optimal Anticoagulation Strategy in Patients with High Risk of Bleeding

Bo-Young Joung (Korea)

17:20 Best Candidates of NOAC Nam-Ho Kim (Korea)

Room S221

[055] Certificate CRM Course - Basics of Cardiac Defibrillation & Resynchronization*For CRM Course Registrants

16:00 – 17:40 Chairs: Susan Song (USA) Wai-Sum Luk (Hong Kong)

16:00 Myocardial Remodeling and Cardiac Resynchronization Therapy

Carsten Israel (Germany)

16:25 Principles of ICD Sensing and Detection of VF / VT

Ji-Hae Yun (Korea)

16:50 Defibrillation Concepts and Determinants of Shock Success

Saeed Hosseini (Canada)

17:15 CRT Optimization Strategies Marleen Irwin (Canada)

60

TH

UR

SD

AY


Room S226

[056] Joint Session Australia-New Zealand Symposium - Ventricular Arrhythmias and SCD Symposium16:00 – 17:40 Chair: To be announced

16:00 MRI Imaging to Identify Ventricular Arrhythmia Substrate

Andrew Taylor (Australia)

16:20 Role of Channels in Ablation of Ventricular Arrhythmias

Kurt Roberts-Thomson (Australia)

16:40 SCD in Chronic Kidney Disease Joseph Morton (Australia)

17:00 SCD-Risk Stratification Post Infarction: Time to Revisit?

Pramesh Kovoor (Australia)

17:20 Role of Genetic Evaluation in Sudden Unexplained Death and Aborted Cardiac Arrest

Jitendra Vohra (Australia)

60 61

TH

UR

SD

AY


Room S227


(Ablation) 3 Chairs: Chi-Yeung Cheung (Hong Kong) Lin-Hua Tam (Hong Kong) Jian-An Wang (China) 16:00 OP 08-1 Sequential hybrid approach: results of novel

approach in the treatment of long-standing persistent atrial fibrillation

Alan BULAVA (Czech Republic)

16:16 OP 08-2 Clinical success of radiofrequency catheter ablation of atrial fibrillation using two different ablation catheter: a comparison between a conventional irrigated tip ablation catheter vs. contact therapy cool path duo ablation catheter with complex impeda

Karlheinz SEIDL (Germany)

16:32 OP 08-3 Conduction gaps after the first round of circumferential pulmonary vein isolation tend to reconnect in the second procedure even after additional ablation

Kojiro TANIMOTO (Japan)

16:48 OP 08-4 Esophageal temperature monitoring during pulmonary vein isolation by electrogram-guided point ablation

Shin-ichi TANIGAWA (Japan)

17:04 OP 08-5 Mapping of undistinguishable focal atrial tachycardia post extensive ablation in the atrium: tricks and tips

Weizhu JU (China)

62

TH

UR

SD

AY


Hall 5G, Level 5

Poster Session 213:50 – 17:20 Poster Display - Atrial Fibrillation (Ablation) II


P2-007 Renal denervation and pulmonary vein isolation in patients with drug resistant hypertension and symptomatic atrial fibrillation


P2-008 Long-term change of heart rate variability after radiofrequency catheter ablation: 1 year follow-up study in irrigation tip catheter era

Ki-woon KANG (Korea)

P2-009 Pulmonary antrum radial-linear ablation for paroxysmal atrial fibrillation

Zhao XUE (China)

P2-010 Using of mathematical scanning for explanation of RFA results in paroxysmal atrial fibrillation patients


P2-011 Inferioseptal vs. left mitral isthmus ablation to cure perimitral flutter


P2-012 Prognostic implication of atrial pressures in patients with nonvalvular atrial fibrillation and preserved systolic function who undergo radiofrequency catheter ablation: a pilot study

Jeonggeun MOON (Korea)

P2-013 The risk factors of periesophageal vagal nerve injury during catheter ablation for atrial fibrillation

Kenji NATSUYAMA (Japan)

P2-014 Catheter ablation of atrial fibrillation raises the plasma level of NGF-beta which is associated with sympathetic nerve activity and arrhythmias


P2-015 The study of substrate of left atrium in the setting of long-standing persistent atrial fibrillation (LPAF)

Xinhua WANG (China)

62 63

TH

UR

SD

AY


P2-016 Left atrial wall thickness rather than epicardial fat related with the complex fractionated atrial electrogram

Junbeom PARK (Korea)

P2-017 Supraventricular tachycardia as a trigger for atrial fibrillation in a young cohort of patients referred for catheter ablation


P2-018 High internal-defibrillation threshold is associated with increased BNP and left atrial enlargement in sustained atrial fibrillation

Masahide HARADA (Japan)

P2-019 The predictor of recurrence after the 2nd standard circumferential PV isolation in the patients with paroxysmal atrial fibrillation

Hiroshi KAWAKAMI (Japan)

P2-020 Safety of catheter ablation without transesophageal echocardiography prior to procedure in patients with atrial fibrillation

Mika HIOKI (Japan)

P2-021 Long-term effects of stepwise linear ablation approach in persistent atrial fibrillation

Ling-Min WU (China)

P2-022 Peri-procedural anticoagulation treatment in patients undergoing atrial fibrillation ablation: comparison of the incidence of procedure-related thromboembolism between warfarin and dabigatran

Mika HIOKI (Japan)

P2-023 Different right atrial conduction pattern between paroxysmal and persistent atrial fibrillation

Hee-Sun MUN (Korea)

P2-024 Pulmonary vein isolation requiring ablation on the intervenous ridge to achieve electrical disconnection: impact on acute and long term outcome


P2-025 The spatial and temporal variability of dominant frequency and complex fractionated atrial electrograms in human atrial fibrillation

Rikitake KOGAWA (Japan)

64

TH

UR

SD

AY


P2-026 Left atrial image integration strategy to further improve the integration accuracy using CartoSound and computed tomography during atrial fibrillation ablation

Kohki NAKAMURA (Japan)

P2-027 Visualization of the left atrial appendage by phased array intracardiac echo from the pulmonary artery in patients with atrial fibrillation

Takahiko NISHIYAMA (Japan)

P2-028 The application of delayed-enhancement MRI on atrial fibrillation ablation

Defeng WANG (Hong Kong)

P2-029 The training and learning process of transseptal puncture using a modified technique

Ligang DING (China)

P2-030 Multidetector computer tomography might be an enough screening test to prevent periprocedural stroke in atrial fibrillation ablation; multicenter study

Sung-Jin HONG (Korea)

P2-031 Blood pressure decreased after catheter ablation of atrial fibrillation-any role of sympathetic tone?

Wei-Hsuan HSU (Taiwan)

P2-032 Improvements in left atria and vascular function following successful balloon valvuloplasty: possibility to slow in disease progression

Carlee SCHULTZ (Australia)

P2-033 Alteration in vascular responsiveness with the progression in atrial fibrillation


P2-034 Impact of peri-procedural coagulation status with dabigatran on occurrence of silent cerebral infarction in patients undergoing atrial fibrillation ablation

Akira UENO (Japan)

P2-035 The effect of linear ablation for fixed atrial fibrillation using three-dimensional mapping

Takahiro GUNJI (Japan)

P2-036 Utilization trends for left atrial appendage closure in the united states from 2005-2010

Neeraj SHAH (USA)

64 65

TH

UR

SD

AY


P2-037 Relationship between intracardiac electrogram amplitude and the mapping point location from the left atrial surface of 3D ultrasound- and merged 3D CT-derived images

Yasuo OKUMURA (Japan)

P2-038 Predictors of multiple (more than two) catheter ablation procedures for atrial fibrillation

Li-Wei LO (Taiwan)

P2-039 Histological and biochemical characteristics of right atrium compared to left atrium in patients with valvular atrial fibrillation

Minjin CHOE (Korea)

P2-040 Impedance-based thresholds for identification of catheter-tissue contact force have limited predictive value during radiofrequency ablation of atrial arrhythmias in humans


P2-041 Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans


P2-042 Very late recurrence of atrial fibrillation following catheter ablation: is it able to predict?

Ryohsuke NARUI (Japan)

P2-043 Spatial difference of esophagus location between on computed tomography and esophagography during atrial fibrillation ablation

Takayuki IIDA (Japan)

P2-044 The quality of life after radio frequency catheter ablation for asymptomatic persistent atrial fibrillation: a single center experience

Naoaki ONISHI (Japan)

P2-045 Localized rotor in the left atrium during atrial fibrillation identified using phase mapping from 56-pole contact electrode baskets catheter

Naoko SASAKI (Japan)

P2-046 Left atrial size predicts the progression of paroxysmal AF despite catheter ablation

Ying-Chieh LIAO (Taiwan)

66

TH

UR

SD

AY


P2-047 Residual pulmonary vein connection gap after the first round of circumferential pulmonary vein isolation predicts early pulmonary vein reconnection even after additional ablation

Yukinori IKEGAMI (Japan)

P2-049 The influence of circumferential pulmonary vein isolation procedure on inter-atrial conduction

Yu QIAO (China)

P2-050 New oral anticoagulants vs warfarin for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation

Ei Ei Moe MON (Singapore)

P2-051 Reduction of the incidence of pleural effusion after catheter ablation of atrial fibrillation with use of a 56-hole irrigated-tip ablation catheter

Naoyuki MIWA (Japan)

P2-052 Impact of the left atrial reverse remodeling in the outcome of catheter ablation of atrial fibrillation

Masateru TAKIGAWA (Japan)

P2-053 The use of magnetic stereotaxis in radiofrequency ablation of atrial fibrillation

Chun Yuan KHOO (Singapore)

P2-054 Long-term outcome after catheter ablation of atrial fibrillation in patients with sick sinus syndrome.

Atsuhiko YAGISHITA (Japan)

P2-055 Increased E/Em is independently associated with a high CHADS2 score or stroke, and catheter ablation reduces E/Em in PAF patients


P2-056 Ventricular reverse remodeling after catheter ablation for atrial fibrillation in patients with cardiomyopathy

Jihei Sara LEE (Korea)

P2-057 The early experiences of left atrial appendage occlusion device in Korean patients with long-standing persistent atrial fibrillation

Hui-Nam PAK (Korea)

66 67

TH

UR

SD

AY


P2-058 Stiff left atrial physiology, estimated by left atrial pulse pressure, is an independent predictor for clinical recurrence after catheter ablation in patients with lone atrial fibrillation


P2-059 Gender difference in left atrial electroanatomical remodeling and hemodynamic association with left atrial pulse pressure in patients with paroxysmal atrial fibrillation


P2-060 The combined use of adenosine and pacing for pulmonary vein isolation line evaluation (APPLE trial)

Tae-Seok KIM (Korea)

P2-061 Voltage mapping of left atrium in patients with fixed atrial fibrillation

Sou TAKENAKA (Japan)

P2-062 Prolonged PR interval is associated with advanced electroanatomical remodeling of left atrium and predicts the clinical outcome after catheter ablation of atrial fibrillation


P2-063 The impact of heterogeneous pulmonary vein anatomy in catheter ablation of atrial fibrillation

Weita CHEN (Taiwan)

P2-064 Clinical utility of adding ablation of localized complex fractionated electrograms after a stepwise linear ablation in persistent atrial fibrillation

Yuichi HORI (Japan)

P2-065 Impact of left atrial appendage ridge ablation on the complex fractionated electrograms within the coronary sinus in persistent atrial fibrillation

Naofumi TSUKADA (Japan)

P2-066 Pulmonary vein isolation extremely attenuate the amplitude of pulmonary vein potential in the second session

Shinji KANEKO (Japan)

P2-067 Predictor of atrial fibrillation inducibility after pulmonary vein isolation assessed by speckle tracking echocardiography in patients with persistent atrial fibrillation

Takeshi HIROSE (Japan)

68

TH

UR

SD

AY


P2-068 Identifying spiral waves in physiological systems: an objective assessment of wave type

Darius CHAPMAN (Australia)

P2-069 Utility of an oesophageal temperature probe for geometry creation

Christopher HAYES (UK)

P2-070 The progression of trigger from non-pulmonary vein foci was the cause of the difficulty of ablation for very long-standing atrial fibrillation

Koichi INOUE (Japan)

P2-071 New appearance of non-pulmonary vein triggers initiating atrial fibrillation in patients with durable pulmonary vein disconnection: lessons from repeat procedure

Takekuni HAYASHI (Japan)

P2-072 Predictors of echocardiographic left atrial reverse remodeling after catheter ablation for chronic atrial fibrillation

Marina OKADA (Japan)

P2-073 Impact of low-dose dipyridamole injection on adenosine test after pulmonary vein isolation

Shinsuke MIYAZAKI (Japan)

P2-074 Study on ablation therapy in primary prevention of cerebral infarction

Kenichi HIROSIMA (Japan)

P2-075 The Association of von Willebrand Factor with Left Atrium Remodeling in Patients with Atrial Fibrillation

Dae In LEE (Korea)

P2-076 The Delay of Electrical Potential in Left Atrial Appendage after Stepwise Ablation in Patients with Persistent Atrial Fibrillation Is Independently Related to Low Recurrence Rate of Atrial Tachyarrhythmias

Dae In LEE (Korea)

P2-077 Long-term changes of heart rate variability after radiofrequency catheter ablation of atrial fibrillation: 1 year follow-up study in irrigation tip catheter era

Ki-Woon KANG (Korea)

68 69

TH

UR

SD

AY


P2-078 Gene and protein expression of transient receptor potential channel in atrium from patients with atrial fibrillation

Feng CAO (China)

P2-079 The Impact of Low Voltage Area and Gross Area of Left Atrium on the Prognosis after Ablative Therapy in Patients with Atrial Fibrillation

Yoon-Jung CHOI (Korea)

P2-080 Successful radiofrequency catheter ablation in a child with paroxysmal atrial fibrillation due to left atrial tachycardia and atrial flutter

Ami CHO (Japan)

P2-081 P Wave Morphology as an Independent Predictive Value for Recurrence of Atrial Tachyarrhythmias after Ablation of Paroxysmal Atrial Fibrillation

Jae Joong LEE (Korea)

P2-082 Left Atrium and Left Atrial Appendage Function: Relation with CHADS2 score and clinical outcome after catheter ablation

Hwan-Cheol PARK (Korea)

P2-083 The difference in autonomic nervous activity between paroxysmal and persistent atrial fibrillation and its change after radiofrequency catheter ablation

Yoko NAKAZAWA (Japan)

P2-084 Prolonged Ablation Duration for Persistent Atrial Fibrillation: Always Bad?

Jaemin SHIM (Korea)

P2-085 The Characteristics of the Patients who Implanted Permanent Pacemaker after Atrial Fibrillation Ablation

Yung-Lung CHEN (Korea)

P2-086 Safety of Catheter Ablation for Atrial Fibrillation in Nonagenarians

L. Bing LIEM (USA)

P2-087 Superior Outcome of Hybrid Procedure as Compared to Catheter Ablation for Atrial Fibrillation

L. Bing LIEM (USA)

70

TH

UR

SD

AY


P2-088 The Affect of Anatomical Pulmonary Vein Variation for Atrial Fibrillation Ablation and its Clinical Outcome in Patients with Atrial Fibrillation.

Yasutsugu NAGAMOTO (Japan)

P2-089 The predictor of early recurrence of atrial fibrillation after pulmonary vein isolation

Kenichi YOKOYAMA (Japan)

13:50 – 17:20 Poster Display - Late-breaking News


P2-090 Extension of ACTs is delayed with NOAC compared to warfarin by the same heparin administration protocol during catheter ablation for atrial fibrillation.

Satoru SEKIMOTO (Japan)

P2-091 The accuracy of electrocardiogram criteria for left ventricular hypertrophy in established Korean cohort

Min-Soo AHN (Korea)

P2-092 The Lifestyle Factors Influencing Antithrombotic Prophylaxis of South Korean Patients with Atrial Fibrillation

Min-Young KIM (UK)

P2-093 Atrial Fibrillation as a Risk Factor for Gastroesophageal Reflux Disease

Toru MARUYAMA (Japan)

P2-094 Radiofrequency Ablation of Idiopathic Premature Ventricular Contractions

Hung Thuy TO (Vietnam)

P2-095 A Prospective Placebo Controlled Randomized Study of Caffeine in Patients with Supraventricular Tachycardia Undergoing Electrophysiological Testing. II. Effects on Arrhythmia Inducibility.

Robert LEMERY (Canada)

P2-096 Proton pump inhibitors prevents and improves esophageal symptoms in the perioperative period of extensive encircling pulmonary vein isolation

Toshiya KOJIMA (Japan)

70 71

TH

UR

SD

AY


13:50 - 17:20 Poster Display - Syncope


P2-097 Long-term follow up of Closed Loop Cardiac Pacing in patients with refractory Neurocardiogenic Syncope.

Shipeng YU (USA)

P2-098 Electrocardiographic features during cardioinhibitory tilt-induced syncope in children

Vladimir DOLGIKH (Russia)

P2-099 Effectiveness of patient’s symptoms based protocol of Head Up Tilt Table Test for evaluation of Vasovagal syncope.

Shomu BOHORA (India)

P2-100 Recurrent Vasovagal syncope: - Is it manifestation of nutritional/endocrinal deficiency or subtle autonomic dysfunction.


P2-101 Paroxysmal Tachycardia Recorded On A Smartphone

Lohendran BASKARAN (Singapore)

P2-102 Risk factors predicting the future presence of long QT syndrome-related symptoms in pediatric patients diagnosed by screening programs in Japan

Masao YOSHINAGA (Japan)

P2-103 Single-center experience of implantable loop recorders in patients with unexplained syncope.

Takeshi MATSUURA (Japan)

P2-104 Syncope due to complete atrioventricular block

Sho TSUSHIMA (Japan)

P2-105 Predictor of presyncopal and syncopal recurrence in neurally mediated and unexplained syncope

Sung Ho LEE (Korea)

P2-106 Prognosis after tilt training in patients with recurrent vasovagal syncope

Eun jeong CHO (Korea)

P2-107 Syncope Clinic: What are Problems in Japan? Toshiyuki FURUKAWA (Japan)

72

TH

UR

SD

AY


P2-108 Association between Traumatic Injury and History of Syncope in Patients with Reflex Syncope

Mika NAGAOKA (Japan)

P2-109 Obtund Hear Rate Increment During Tilt Testing Is Associated with Aging and Severe Syncopal Attack

Eun-Sun JIN (Korea)

P2-110 Whole exome sequencing to identify a novel LMNA gene mutation associated with sick sinus syndrome

Lung-Sheng WU (Taiwan)

Hall 5G, Meet the Experts Corner A

[058] Medtronic Cocktail Symposium - Zoom in on New Ablation Technology and Approaches17:00 – 18:00 Chairs: Mark McGuire (Australia) Shu Zhang (China)

17:00 Speeding Up the Learning Curve: Lessons from an Arctic Front Ablationist

Bradley Knight (USA)

17:20 How to Reduce the Recurrence Rate of Cryoablation in AVNRT?

Ngai-Yin Chan (Hong Kong)

17:40 Lessons Learned from Arctic Front Advances Karl-Heinz Kuck (Germany)

72 73

TH

UR

SD

AY


Hall 5G, Room A

Opening Ceremony18:00 – 19:00 Officiated by Guests-of-Honor: •Wing-ManKo,SecretaryforFood&Health,HKSAR

Government

• LingLuo,Vice-SecretaryGeneral,ChineseMedicalAssociation

• Donald Li, President, Hong Kong Academy ofMedicine

There will be cultural performance in Ceremony. Don’t miss this unique experience!

Hall 5G, Room A

[059] Hong Kong Heart Foundation Lecture In memory of Sir QW Lee19:00 – 19:30 Chairs: Patrick Pau (Hong Kong) Tak-Fu Tse (Hong Kong)

Atrial Fibrillation and Dementia - Cause or Coincidence

John Camm (UK)

Friday, 4 October 2013

08:30-10:10 Main Sessions on Atrial Fibrillation (Device), VT Ablation, Heart Failure & Remote Patient Monitoring

Certificate CRM Course Focus Session Workshop CSPE Best Abstract Award Session Oral Abstract Session Joint Session with Italian AIAC Industry Supported Session - Emerging Leaders (Medtronic)

10:10-10:40 Coffee Break & Chaired Poster Session – Ablation

10:40-12:20 Main Sessions on Atrial Fibrillation (Device), VT Ablation, Sudden Cardiac Death

Certificate CRM Course Clinical Trial Updates Workshop CSPE Young Investigator Award Session Oral Abstract Session Industry Supported Session – Learn from the Expert: Case

Based ECG Tutorial (Medtronic)

12:20-13:50 Luncheon Symposium (Bristol-Myers Squibb/Pfizer) Luncheon Symposium (Boston Scientific) Luncheon Symposium (St. Jude Medical)

13:50-15:30 Main Sessions on Atrial Fibrillation (Ablation), Bradycardia Pacing, Tachycardia Therapy Device, Genetic & Inherited Syndrome

Certificate CRM Course Basic Research Debate Live Transmission (Medtronic) Workshop Oral Abstract Session

15:30-16:00 Coffee Break & Chaired Poster Session - Basic & Translation Science

16:00-17:40 Main Sessions on Atrial Fibrillation (Drug), SVT Ablation, Heart Failure & Remote Patient Monitoring, Surgical Therapy Device & Ablation, Sudden Cardiac Death Prevention in Asia

Certificate CRM Course Basic Research Live Transmission (Boston Scientific) Workshop Oral Abstract Session

18:00-20:00 Industry Supported Session – EP Tracing (Bard) Industry Supported Session – China Heart Failure Forum (St. Jude Medical)

76


FR

IDA

Y

Hall 5G, Room A

[060] Atrial Fibrillation (Ablation) 3 - Strategies for Recurrent Atrial Arrhythmias After Ablation08:30 – 10:10 Chairs: Hitoshi Hachiya (Japan) Duncan HK Ho (Hong Kong) Bambang Budi (Indonesia)

08:30 Progression of Substrate Yohei Sotomi (Japan)

08:50 Atrial Tachycardias Young-Hoon Kim (Korea)

09:10 Energy Consideration Jonathan S. Steinberg (USA)

09:30 Mitral Isthmus Ablation Seiji Takatsuki (Japan)

09:50 Atrial Tachycardia Versus Atrial Fibrillation Recurrence

Prashanthan Sanders (Australia)

Hall 5G, Room B

[061] VT Ablation 2 - Nonischemic Scar-related VT Ablation08:30 – 10:10 Chairs: Ahmad Fazil (Malyasia) Beny Hartono (Indonesia)

08:30 Septal VT in Nonischemic Cardiomyopathy: Unipolar or Bipolar Ablation?

Vivek Reddy (USA)

08:50 Catheter Ablation of Ventricular Arrhythmias in Brugada Syndrome: Beyond Storm?

Koonlawee Nademanee (USA)

09:10 Ablation of Scar-related VT in Granulomatous Cardiomyopathy

Calambur Narasimhan (India)

09:30 Hybrid Approaches to Successful VT Ablation in Nonischemic Cardiomyopathy

David Callans (USA)

09:50 VT Ablation in Valvular Cardiomyopathy: Endocardial, Epicardial and Transapical

Yan Yao (China)

76 77


FR

IDA

Y

Hall 5G, Room C

[062] Heart Failure & Remote Patient Monitoring 3 - Impact of Remote Monitoring in Clinical Practice08:30 – 10:10 Chairs: Yi-Hui Chen (Taiwan) Wing-Hung Chui (Hong Kong)

08:30 Role of Remote Monitoring in Ventricular Arrhythmia Management in Heart Failure Patients


08:50 Can Remote Monitoring of CRT Devices Help to Prevent the Occurrence of Electrical Storm in End Stage Heart Failure Patients?

Tetsuyuki Manaka (Japan)

09:10 Remote Monitoring of Myocardial Ischemia in Heart Failure Patients

Massimo Santini (Italy)

09:30 Can Remote Monitoring of CRT Devices Drive to an Earlier Cardioversion Strategy for AF Recurrences in HF Patients?

Fayez Bokhari (Saudi Arabia)

09:50 Who Benefits from Hemodynamic Monitoring and CRT Optimization

Michael Gold (USA)

Room S421

[063] Focus Session 2 - Sudden Cardiac Death08:30 – 10:10 Chair: Sumeet Chugh (USA) Panelists: Mohan Nair (India) Tachapong Ngarmukos (Thailand) Jae-Min Shim (Korea)

08:30 Case Based: Cardiac Arrest Following Extensive Anterior Myocardial Infarction

Mohan Nair (India)

09:03 Case Based: Electrical Storm during Therapeutic Hypothermia

Jae-Min Shim (Korea)

09:36 Case Based: Frequent Shocks in a Patient with Implantable Defibrillator

Tachapong Ngarmukos (Thailand)

78


FR

IDA

Y

Room S423

[064] Pacing Workshop 2 - Controversies in Lead Implantation08:30 – 10:10 Chair: Bing Liem (USA)

08:30 The Status of the Leadless Electrode David Benditt (USA)

08:50 Where Should We Implant the RV Lead Ben Pang (Australia)

09:10 Where Should We Implant the Left Ventricular Lead?

Wei Hua (China)

09:30 How do We Plan and Perform Lead Replacements?

Peter Belott (USA)

09:50 Where Should We Implant the Right Atrial Lead?

Ruth Kam (Singapore)

Room S424

[065] SVT Workshop 2 – Anatomy for SVT Ablation08:30 – 10:10 Chair: Soot-Keng Ma (Malaysia)

08:30 Specialize in Cardiac Anatomy Relating to SVT and Catheter Ablation

Osamu Igawa (Japan)

08:50 Novel Approach for Ablation of Mahaim Fiber Kaoru Okishige (Japan)

09:10 AV Nodal Reentry Revisited: Demonstration of Possible Atrial Fusion Beats During Atrial Overdrive Pacing or Extrastimulation of AV Nodal Reentrant Tachycardia

Fumio Suzuki (Japan)

09:30 Multiple Mahaim Fibers Blair Singh (India)

09:50 SVT in Ebstein Anomaly Narayanan Namboodiri (India)

78 79


FR

IDA

Y

Room S425

[066] Atrial Fibrillation (Ablation) Workshop 4 - Special Consideration08:30 – 10:10 Chairs: Kun-Tai Lee (Taiwan) Kyoung-Min Park (Korea)

08:30 Indications for AF Ablation Yun-Long Xia (China)

08:50 How to Apply 4D CT Imaging for AF Ablation Hsuan-Ming Tsao (Taiwan)

09:10 How to Select Patients for Superior Vena Cava Ablation?

Yasuteru Yamauchi (Japan)

09:30 Application of NOAC for AF Ablation Gregory Lip (UK)

09:50 How to Monitor and Follow-Up Patient after AF Ablation?

Wen-Chin Tsai (Taiwan)

80


FR

IDA

Y

Room S426

[067] Oral Abstract Session08:30 – 10:10 Oral Presentation - CSPE Best Abstract Award Judges: Yi-Gang Li (China) Li-Qun Wu (China)

08:30 CSPE 01-1 Comparison of the retrograde and transseptal methaods for ablation of left accessory pathway by three-dimensional mapping system

Guoqiang ZHONG (China)

08:46 CSPE 01-2 Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure

Qingyan ZHAO (China)

09:02 CSPE 01-3 A novel individualized substrate modification approach for the treatment of long-standing persistent atrial fibrillation (LPAF): preliminary results

Xin-hua WANG (China)

09:18 CSPE 01-4 Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing

Qina ZHOU (China)

09:34 CSPE 01-5 A common NOS1AP genetic polymorphism is associated with QTc interval and mortality in chronic heart failure in a Chinese han case-control population

Xiaoyan LIU (China)

09:50 CSPE 01-6 The effects of adenosine triphosphate on inducing atrial fibrillation after circumferential pulmonary vein isolation in paroxysmal atrial fibrillation: an insight into the mechanism and implication for ablation

Jinlin ZHANG (China)

80 81


FR

IDA

Y

Room S427

[068] Medtronic Symposium - Emerging Leaders08:30 – 10:20 Chair: Eric Prystowsky (USA) Faculties: Shih-Ann Chen (Taiwan) Young-Hoon Kim (Korea) Chu-Pak Lau (Hong Kong) Mohan Nair (India)

Room S429

[069] Oral Abstract Session08:30 – 10:10 Oral Presentation - Genetic 1 Chairs: Yih-Ling Chiou (Taiwan) Jitu Vohra (Australia) Dong-Qi Wang (China)

08:30 OP 09-1 Genome-wide association analysis identifies 3 common variants predisposing to brugada syndrome

Yuka MIZUSAWA (The Netherlands)

08:46 OP 09-2 SCN5A mutation is not a risk predictor of recurrent cardiac events for patients with symptomatic brugada syndrome: ten-year follow-up in a large Chinese cohort (COBRA_ChiP registry)

Jyh-Ming Jimmy JUANG (Taiwan)

09:02 OP 09-3 Variants in SCN5A promoter and regulatory regions associated with various arrhythmia phenotypes including sinus node dysfunction, conduction disease, atrial fibrillation, and idiopathic ventricular fibrillation

Nobue YAGIHARA (Japan)

09:18 OP 09-4 The screening of catechol-o-methyl transferase gene (COMT) is a powerful tool to diagnose susceptibility for long QT-syndrome and for stratification for sudden cardiac death (SCD)

Jerzy DYCZYNSKI (Australia)

09:34 OP 09-5 Genetic background and management of long QT syndrome

Akiko KOMORI (Japan)

09:50 OP 09-6 Angiotensin II type 1-receptor gene polymorphism, rs5182, is associated with clinical recurrence of atrial fibrillation after radiofrequency catheter ablation

Jaemin SHIM (Korea)

82


FR

IDA

Y

Room S430

[070] Oral Abstract Session08:30 – 10:10 Oral Presentation - Anticoagulation

Management Chairs: Arun Chopra (India) Ka-Hing Lam (Hong Kong) Fang Wang (China)

08:30 OP 10-1 Does the peri-procedural anticoagulation management for AF affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging (DMRI) in patients undergoing atrial fibrillation ablation with open irrigated radio


08:46 OP 10-2 Safety of right-sided atrial flutter ablation performed under novel oral anticoagulants

Jean-Francois SARRAZIN (Canada)

09:02 OP 10-3 Pulmonary vein isolation in patients with atrial fibrillation with peri-procedural dabigatran

Amitabh YADUVANSHI (India)

09:18 OP 10-5 Cost-effectiveness analysis of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation: a population-based study in Taiwan

Chieh-Yu LIU (Taiwan)

09:34 OP 10-6 Dabigatran use in atrial fibrillation patients at high risk of stroke: a single centre experience

Lok Bin YAP (Malaysia)

82 83


FR

IDA

Y

Room S221

[071] Certificate CRM Course 5 - ECG Interpretation08:30 – 10:10 Chairs: June Huh (Korea) Ji-Hae Yun (Korea)

08:30 Systematic Approach to Arrhythmia Recognition

Shoei K. Stephen Huang (USA)

09:03 ECG Features in ARVC, Long QT, J Wave and Brugada Syndromes

Tohru Ohe (Japan)

09:36 Systematic Approach to Pacemaker/CRT ECG Troubleshooting

Michael Wan (Australia)

Room S226

[072] Joint Session with Italian AIAC08:30 – 10:10 Chair: Luigi Padeletti (Italy)

08:30 Women and CRT Devices, Favourable Outcomes. Why and Where are the Gaps, How Do We Address Them?

Maurizio Lunati (Italy)

08:50 CRT Issues: Endocardial LV Pacing Paolo Pieragnoli (Italy)

09:10 CRT in HF Patients with Preexistent or New Onset AF: Ablate the His Bundle

Gianluca Botto (Italy)

09:30 Syncope 2013: The Italian Approach Fabrizio Ammirati (Italy)

09:50 CRT-D Luigi Padeletti (Italy)

84


FR

IDA

Y

Room S227

[073] VT Workshop 3 - Structural Heart Disease VT08:30 – 10:10 Chair: Ahmed Al-Fagih (Saudi Arabia)

08:30 How to Decide the Exit of the Circuit - Entrainment, ECG Criteria

Kyoko Soejima (Japan)

08:50 How to Map-Activation, Substrate Anees Thajudeen (India)

09:10 How to Ablate-Several Methods-Delayed Potential, Exit Linear Ablation etc.

Yong-Seog Oh (Korea)

09:30 When to Decide the Epicardial Ablation Masaomi Chinushi (Japan)

09:50 Alternative Method-Surgical, Bipolar etc. Vivek Reddy (USA)

Hall 5G, Level 5

[074] Poster Session 310:10 – 10:40 Chaired Poster Session – Ablation Judge: Cathy Lam (Hong Kong)

P3-001 Low entropy in the sub-endocardial scar can localize ventricular tachycardia supporting channels in post-infarct ventricles


P3-002 First experience of the new nMARQ multi-electrode catheter for mapping and ablation of paroxysmal and persistent atrial fibrillation

Shui Hao CHIN (UK)

P3-003 Hybrid procedure using total thoracoscopic ablation and postprocedural confirmation: road to overcome chronic atrial fibrillation

Dong Seop JEONG (Korea)

P3-004 Multiple left sided accessory pathways associated with an anomalous coronary sinus drainage at the lateral tricuspid annulus

Danny CHOW (Hong Kong)

84 85


FR

IDA

Y

P3-005 Radiofrequency ablation of left atrial flutter mediated with double potentials in seemingly Structurally Normal Heart

Hui PENG (China)

P3-006 Atrial fibrillatory cycle length derived from the 12-lead ECG: longer cycle length activity is associated with more advanced electroanatomic remodeling

Tomos WALTERS (Australia)

Hall 5G, Room A

[075] Atrial Fibrillation (Device) 2: AF in Patients with Pacemakers and/or ICDs: What Have We Learned?10:40 – 12:20 Chairs: Maria Belen O. Carisma (Philippines) Kee-Joon Choi (Korea) Chris KY Wong (Hong Kong)

10:40 Implantable Loop Recorders for AF Monitoring: Techniques and Results

Yi-Gang Li (China)

11:00 AF in Pacemaker Patients: Preventive Pacing and Atrial ATP

John Ip (USA)

11:20 AF in ICD Patients: From Inappropriate Shocks to Internal Cardioversion

Luigi Padeletti (Italy)

11:40 Where to Implant the Atrial Lead for AF Prevention?

Chun-Chieh Wang (Taiwan)

12:00 AF in CRT Patients: What Should Be Done? David Benditt (USA)

86


FR

IDA

Y

Hall 5G, Room B

[076] VT Ablation 3: Miscellaneous Topics in Scar-Related VT Ablation 10:40 – 12:20 Chairs: Anthony King (Philippines) Yuji Murakawa (Japan) Frank LY Tam (Hong Kong)

10:40 VT Ablation in the Setting of Left Ventricular Assist Devices


11:00 The Role of Programmed Stimulation in 2013: Guide to ICD Placement or RFA Success?

Henry Hsia (USA)

11:20 Image Integration in VT Ablation: Where We Are and Where We Are Going

Alejandro Jimenez (New Zealand)

11:40 Role of Contact Force Sensing in VT Ablation: Pushing Harder or Smarter?

David Callans (USA)

12:00 VT Ablation in Repaired Tetralogy of Fallot: The Other Isthmuses

June Huh (Korea)

Hall 5G, Room C

[077] Sudden Cardiac Death 2 - Reduction of SCD in Inherited Cardiac Disorders10:40 – 12:20 Chairs: Carmen Chan (Hong Kong) Jen-Yuan Kuo (Taiwan) Boon-Yew Tan (Singapore)

10:40 Long QT Syndrome YongKeun Cho (Korea)

11:00 Hypertrophic Cardiomyopathy Sumeet Chugh (USA)

11:20 Arrhythmogenic Right Ventricular Cardiomyopathy

Yenn-Jiang Lin (Taiwan)

11:40 Brugada Syndrome Wataru Shimizu (Japan)

12:00 Catecholaminergic Polymorphic Ventricular Tachycardia

Silvia Priori (Italy)

86 87


FR

IDA

Y

Room S421

[078] Clinical Trial Updates10:40 – 12:20 Chairs: Chu-Pak Lau (Hong Kong) Shu Zhang (China)

10:40 An Update on ARISTOTLE Sub-analysis of Asian Patients

Shinya Goto (Japan)

11:00 New Advances in Shock Reduction: Pain Free SST

David Benditt (USA)

11:20 MADIT-CRT - Long Term Outcome Kenneth Stein (USA)

11:40 PROTECT-AF Vivek Reddy (USA)

12:00 Quadri Polar CRT Bernard Thibault (Canada)

Room S423

[079] CRT Workshop 1 - Toward Personalized Pacing Strategy10:40 – 12:20 Chair: Kin-Lam Tsui (Hong Kong)

10:40 Importance of Multidisciplinary Approach to CRT Patients: A Key Factor for Improved Response

Bruce Wilkoff (USA)

11:00 Is RV Pacing Needed for CRT or is LV-only Sufficient

David Cannom (USA)

11:20 Should Patients with RBBB not Considered for CRT?

Kuan-Hung Yeh (Taiwan)

11:40 Ablation Strategies in CRT Candidates Sang-Weon Park (Korea)

12:00 Should CRT be Considered for Any Patient Requiring a Pacemaker

David Hayes (USA)

88


FR

IDA

Y

Room S424

[080] Lead Extraction Workshop 2: Cardiovascular Implantable Device Complications 10:40 – 12:20 Chair: Stephen KM Tam (Hong Kong)

10:40 Complications Associated with Cardiac Device Replacement

Paul Gould (Australia)

11:00 Prognosis (Pocket, Bacteremia, Sepsis, Vegetations, Risk Factors)

Hideo Okamura (Japan)

11:20 Treatment Alternatives (Extraction, Revision, Vacuum Dressings, Reimplantation)

Chi-Wo Chan (Hong Kong)

11:40 Choosing Surgical Extraction & Reimplantation Charles Kennergren (Sweden)

12:00 Cultures, Bacteriology, Antibiotics, Route of Administration & Duration

Wee-Siong Teo (Singapore)

Room S425

[081] Pediatric Workshop 3 - Challenging Issue in the Management & Pediatric Arrhythmias10:40 – 12:20 Chair: Naokata Sumitomo (Japan)

10:40 Cardiac Resynchronization Therapy in Children and Congenital Heart Disease Patients

Eun-Jung Bae (Korea)

11:00 Challenges in Device Management: Out of the Box Settings are Inappropriate for Children

Robert Gow (Canada)

11:20 Transcatheter Ablation for Cardiac Arrhythmia in Congenital Heart Diseases

Ming-Chih Lin (Taiwan)

11:40 Risk Stratification for Asymptomatic WPW Manoj N Obeyesekere (Australia)

12:00 Psychosocial Problems in Children with ICD Elizabeth Stephenson (Canada)

88 89


FR

IDA

Y

Room S426

[082] Oral Abstract Session10:40 – 12:20 Oral Presentation - CSPE Young Investigator

Award Judges: Ke-Jiang Cao (China) De-Jia Huang (China)

10:40 CSPE 02-1 Invasive ablation for atrial fibrillation aided by sparse imaging of epicardial potentials

Liansheng WANG (China)

10:56 CSPE 02-2 Focal adhesion kinase mediates atrial fibrosis via the AKT/S6K signaling pathway in chronic atrial fibrillation patients with rheumatic mitral valve disease

Peide ZHANG (China)

11:12 CSPE 02-3 Influence of intra-atrial block on the incidence of new onset atrial fibrillation after cardiac resynchronization therapy

Qi SUN (China)

11:28 CSPE 02-4 A novel SCN5A gene mutation in Chinese patients of atrial fibrillation

Zhen-yan XU (China)

11:44 CSPE 02-5 Catheter ablation of atrial flutter originated from a giant left atrium

Yu ZHANG (China)

12:00 CSPE 02-6 Feasible and effective predictor of cardiac resynchronization therapy: paced left ventricular QRS width

Chunsheng AN (China)

Room S427

[083] Medtronic Symposium - Learn from Expert: Case Based ECG Tutorial10:40 – 12:20 Chair: George Klein (Canada)

10:40 Case 1 Wee-Siong Teo (Singapore)

11:13 Case 2 Jonathan Kalman (Australia)

11:46 Case 3 Calambur Narasimhan (India)

90


FR

IDA

Y

Room S429

[084] Oral Abstract Session10:40 – 12:20 Oral Presentation: Genetic 2 Chairs: Lok-Yee So (Hong Kong) Nwe Nwe (Myammar) Zu-Lu Wang (China) 10:40 OP 11-1 Cardiac genetic service in management

of inherited arrhythmogenic diseases – pioneering experience of a regional referral centre

Ngai-Shing MOK (Hong Kong)

10:56 OP 11-2 Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in aborted cardiac arrest syndromes


11:12 OP 11-3 Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure

Yang LIU (China)

11:28 OP 11-4 Low P wave amplitude in lead I is protective for clinical recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with ZFHX3 rs2106261 GG genotype


11:44 OP 11-5 Prolonged PR interval has a predictive value for clinical recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with chromosome 4q25 rs2200733 variants

Minjin CHOE (Korea)

12:00 OP 11-6 The early experiences of high efficiency mesh like irrigation tip ablation catheter (Coolflex) in atrial fibrillation ablations

Hui-Nam PAK (Korea)

90 91


FR

IDA

Y

Room S430

[085] Oral Abstract Session10:40 – 12:20 Oral Presentation: Basic and Translational

Science 1 Chairs: Xiao-Shu Cheng (China) Li-Qun Wu (China) Xiang-Jun Yang (China)

10:40 OP 12-1 High resolution unipolar mapping with a new multi electrode mapping system predicts infarct scar thickness in a canine infarct model

Anees THAJUDEEN (USA)

10:56 OP 12-2 Left stellate ganglion block suppress Ca2+/Calmodulin-dependent protein kinase ii activation and arrhythmia in autoimmune myocarditis model

Hyelim PARK (Korea)

11:12 OP 12-3 Expression and regulation of the small-conductance calcium-activated potassium channels in diabetic mouse atria

Fu YI (China)

11:28 OP 12-4 The relationship among complex fractionated electrograms, wavebreak, phase singularity, and local dominant frequency in fibrillation wave-dynamics: a modeling comparison study

Minki HWANG (Korea)

11:44 OP 12-5 Feasibility, efficacy and safety of percutaneous retrieval of a leadless cardiac pacemaker in an IN VIVO ovine model


12:00 OP 12-6 Renal sympathetic denervation attenuates the inducibility of ventricular arrhythmia and electrophysiological substrate in dogs with pacing-induced heart failure

Qingyan ZHAO (China)

Room S221

[086] Certificate CRM Course 6 – Basic Course Quiz10:40 – 12:20 Chairs: Christine Chiu-Man (Canada) Yoshinori Kobayashi (Japan)

This will serve as review of topics covered in the Basic Course day.

92


FR

IDA

Y

Room S226

[087] Syncope Workshop - What's New in Syncope Management?10:40 – 12:20 Chair: Luca Santini (Italy)

10:40 How to Diagnosis Unexplained Syncope Using HUT?

Youichi Kobayashi (Japan)

11:00 Are there Different Hemodynamic and Autonomic Nervous Response to Head-Up Tilt between Postural Tachycardia Syndrome and Neurally Mediated Syncope?

Koichi Mizumaki (Japan)

11:20 What is the Latest Guidelines, Algorithms of Management of Syncope?

Bonpei Takase (Japan)

11:40 Role of ILR in the Evaluation of Unexplained Syncope

June-Soo Kim (Korea)

12:00 Is There a Role for Pacing for Syncope? Kuo-Hung Lin (Taiwan)

Room S227

[088] Atrial Fibrillation (Ablation) Workshop 5 - Optimizing Outcomes of RF Catheter Ablation10:40 – 12:20 Chair: Bien-Hsien Huang (Taiwan)

10:40 Techniques to Achieve Permanent PV Isolation Yoshito Iesaka (Japan)

11:00 Techniques to Create and Confirm Linear LA Ablation

Meleze Hocini (France)

11:20 Techniques to Ablate Complex Fractionated Atrial Electrograms


11:40 Techniques to Map and Ablate Non PV Triggers Ming-Long Chen (China)

12:00 Rotor Ablation: The FIRM Experience Sanjiv Narayan (USA)

92 93


FR

IDA

Y

Hall 5G, Level 5

Poster Session 308:30 – 12:20 Poster Display - Bradycardia Pacing


P3-007 Femoral extraction and focused force venoplasty: an alternative to protectoral extraction for venous access

Seth WORLEY (USA)

P3-008 Preliminary diagnosis of asymptomatic atrial tachyarrhythmia using pacemakers is not a risk for stroke

Takanao MINE (Japan)

P3-009 Real necessity of magnetic resonance imaging examinations after permanent pacemaker implantation

Akira TARUYA (Japan)

P3-010 The type of sinus node dysfunction might predict the atrial remodeling and the outcome after catheter ablation of atrial fibrillation

Boyoung JOUNG (Korea)

P3-011 The relationship between acute changes in the pacing threshold after screw-in and the pacing impedance before screw-in in the active-fixation leads

Hideyuki HASEBE (Japan)

P3-012 Usefulness of measurement of current of injury during screw-in lead implantation into right ventricular septum

Daisuke FUJIBAYASHI (Japan)

P3-013 The experience of automatic pacemaker data entry system “trophy” from the programmer to an electronic medical record.

Yoshio KOSAKAI (Japan)

P3-014 The long-term result of the single lead VDD pacemaker in the patient with atrioventricular block:a comparison of VDD and DDD pacemaker

Chisa MIYASAKA (Japan)

P3-015 Incidence of pacing-induced myocardial perfusion defect

Hisaharu OHE (Japan)

94


FR

IDA

Y

P3-016 Evaluation of the ventricular intrinsic preference and ventricular autocapture features in pacemaker patients: results of the VALIDATE study

Rakesh YADAV (India)

P3-017 Screening of sleep disordered breathing with thoracic impedance in patients with cardiac pacemaker implantation

Kensuke FUJIWARA (Japan)

P3-018 Pacemaker implantation in dextrocardia Yui-Chi SO (Hong Kong)

P3-019 The risk for newly occurrence of atrial fibrillation in pacemaker patients with atrioventricular block

Katsuhide HAYASHI (Japan)

P3-020 Comparison of outcomes of permanent pacemaker insertion using right ventricular apex versus right ventricular outflow tract septal pacing: a single center retrospective study

Ritche GO (Philippines)

P3-021 Evolution mechanical dilator sheath as a first choice for transvenous lead extraction

Rana COSTA (Lebanon)

P3-022 Foreign body retrieval from coronary sinus during CRT implantation

Sathish REDDY (India)

P3-023 Real-world, long-term comparison of titanium nitride coating versus non-coating platinum stimulating electrodes

Il-Young OH (Korea)

P3-024 Transvenous pacemaker in a patient of bioprosthetic tricuspid valve following surgical excision of tricuspid valve vegetations

Manoj KUMAR (India)

P3-026 Corrected QT interval of paced-QRS complex as a risk factor for new-onset heart failure after permanent pacemaker implantation

Seung-Jung PARK (Korea)

P3-027 Lack of atrial contraction as a predictor for permanent pacemaker implantation after the Cryo-Maze procedure combined with valve surgery

Seung-Jung PARK (Korea)

94 95


FR

IDA

Y

P3-028 Assessment of developing heart failure after pacemaker implantation by means of thoracic impedance and cytokines

Yoichi AJIRO (Japan)

P3-029 Wrap sleeve method: a novel suture sleeve fixation method after lead implantation by cephalic vein cut-down

Taku NISHIDA (Japan)

P3-030 Where to pace in RV for pacemaker dependent or frequent need of ventricular pacing

Ramdeo YADAVE (India)

P3-031 A rare complication with pacemakers- 'lead tip fracture'

Manoj KUMAR (India)

P3-032 Predictors of development of new-onset heart failure in patients underwent permanent cardiac pacemaker implantation: the QRS vector amplitude involves

Jianfeng XU (China)

P3-033 Long-term outcome of right ventricular septal versus apical pacing on left ventricular dysfunction patients with high degree heart block

Dongyan WU (China)

P3-034 Late recurrence of persistent third degree atrioventricular block after implantation of permanent pacemaker

Ling SUN (China)

P3-035 Capturing the His-Purkinje system is not possible from right ventricular apical and non-apical pacing sites


P3-036 Pacing and implantable cardioverter-defbrillator lead perforation as assessed by cardiac computer tomography: appearances and clinical correlates


P3-037 The proximity of implanted pacemaker and implantable cardioverter-defibrillator leads to coronary arteries as assessed by cardiac computer tomography


96


FR

IDA

Y

P3-038 A cardiac computer tomography assessment of conventional fluoroscopic and ECG criteria for RV septal pacemaker lead placement


P3-039 Related risk factors and treatment experience in cardiovascular implantable electronic device infection

Danhong FANG (China)

P3-040 ATAF burden in pacemaker patients with algorithms for the reduction of ventricular pacing in the COMPARE study

Qianmin TAO (China)

P3-041 To assess the long term effects of RV apical pacing on left ventricular function in patients with normal baseline left ventricular function

Balasubramaniyan JAYANTI VENKATA (India)

P3-042 Enrhythm pacemaker longevity post software upgrade: a single centre experience

Shufen LIANG (Singapore)

P3-043 Correlation analysis of risk factors of shoulder pain after artificial cardiac pacemaker implantation

Jiwen LI (China)

P3-044 Alternatives for pacemaker rate sensor optimization: can the outcome be comparable with conventional exercise test method?

Yuen-Wa LEUNG (Hong Kong)

P3-045 Our strategy to prevebt device infection Takayuki UCHIDA (Japan)

08:30 – 12:20 Poster Display - Sudden Cardiac Death


P3-046 Pharmacological rescue of nonsense mutations of HERG gene as a potential therapeutic approach for LQT2 syndrom

Haiyun YU (China)

P3-047 Updates on the management of sudden cardiac death

Sui-Yu YAU (Hong Kong)

P3-048 A novel KCNQ1 gene mutation R397Q in a patient with overlapping DCM phenotype could be associated with therapy

Qinmei XIONG (China)

96 97


FR

IDA

Y

P3-049 SCN5A mutation with lethal ventricular arrhythmias and invalidation of lidocaine in acute myocardial infarction

Qinmei XIONG (China)

P3-050 Pressure overload causes right ventricular lethal arrhythmias: analysis by optical mapping in pulmonary artery banding and pneumonectomy model

Bonpei TAKASE (Japan)

P3-051 Fever and physical exercise unmasking type 1 BRUGADA ECG in a cohort of Chinese patients with brugada syndrome


P3-052 Sudden cardiac death and the indian context: the need for holistic efforts

Kishore R. R. (India)

P3-053 Cross effects of acute adrenergic stimulation on rapid component of delayed rectifier potassium current in guinea-pig left ventricular myocytes

Ting-Ting WU (China)

P3-054 Long-term reproducibility of ventricular tachyarrhythmia inducibility and new markers for risk stratification in brugada syndrome

Atsushi DOI (Japan)

P3-055 Left stellate ganglion block improves ventricular function and conduction with the suppression of the inflammation in autoimmune myocarditis model

Hyelim PARK (Korea)

P3-056 Sleep disordered breathing in children is associated with pathophysiological changes in platelet aggregation, inflammation and endothelial dysfunction

Scott WILLOUGHBY (Australia)

P3-057 Early repolarization characterized by J wave on the electrocardiogram is highly detected in diagnostic epilepsy patients

Kenzaburo KOBAYASHI (Japan)

P3-058 Combination therapy with pravastatin and valsartan has additive effects to improve vascular and metabolic phenotypes over monotherapy in hypercholesterolemic patients

Kwang KOH (Korea)

98


FR

IDA

Y

P3-059 Impact of acute phase VT/VF on in-hospital and long-term prognosis in the percutaneous coronary intervention era

Masaharu MASUDA (Japan)

P3-060 Ubiquitin-like protein modifier FAT10 protects cardiac myocytes against apoptosis

Yang SHEN (China)

P3-061 Risk stratification for ventricular arrhythmia from right ventricular outflow tract: signal-averaged electrocardiograms provide more than diagnosis


P3-062 Sudden cardiac death and ventricular arrhythmias in young patients without coronary artery disease

Kit CHAN (Hong Kong)

P3-063 Prevalence of brugada electrocardiograms and brugada syndrome in brunei darussalam

Bee LAU (Brunei)

P3-064 Relationship between sleep apnea syndrome with normal cardiac function and T-wave alternans during sleep: analysis using a newly developed holter eectrocardiogram system

Shunji FUKUNAGA (Japan)

P3-065 Difference in leave hospital mortality of ventricular fibrillation between ACS and non-ACS.

Tomonori KANAEDA (Japan)

P3-066 A novel synonymous mutation in lamin A/C gene causes aberrant splicing in patients with familial dilated cardiomyopathy and conduction diseases

Suguru NISHIUCHI (Japan)

P3-067 Coronary artery reperfusion for ST elevation myocardial infarction results in shorter cycle length VT and fewer spontaneous arrhythmias

Chrishan NALLIAH (Australia)

P3-069 Median nerve stimulation reduces ventricular arrhythmia induced by isoproterenol infusion in normal dogs

Xiaolin ZHENG (China)

98 99


FR

IDA

Y

P3-070 Poor prognosis in heart failure patients with history of myocardial infarction or revascularization surgery: from 31 heart centers in china

Hongxia NIU (China)

P3-071 Identification of cardiomyocytes derived from human induced pluripotent stem cells using a cardiac specific promoter lentiviral vector

Yimin WURIYANGHAI (Japan)

P3-072 Speckle-tracking echocardiographic assessment in post-myocardial infarction patients with ventricular arrhythmias

Alessandro PERSI (Italy)

P3-073 Rotational anisotropy prevents transition of tachycardia to fibrillation in the ventricular wall model: a simulation study

Ryo HARAGUCHI (Japan)

P3-074 Heart rate variability measurement with detrended fluctuation analysis as a predictor of death among patients undergoing peritoneal dialysis

Henghsu LIN (Taiwan)

P3-075 Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study


P3-076 Clinical significance of increased variability of the coupling interval of premature ventricular contractions: validations in ICD recipients due to heart failure

Dong-Gu SHIN (Korea)

P3-077 Increased variability of the coupling interval of premature ventricular contractions as an adjunctive predictor of cardiac mortality in mild to moderate heart failure

Dong-Gu SHIN (Korea)

P3-078 Phenotypic characterization of two patients with lethal arrhythmia related to KCNH2-R148W variant

Seiko OHNO (Japan)

P3-079 Sudden cardiac death and the use of ICDs in the Singapore brugada syndrome registry

Eric LIM (Singapore)

100


FR

IDA

Y

P3-080 A loss-of-function mutation in SCN5A associated with monomorphic ventricular tachycardia in brugada syndrome

Keiko SONODA (Japan)

P3-081 Epinephrine/exercise-triggered QT prolongation without KCNQ1 mutations

Jiarong CHEN (Japan)

P3-082 Gap Junction Modifier Rotigaptide Increases Ventricular Conduction Velocity and Prevents Pacing-induced Ventricular Fibrillation during Therapeutic Hypothermia in Isolated Rabbit Hearts

Yu-Cheng HSIEH (Taiwan)

P3-083 Arrhythmic Events of Elderly Patients with Brugada Syndrome

Tsukasa KAMAKURA (Japan)

P3-084 Study on the cardiac ventricular myocytes electrophysiology by the patch-clamp technique

Bin LIU (China)

P3-085 Fragmented QRS after acute inferior MI and future risk of sudden cardiac death

Yu-Zhen LAU (Hong Kong)

08:30 – 12:20 Poster Display - Tachycardia Therapy Device (ICD)


P3-086 Complicated course following AICD implantaiton in a middle aged diabetic woman

Jaishankar KRISHNAMOORTHY (India)

P3-087 Barriers to implantable cardioverter defibrillator (ICD) implantation for the primary prevention of sudden cardiac death in an Asian population

Laura Lihua CHAN (Singapore)

P3-088 Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy

Yoshiyasu AIZAWA (Japan)

P3-089 Is the presence of non-sustained ventricular tachycardias associated with true ventricular tachycardias and ventricular fibrillation in primary prevention patients?

Paul ZIEGLER (USA)

100 101


FR

IDA

Y

P3-090 Sensitivity and negative predictive value of intermittent monitoring for non-sustained ventricular tachycardias in primary prevention patients

Paul ZIEGLER (USA)

P3-091 Factors affecting implantable cardioverter defibrillator (ICD) lifespan

Guy FURNISS (New Zealand)

P3-092 A path to safe MRI scanning of patients with implantable cardioverter defibrillators: a pre-clinical testing strategy

Michael GOLD (USA)

P3-093 The presence of SVC coil on ICD leads does not impact efficacy of atrial tachyarrhythmia termination by shock

Yelena NABUTOVSKY (USA)

P3-094 Impact of ICD therapies on atrial tachyarrhythmias

Yelena NABUTOVSKY (USA)

P3-095 The role of lead integrity alerts and remote monitoring in reducing morbidity associated with the St. Jude Medical Riata ICD lead

James LINDEMANN (Australia)

P3-096 Effects of epinephrine in local anesthetics for implantable cardioverter defibrillator implantation

Takatsugu KAJIYAMA (Japan)

P3-098 Incidence of high defibrillation threshold in non-left pectoral implantable cardioverter defibrillators and defibrillation threshold testing


P3-099 Differential lead component pulling as a possible mechanism of inside-out abrasion and conductor cable externalization

Ernest LAU (UK)

P3-100 Experience of Sprint Fidelis single and dual coil ICD lead failure at National Heart Center singapore


P3-101 Riata and Durata defibrillator lead failure rates at the National Heart Centre Singapore


102


FR

IDA

Y

P3-102 Factors predicting future bradycardia in patients with high-voltage devices

Akiko UEDA (Japan)

P3-103 Selection of single or dual-leads system in high voltage device implantation

Akiko UEDA (Japan)

P3-104 Is the transvenous extraction of cardioverter-defibrillator leads and left ventricular leads more risky than that of pacemaker leads?

Kennosuke YAMASHITA (Japan)

P3-105 Evolution in transvenous extraction of pacemaker and implantable cardioverter defibrillator leads using an excimer laser sheath

Kennosuke YAMASHITA (Japan)

P3-106 Efficacy of implantable cardioverter defibrillators in patients with idiopathic ventricular tachyarrhythmias

Hyoung-Seob PARK (Korea)

P3-107 Clinical characteristics and to follow-up effective with cardioverter-defibrillators in 32 isolated noncompaction cardiomyopathy patients

Cuihong HOU (China)

P3-108 Feasibility of TWA detection by a local left ventricular lead in CRT-ICD patients

Wei HUA (China)

P3-109 A comparison of North America and Australia/New Zealand ICD programming: compliance with the evidence base

Martin STILES (New Zealand)

P3-110 Serum eicosapentaenoic acid (EPA) / arachidonic acid (AA) ratio and arrhythmic events in patients having received CRT device

Kenshiro ARAO (Japan)

P3-111 Detection of a recurrent non-sustained slow VT by home monitoring ICD missed by the conventional ICD device check

Niti CHADHA (India)

P3-112 Bleeding complications associated with implantation of subcutaneous cardiac defibrillator

Jose TORRES (USA)

102 103


FR

IDA

Y

P3-113 Subcutaneous cardiac defibrillator in patients with inherited arrhythmia (IA): a single center experience

Jose TORRES (USA)

P3-114 Does gender have an influence on the use of implantable cardiac defibrillators? A propensity score analysis on a geographically diverse cohort

Majed Al FAYYAD (Saudi Arabia)

Hall 5G, Room A

[089] Joint Sponsorship by BMS/Pfizer Luncheon Symposium - Dawn a New Era of Oral Anticoagulation in Asia12:20 – 13:50 Chairs: Shinya Goto (Japan) Hung-Fat Tse (Hong Kong)

12:20 Stroke Prevention in Atrial Fibrillation: Where are We now?

Gregory Lip (UK)

12:50 Apixaban for Stroke Prevention: Lessons from ARISTOTLE and AVERROES

Shinya Goto (Japan)

13:20 The Selection of Oral Anti Anticoagulant: A Challenge in Clinical Practice

Michael Ezekowitz (USA)

104


FR

IDA

Y

Hall 5G, Room B

[090] Boston Scientific Luncheon Symposium: The Subcutaneous ICD: Protection from SCA without Touching the Heart12:20 – 13:50 Chair: Martin Stiles (New Zealand) Panelists: Kazuo Matsumoto (Japan) Hung-Fat Tse (Hong Kong) Shu Zhang (China)

12:20 The S-ICD® System: Technical Overview and Implant Experience

Bradley P Knight (USA)

12:50 Evolution of the S-ICD® System: What We’ve Learned through Clinical Data

Michael Gold (USA)

13:20 Past, Present and Future of the S-ICD® in Clinical Practice

Andrew Grace (UK)

Hall 5G, Room C

[091] St. Jude Medical Luncheon Symposium - AF & VT Ablation Technologies12:20 – 13:50 Chairs: Shih-Ann Chen (Taiwan) Young-Hoon Kim (Korea)

12:20 Advanced Ablation Technologies for Improved Clinical Outcomes

Wing-Hong Fung (Hong Kong)

12:50 Strategy for Complex Arrhythmia Ablation (AF & VT) Yan Yao (China)

13:20 Future Imaging Technologies (MediGuide) Gerhard Hindricks (Germany)

104 105


FR

IDA

Y

Hall 5G, Room A

[092] Atrial Fibrillation (Ablation) 4 - State of the Art in 201313:50 – 15:30 Chairs: Elaine Chau (Hong Kong) Toru Kawakami (Japan) Ahmad Fazil (Malyasia)

13:50 Techniques and Outcomes of Catheter Ablation of Paroxysmal AF


14:10 Techniques and Outcomes of Catheter Ablation of Long Standing Persistent AF

Robert Lemery (Canada)

14:30 Complications of AF Ablation Yan-Zong Yang (China)

14:50 Anticoagulation Strategies During and Following AF Ablation

John Day (USA)

15:10 Indications for AF Ablation Eric Prystowsky (USA)

Hall 5G, Room B

[093] Bradycardia Pacing 2 - Pacemakers: Indications and Follow-Up 201313:50 – 15:30 Chairs: Yih-Ling Chiou (Taiwan) Yan Dai (China) Xi-Wei Deng (Macau)

13:50 Is Remote Monitoring for Bradycardia Devices Really Helpful?

De-Jia Huang (China)

14:10 Ventricular Pacing Avoidance Algorithms: When to Apply and When to Avoid

Cathy Lam (Hong Kong)

14:30 Programming Rate-Adaptive Sensors: Is There a Best Practice?

Hsiang-Chiang Hsiao (Taiwan)

14:50 Should Pacemaker Selection and Programming in the Very Elderly (> 80 years) Be Simpler?

John Fisher (USA)

15:10 A Pacemaker is Indicated – When Should CRT-P Be the Device of Choice?

David Hayes (USA)

106


FR

IDA

Y

Hall 5G, Room C

[094] Tachycardia Therapy Device 2 - TOPICS IN CRT: Session I13:50 – 15:30 Chairs: Hau-Kwong Chung (Hong Kong) Yamaji Hirasuke (Japan) Aiay Naik (India)

13:50 What’s New on Echo and CRT Optimization in 2013?

Ivan Ho (USA)

14:10 Use of EKG, Intracardiacs and CXR to Get the Best Outcome for CRT at Implant

Quan Fang (China)

14:30 How to Get the Right CS Branch for Your LV Lead for the Best Outcome: Tools and Techniques

David O'Donnell (Australia)

14:50 Alternative Options for LV Lead Placement Ashish Nabar (India)

15:10 Management of Patients Post-CRT Implant: Is It Auto-Pilot or Does It Require Tuning?

Fang Fang (Hong Kong)

Room S421

[095] Medtronic Live Transmission - AF Cryoballoon13:50 – 15:30 Moderators: Shao-Wen Liu (China) Vivek Reddy (USA) Chairs: Gary CP Chan (Hong Kong) Chris KY Wong (Hong Kong) Panelists: Wyn Davies (UK) Young-Hoon Kim (Korea) Chang-Sheng Ma (China)

13:50 Lessons Learned after 300+ Cases Cryoballoon Procedure

Marcin Kowalski (USA)

14:05 SUPIR Study Vivek Reddy (USA)

106 107


FR

IDA

Y

Room S423

[096] CRT Workshop 2 - Non-responders in CRT13:50 – 15:30 Chairs: Toon-Wei Lim (Singapore) Ming-Ho Wong (Hong Kong)

13:50 Overview David Hayes (USA)

14:10 Optimization of CRT with Electrogram Parameters

Vince Paul (Australia)

14:30 Optimization of CRT by SPECT Jian-Gang Zou (China)

14:50 How to Select CRT Responders Ulhas M. Pandurangi (India)

15:10 Characteristion of Non-Responders after CRT by Speckle-Tracking Echocardiography

Kazuhiro Tatsumi (Japan)

Room S424

[097] VT Workshop 4 - VT in Cardiomyopathy13:50 – 15:30 Chairs: Alejandro Jimenez (New Zealand) Prakash Vadagenahalli (India)

13:50 Catheter Ablation of VT in Dilated Cardiomyopathy

Masahiko Goya (Japan)

14:06 Epicardial Ablation in DCM Kalyanam Shivkumar (USA)

14:22 Electrophysiological Characteristics and Catheter Ablation of Bundle Branch Reentrant Ventricular Tachycardia

Harumizu Sakurada (Japan)

14:38 Ablation of VT in ARVD Francis E. Marchlinski (USA)

15:54 Ablation of VT in Hypertrophic Cardiomyopathy

Luigi Di Biase (USA)

16:10 Illustrative Cases of Idiopathic VT and Scar VT in DCM and ICM

Kalavakolanu Sharada (India)

108


FR

IDA

Y

Room S425

[098] Genetic and Inherited Syndrome 1 - Update on Clinical Applications of Genetic Testing13:50 – 15:30 Chairs: Hasri Samion (Malaysia) Chiu-Sun Yue (Hong Kong)

13:50 Genotype-Phenotype Correlation in LQTS Tohru Ohe (Japan)

14:10 Genetic Testing in Brugada and CPVT Silvia Priori (Italy)

14:30 Genetic Testing in ARVC Minoru Horie (Japan)

14:50 Genetic Testing in Sudden Unexplained Death Chris Semsarian (Australia)

15:10 Key Role of Cardiac Genetic Counselling Jodie Ingles (Australia)

Room S426

[099] Atrial Fibrillation (Drug) Debate - Anti-Thrombotic 13:50 – 15:30 Chairs: Sirin Apiyasawat (Thailand) Cyrus R Kumara (Hong Kong)

13:50 Oral Anticoagulation Should be Interrupted for Pacemaker or ICD Surgery

Pro: Li-Qun Wu (China) Con: Martin Stiles (New Zealand)

14:40 Oral Anticoagulation Should be Interrupted for AF Ablation

Pro: Gerhard Hindricks (Germany) Con: Atul Verma (Canada)

108 109


FR

IDA

Y

Room S427

[100] Basic Research 5 - New Therapeutic Target for Treatment of AF13:50 – 15:30 Chairs: Boron CW Cheng (Hong Kong) Kee-Joon Choi (Korea) Daniel Tanubudi (Indonesia)

13:50 The Relationship of Adipocytokines and Potassium Channels

Kun-Tai Lee (Taiwan)

14:10 Use Neural Simulation to Control Atrial Fibrillation

Sunny Po (USA)

14:30 Epicardial Rotor Ablation for the Treatment of AF

Chung-Chuan Chou (Taiwan)

14:50 Optical Mapping in AF José Jalife (USA)

15:10 Ultrarapid Delayed Rectifier (IKUR) and Acetylcholine-Activated Potassium Channels (IKACh) as Atrial Selective Targets for AF

Gui-Rong Li (Hong Kong)

110


FR

IDA

Y

Room S429

[101] Oral Abstract Session13:50 – 15:30 Oral Presentation: Sudden Cardiac Death Chairs: Wan-yip Chong (Hong Kong) Kin-Shing Lun (Hong Kong) Edmond ML Wong (Hong Kong)

13:50 OP 13-1 Clinical outcomes among patients using a wearable external cardiac defibrillator vest

Robert HANSON (USA)

14:06 OP 13-2 Surgical sympathectomy reduces ventricular tachycardia burden: a single center cohort study

Soumen DEVIDUTTA (India)

14:22 OP 13-3 Early defibrillation without chest compressions improves outcome of out of hospital cardiac arrest

Alessandro CAPUCCI (Italy)

14:38 OP 13-4 Chronic baroreflex activation reduces sympathetic tone in reduced-ejection fraction heart failure with maximally-tolerated beta-blockade: implications for arrhythmia susceptibility?

Edoardo GRONDA (Italy)

14:54 OP 13-5 Pregnancy in severe hypertrophic cardiomyopathy: a multidisciplinary approach to care

Belinda GRAY (Australia)

15:10 OP 13-6 Use of cardiac magnetic resonance imaging in predicting risk of idiopathic ventricular fibrillation

Michael WONG (Australia)

110 111


FR

IDA

Y

Room S430

[102] Oral Abstract Session13:50 – 15:30 Oral Presentation: AFL Ablation Chair: Shu-Lap Chow (Hong Kong)

13:50 OP 14-1 Effect of respiration on catheter movement and stability during cavotricuspid isthmus ablation for atrial flutter


14:06 OP 14-2 Electroanatomic characterization and ablation outcome of nonlesion related left atrial macroreentrant tachycardiain patients without obvious structural heart disease

Jinlin ZHANG (China)

14:22 OP 14-3 Characteristics of atrial flutter in children and young adults

Yuriko ABE (Japan)

14:38 OP 14-4 Predictors of development of atrial fibrillation on long-term follow up in patients with macro re-entrant tachycardias: insights from an atrial flutter ablation registry

Shunmuga SUNDARAM (India)

14:54 OP 14-5 Long term outcome of atrial flutter ablation in surgically corrected ASD patients

Zulkeflee MUHAMMAD (Malaysia)

15:10 OP 14-6 Pouch depth is the sole factor affecting the radiofrequency duration and energy for right atrial cavotricuspid isthmus catheter ablation

Kazuto KUJIRA (Japan)

112


FR

IDA

Y

Room S221

[103] Certificate CRM Course 7 - SVT Tutorial13:50 – 15:30 Chairs: Christine Chiu-Man (Canada) Yui-Chi So (Hong Kong)

13:50 AV Nodal and Pathway Mediated SVT: Substrate, Mechanism and Diagnostic Criteria

Chun-Ja Yoo (Korea)

14:23 Pacing Techniques in SVT Differentiation in the EP Lab

Kyoto Soejima (Japan)

14:56 Workshop: Troubleshooting Difficult Cases of SVT

Kyoto Soejima (Japan)

Room S227

[104] Atrial Fibrillation (Ablation) Workshop 6 - Special Population13:50 – 15:30 Chair: Jen-Che Hsieh (Taiwan)

13:50 Patients with Valvular Heart Disease Atsushi Takahashi (Japan)

14:10 Patients with Hypertrophic Cardiomyopathy Andrea Natale (USA)

14:30 Patients with Chronic Renal Disease Yoshihide Takahashi (Japan)

14:50 Patients with Systolic Heart Failure Rahul Singhal (India)

15:10 Patients with Sleep Apnea Prashanthan Sanders (Australia)

112 113


FR

IDA

Y

Hall 5G, Level 5

[105] Poster Session 415:30 – 16:00 Chaired Poster Session – Basic & Translation

Science Judge: Andrew Grace (UK)

P4-001 The circadian rhythm of the ßadrenergic modulation on the IKr current in healthy guinea pig ventricular cardiomyocytes

Yanhong CHEN (China)

P4-002 Intra-sinus, inter-sinus competition in heartbeat generation by the sinus node

Hye Jin HWANG (Korea)

P4-003 Incremental prognostic value of the combination of 4q25 and ZFHX3 gene single nucleotide polymorphisms in patients who underwent radiofrequency catheter ablation for atrial fibrillation

Jaemin SHIM (Korea)

P4-004 Spiral wave pivots; localisation with high density square or circular electrode layout

Darius CHAPMAN (Australia)

P4-005 Next-generation sequencing of nine atrial fibrillation candidate genes identified novel mutations in patients with extreme trait of atrial fibrillation

Chia-Shan HSIEH (Taiwan)

P4-006 A novel molecular mechanism involved in atrial fibrillation suppression by red wine extract-resveratrol in ischemic heart failure model via PI3K/AKT/eNOS activation

Eric CHONG (Singapore)

114


FR

IDA

Y

Hall 5G, Room A

[106] Atrial Fibrillation (Drug) 2 - Meet the Experts: Using CHA2DS2-VASc and HAS-BLED in Everyday Clinical Practice16:00 – 17:40 Chairs: Kok-Han Chee (Malaysia) Bernard MY Cheung (Hong Kong) Yoshio Kosakai (Japan)

16:00 Balancing Stroke vs Bleeding Risk in the Clinic Chern-En Chiang (Taiwan)

16:20 Patient with Lone AF - How "Lone" is "Lone AF"?

Stuart Thomas (Australia)

16:40 What the Guidelines Say Satoshi Ogawa (Japan)

17:00 Is CHADS2 Score Valid in Asians? Ru-San Tan (Singapore)

17:20 Use of NOAC in Practice Paul Dorian (Canada)

Hall 5G, Room B

[107] SVT Ablation 2 - Ablation of Atrial Flutter16:00 – 17:40 Chairs: Yoshihide Nakamura (Japan) Daniel Tanubudi (Indonesia)

16:00 Diagnosis and Mapping of AFL Rong Bai (China)

16:20 Non-Contact Mapping in Atypical AFL Satoshi Higa (Japan)

16:40 Ablation of AFL after AF Ablation Young-Hoon Kim (Korea)

17:00 Ablation of AFL Following Surgical Maze Yasushi Miyauchi (Japan)

17:20 Remote Navigation for AFL Ablation Yong-Seog Oh (Korea)

114 115


FR

IDA

Y

Hall 5G, Room C

[108] Heart Failure & Remote Patient Monitoring 4 - New Implantable Sensors: From Remote Control of Devices to Remote Control of Heart Failure Patients16:00 – 17:40 Chair: To be announced

16:00 Pulmonary Artery Sensor Michael Gold (USA)

16:20 Left Atrial Pressure Sensor Iain Melton (New Zealand)

16:40 Pulmonary Fluid Status Hiroshi Tada (Japan)

17:00 HF Therapy Optimization Guided by Monitoring Right Ventricular Pressure

Werner Jung (Germany)

17:20 Respiratory Rate Trend Monitoring and Clinical Outcome

Eiichi Watanabe (Japan)

Room S421

[109] Boston Scientific Live Transmission / Watchman Session16:00 – 17:40 Chair: Margaret Hood (New Zealand)

16:00 S-ICD Live Transmission Panelists: Andrew Grace (UK) Razali Omar (Malaysia) Prashanthan Sanders (Australia) Wee-Siong Teo (Singapore) Hung-Fat Tse (Hong Kong)

17:00 Watchman Video Case Presentation Panelists: Andrew Grace (UK) Takashi Nitta (Japan) Prashanthan Sanders (Australia) Wee-Siong Teo (Singapore) Hung-Fat Tse (Hong Kong) Speaker: Razali Omar (Malaysia)

116


FR

IDA

Y

Room S423

[110] Atrial Fibrillation (Ablation) Workshop 7 - New Insights on the Mechanisms16:00 – 17:40 Chairs: Eun-Sun Jin (Korea) Hsuan-Ming Tsao (Taiwan)

16:00 Neural Mechanisms of AF and Ventricular Rate Hyung-Wook Park (Korea)

16:20 Atrial Refractory Period and Associated Structural Heart Disease

Jae-Sun Uhm (Korea)

16:40 Atrial Remodeling after Catheter Ablation of AF

Li-Wei Lo (Taiwan)

17:00 Atrial Electromechanical Interval Mapping in AF

Wen-Chung Yu (Taiwan)

17:20 Nonlinear Signal Analysis in AF Men-Tzung Lo (Taiwan)

Room S424

[111] ICD Workshop 2 - ICD Follow-Up16:00 – 17:40 Chair: Fayez Bokhari (Saudi Arabia)

16:00 Detection of AF by ICDs John Fisher (USA)

16:20 Management of High DFT Jan-Yow Chen (Taiwan)

16:40 ICD Lead Integrity Surveillance Chi-Wo Chan (Hong Kong)

17:00 Efficacy and Safety of Remote Monitoring for ICDs

Wei Hua (China)

17:20 Predictors and Impacts of Inappropriate ICD Shocks

Young-Keun On (Korea)

116 117


FR

IDA

Y

Room S425

[112] SCD Workshop 1 - Early Repolarization Syndrome16:00 – 17:40 Chair: Hon-Chi Lee (USA)

16:00 Genetics, Underlying Mechanisms, and Clinical Characteristics in Early Repolarization Syndrome

Hiroshi Watanabe (Japan)

16:20 Bundle Branch Block may Mask Early Repolarization Syndrome

Yoshifusa Aizawa (Japan)

16:40 Differentiation of Early Repolarization Syndrome, J Wave Syndrome, and Idiopathic VF

Gi-Byoung Nam (Korea)

17:00 Is It the Prime Time to Treat the Patients with Early Repolarization?

Naomasa Makita (Japan)

17:20 Genome Wide Screening for Early Repolarization

Jyh-Ming Juang (Taiwan)

Room S426

[113] Pacing Workshop 3: Special Industry Symposium16:00 – 17:40 Chair: Byron Lee (USA)

16:00 Update on Industry Efforts to Create New Standardized Pre-Clinical Lead Testing

Daniel J. Cooke (USA)

16:20 Lead Design and Design Aspects that Are Important to Know for Lead Extractors

Avi Fischer (USA)

16:40 Lead Connectors: New DF4 / IS4 Connector Designs

Shantanu Reddy (USA)

17:00 Quadripolar Left Ventricular Leads for CRT Michael Hill (USA)

17:20 Design and Testing of MRI Safe Lead Erik Trip (Germany)

118

Room S427

[114] Basic Research 6 - New Insights into the Mechanism and Management of Ventricular Arrhythmias16:00 – 17:40 Chair: Kengo Kusano (Japan) Muhammad Yamin (Indonesia) Jun Zhu (China)

16:00 A Revisit of VF Types Tsu-Juey Wu (Taiwan)

16:20 Application of Biological Simulation to the Studies of Ventricular Defibrillation

Takashi Ashihara (Japan)

16:40 Computational Modeling for Studying Mechanisms of Arrhythmogenesis in Ion Channelopathies

Chu-Pin Lo (Taiwan)

17:00 Rotors and Cardiac Fibrillation José Jalife (USA)

17:20 Arrhythmia Mechanisms and Treatments of Catecholaminergic Polymorphic Ventricular Tachycardia


Room S429

[115] Oral Abstract Session16:00 – 17:40 Case Based Oral Presentation: Genetic Chairs: John TH Wong (Hong Kong) Li-Rong Wu (China) Ya-Wei Xu (China) 16:00 OP 15-1 Molecular autopsy unmasked a novel mutation

in CACNA1C underlying brugada syndrome in a young victim of sudden nocturnal death


16:16 OP 15-2 The profile of arrhythmia and its substrate during pregnancy in first relative andersen-tawil syndrome

Hidetoshi HATTORI (Japan)

16:32 OP 15-3 Catecholaminergic polymorphic ventricular tachycardia in Chinese children

TC YU (Hong Kong)


FR

IDA

Y

118 119

16:48 OP 15-4 A case report and literature review of kearns-sayre syndrome

Xin ZHAO (China)

17:04 OP 15-5 A family of long QT syndrome with the ECG characteristics provoked prominently in the response to brisk standing

Masamichi TANAKA (Japan)

17:20 OP 15-6 Arrhythmogenic right ventricular dysplasia with total AV block manifestation

Aprilianasary UTAMI (Indonesia)

Room S430

[116] Oral Abstract Session16:00 – 17:40 Oral Presentation: Ablation Technology Chairs: Gary YK Mak (Hong Kong) Kin-Tak Wong (Hong Kong) Bing Yang (China)

16:00 OP 16-1 Feasibility and clinical usefulness of high resolution sound map with cross plane method for AF ablation

Yeong-Hwa CHUN (Eiwa Zen) (Japan)

16:16 OP 16-2 Robotic navigation for catheter ablation of atrial fibrillation – is there a learning curve?


16:32 OP 16-3 Effect of atrial fibrillation on catheter-tissue contact during antral pulmonary vein isolation in humans: lower contact force at the left anterior pulmonary vein in atrial fibrillation compared to sinus or paced rhythm


16:48 OP 16-4 First human validation of a new epicardial access needle with a real time pressure monitoring to facilitate epicardial access


17:04 OP 16-5 Endoscopic ablation by unilateral approach (left chest) for lone atrial fibrillation: a single center experience in 100 consecutive patients

Ju MEI (China)

17:20 OP 16-6 Exploring the relationship between contact force and clinical outcomes between human and robot-assisted AF ablation: early results of MAST-AF

Gavin S CHU (UK)


FR

IDA

Y

120


FR

IDA

Y

Room S221

[117] Certificate CRM Course 8 - VT Tutorial16:00 – 17:40 Chairs: Khalid Dagriri (Saudi Arabia) Chang-Hee Lee (Korea)

16:00 VT: ECG-Anatomic Correlation Ahmed Al-Fagih (Saudi Arabia)

16:33 VT in Structural Heart Disease: Substrate and Catheter Ablation

Yoshinori Kobayashi (Japan)

17:06 Cases Workshop: Difficult VT Amitabh Yaduvshi (India)

Room S226

[118] Surgical Therapy-Device and Ablation - Minimally Invasive AF Surgery16:00 – 17:40 Chair: James Wong (Singapore)

16:00 Recent Progress in Minimally Invasive AF Surgery

Xu Meng (China)

16:25 Optimal Lesion Set in AF Surgery Michael Yii (Australia)

16:50 Minimal Invasive or Total Scopic Maze Surgery Katsuhiko Imai (Japan)

17:15 Totally Thoracoscopic Atrial Fibrillation Ablation

Indran Ramanathan (New Zealand)

120 121


FR

IDA

Y

Room S227

[119] Sudden Cardiac Death Prevention in Asia16:00 – 17:40 Chairs: Kyoungim Cho (Korea) Ji-Yun Wang (China)

16:00 Call and Push as the Key Facilitator of Public Access Defibrillation

Hideo Mitamura (Japan)

16:20 Non-Invasive Markers of Risk Stratification Markers for SCDs

Takanori Ikeda (Japan)

16:40 Early Detection and Prediction of Cardiac Event Using Electrocardiogram and Pulse Wave Recording from Car Steering Wheel Sensors

Ajit Kumar Valaparambil (India)

17:00 Analysis of Electrocardiography from Automated External Defibrillator during Resuscitation of Out-of-Hospital Cardiac Arrests: From Monitoring to Prognostication

Kit Chan (Hong Kong)

17:20 ECG - Clinical Perspectives on Fragmented QRS Complex (fQRS)

Jin-Bae Kim (Korea)

122


FR

IDA

Y

Hall 5G, Level 5

Poster Session 413:50 – 17:40 Poster Display - Ablation - VT/SVT


P4-007 Frequent premature ventricular contractions induces left atrial enlargement in patients with normal left ventricular ejection fraction

Yeonjeong PARK (Korea)

P4-008 Non-fluoroscopic guidance for radiofrequency catheter ablation of supraventricular tachycardia reduces ionizing radiation times

Jason SEE (Singapore)

P4-009 Unique electrocardiogram pattern q wave in lead i of idiopathic ventricular arrhythmias from within the great cardiac vein

Li TENG (China)

P4-010 Supraventricular tachycardia ablation in a patient with complex congenital heart disease

Jaishankar KRISHNAMOORTHY (India)

P4-011 Contact force-controlled catheter ablation for patients with ventricular arrhythmias

Takehito SASAKI (Japan)

P4-012 Feasibility and safety of short-stay radiofrequency catheter ablation

Won Woo YOO (Korea)

P4-013 Predictors of sinus node dysfunction in patients after successful radiofrequency catheter ablation of typical atrial flutter

Changho SONG (Korea)

P4-014 The destruction of castle wolff-ebstein: successful management of Wolff Parkinson White syndrome in an Ebstein anomaly patient presenting with sudden cardiac death

Raymond DELA CRUZ (Philippines)

P4-015 Analysis of safety and benefits of conventional fluoroscopy versus ENSITE NAVX guided radiofrequency ablation for AVNRT

Ulhas PANDURANGI (India)

P4-016 Electrocardiographic characteristics and optimal ablation strategy for idiopathic ventricular tachyarrhythmia originated from aortic sinus cusp (ASC-IVT)

Koji MIYAMOTO (Japan)

122 123


FR

IDA

Y

P4-017 Divergent long-term outcome of catheter ablation for ventricular tachycardia in cardiomyopathy with different etiologies

Wen-Yu LIN (Taiwan)

P4-018 Beneficial effects of catheter ablation on left ventricular function in patients with frequent premature ventricular complexes

Minhua ZANG (China)

P4-019 Successful bipolar radiofrequency catheter ablation between the left ventricular endocardium and epicardium for post-infarct ventricular tachycardia: a case report

Seiji FUKAMIZU (Japan)

P4-020 Comparison of spontaneous and induced clinical ventricular tachycardia cycle length throughout multiple ablation procedures

Michifumi TOKUDA (Japan)

P4-021 Prediction of the atrial remodeling from tissue velocity imaging in patients with atrial fibrillation

Sonoda KAZUMASA (Japan)

P4-022 Using 3D electroanatomical navigation system to explore no fluoroscopy exposure in supraventricular arrhythmia ablation

Hai-Ming CUI (China)

P4-023 No alteration in endothelial function or platelet reactivity in supraventricular tachycardia


P4-024 Incidence of arrhythmias in heterotaxy syndrome

Hisaaki AOKI (Japan)

P4-025 Does electrogram morphology & lesion size predict catheter-tissue contact force during epicardial RF ablation in an ovine model

Michael WONG (Australia)

P4-026 High density mini-electrode mapping during ablation: first human experience during catheter ablation of cavo-tricuspid isthmus dependent macro-rentry

Darragh TWOMEY (Australia)

124


FR

IDA

Y

P4-027 Correlation of electrophysiological characteristics with genotype in arrhythmogenic right ventricular cardiomyopathy

Jing-Ru BAO (China)

P4-028 Characteristics of catheter ablation of atrial tachycardia involving interatrial septum

Toru ADACHI (Japan)

P4-029 The impact of fasiculoventricular bypass tracts on the diagnosis and treatment of concomitant arrhythmias

Woo Seok LEE (Korea)

P4-030 Fasciculoventricular bypass tracts: diagnosis and impact of concomitant tachycardias


P4-031 Catheter ablation of polymorphic ventricular tachycardia in patients with ischemic heart disease

Soo Yong LEE (Korea)

P4-032 New methods for ablating the difficult left accessory pathway: targeting by atrial electrogram reversal

Zheng LIU (China)

P4-033 Recurrence and complications of radiofrequency catheter ablation for arrhythmias in 19,476 patients from 1997 to 2010: population-based study from National Health Insurance Research Database

Tien Hsing CHEN (Taiwan)

P4-034 Tachycardiomyopathy due to fascicular ventricular tachycardia


P4-035 Systemic effect of intrapericardial triamcinolone acetate following epicardial mapping and ablation

Himabindu SAMARDHI (Australia)

P4-036 Single centre outcomes following ablation of non-infundibular idiopathic VT

Himabindu SAMARDHI (Australia)

P4-037 An uncommon procedure for common arrhythmia

Sathish REDDY (India)

124 125


FR

IDA

Y

P4-038 Impact of catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators

Masato FUKUNAGA (Japan)

P4-039 Analyses of QT interval duration and QT interval dispersion in patients with ventricular tachycardia of endocardial versus epicardial origin

Mehmet AKKAYA (USA)

P4-040 Reduced fluoroscopic exposure and ablation time in ablation of cavotricuspid isthmus-dependent atrial flutter in congenital heart disease using maximum voltage-guided ablation technique and 3-D mapping system

Kaijun CUI (China)

P4-041 Bundle branch reenterant tachycardia Raghav SHARMA (India)

P4-042 Difficult Ablation of a Common Arrythmia (Typical Avnrt)

Chandrasekaran KOLANDAISAMY (India)

P4-043 Successful control of congenital ventricular tachycardia, junctional ectopic tachycardia, and atrio-ventricular block in an infant

Masataka KATO (Japan)

P4-044 Focal ventricular tachycardia in a young adult Jaishankar KRISHNAMOORTHY (India)

P4-045 Procedure times and radiation exposure for various electrophysiology procedures

Bradley WILSMORE (Australia)

P4-046 A QS pattern with notched downstroke in unipolar electrogram is a specific indicator for successful ablation of ventricular outflow tract premature contractions

Xu ZHOU (China)

P4-047 Nonfluoroscopic transaortic catheter ablation of a left-sided accessory pathway under the guidance of a 3D electroanatomical mapping system

Xu ZHOU (China)

P4-048 Left lateral mahaim like accessory pathway ablation


126


FR

IDA

Y

P4-049 Radiofrequency catheter ablation in children and adults with Wolff-Parkinson-White syndrome

Sunu Budhi RAHARJO (Indonesia)

P4-050 Effects of pure potassium channel blockers nifekalant on malignant ventricular tachyarrhythmias

Sou OTSUKI (Japan)

13:50 – 17:20 Poster Display - Case Reports I


P4-051 A closely spaced bipolar electrode to eliminate phrenic pacing: two leads in the same vein connected by an adapter

Seth WORLEY (USA)

P4-052 Atrial tachycardia ablation facilitated by residual ASD in a child post ASD closure

Prafithrie Avialita SHANTI (Indonesia)

P4-053 Congenitally corrected transposition of the great arteries in a forty-four year old male

Mohammad ABEDIN (Philippines)

P4-054 A case of recurrent loss of consciousness, who was correctly diagnosed as having epilepsy by using implantable loop recorder

Osamu WAKISAKA (Japan)

P4-055 Atrial tachycardias utilizing the ligament of marshall region and pulmonary vein-left atrial appendage ridge following single ring pulmonary vein isolation for atrial fibrillation

Jacky Kit CHAN (Hong Kong)

P4-056 Confined rapid pulmonary vein activities were revealed to be responsible for recurrent atrial tachyarrhythmias by adenosine triphosphate: a case report

Hiroaki NAKAMURA (Japan)

P4-057 Atrioventricular block triggered by REM sleep and mild desaturation in a patient with sleep apnea

Zijuan HUANG (Singapore)

P4-058 A holter based methodology for screening of sleep apnea syndrome may overestimate the degree of sleep apnea in patients with Wenckebach atrioventricular block


126 127


FR

IDA

Y

P4-059 A male adolescent with hypertrophic cardiomyopathy who showed a Brugada-like electrocardiogram at the first visit

Kazuyuki TANOUE (Japan)

P4-060 A case of recurrent undifferentiated wide complex tachycardia on implantable loop recorder

Wandy CHAN (Australia)

P4-061 Catheter-induced mechanical conduction block of a fasiculoventricular bypass tract

Rintaro HOJO (Japan)

P4-062 Clinical significance of atrial pacing in a patient with constrictive pericarditis

Moritoshi FUNASAKO (Japan)

P4-063 A catheter ablation case of atrial tachycardia initiated by non-pulmonary vein ectopy adjacent to Fossa Ovalis of the left atrium - do we always have to detect arrhythmogenic triggers after pulmonary vein isolation?

Naoto NISHINA (Japan)

P4-064 “LAST (local anesthetic systemic toxicity) but not least”: systemic lidocaine toxicity during cardiac device implantation

Juan Viles GONZALEZ (USA)

P4-065 Case report: intravenous amiodarone infusion as a risk factor for torsades de pointes

Niti CHADHA (India)

P4-066 A case of successful radiofrequency catheter ablation with multiple atrioventricular accessory pathways - is it “multiple” or “broad multi-fiber” pathway?

Masahiro ESATO (Japan)

P4-067 Differential response of myocardium and thoracic lymph nodes in patients with isolated cardiac sarcoidosis

Abhijeet SHELKE (India)

P4-068 Arrhythmia in the ICUs Su Ryeon PAHK (Korea)

P4-069 Arrhythmias without arrhythmic ECG in recurrent syncope patient Implantable loop recorder revealed paroxysmal AV block

Tien Hsing CHEN (Taiwan)

128


FR

IDA

Y

P4-070 A young case of atypical type-B Wolff-Parkinson-White syndrome accompanied by left ventricular dysfunction

Takahiro TAKEUCHI (Japan)

P4-071 Daily fluctuation of pharmacologic challenge test in a patient with Brugada syndrome

Atsuyuki WATANABE (Japan)

P4-072 A case of ventricular tachycardia originated from right ventricular outflow tract during parasympathetic nervous activity dominance

Manabu FUJIMOTO (Japan)

P4-073 A case of sudden cardiac death confirmed with remote monitoring system

Kazumasa ADACHI (Japan)

P4-074 Bipolar radiofrequency catheter transmural ablation on refractory arrhythmia originating from deep myocardium

Seungyoung ROH (Korea)

P4-075 2:1 rhythm - what is the mechanism? Dev VENUGOPAL (USA)

P4-076 Ablation guided by isolated late potentials for the treatment of ventricular tachycardia associated with dilated phase of hypertrophic cardiomyopathy

Masayuki INAGAKI (Japan)

P4-077 An uncommon cause of ventricular tachycardia in patient of myotonia dystrophica and conduction system disease

P Shunmuga SUNDARAM (India)

P4-078 Ablation of intraatrial reentrant circuits from within intracardic lateral tunnel in a Fontan circulation

Narayanan NAMBOODIRI (India)

13:50 – 17:20 Poster Display - ECG: Class, Complex and Unknown


P4-079 A new algorithm differentiate the septum originated ventricular arrhythmias from the free wall in the right ventricular outflow tract

Fengxiang ZHANG (China)

P4-080 ECG abnormalities in Kawasaki disease Hae-Yong LEE (Korea)

128 129


FR

IDA

Y

P4-081 Electrocardiography recordings in higher intercostal space for children with right ventricular outlet obstruction reconstruction operation

Myung Chul HYUN (Korea)

P4-082 Clinical relevant factors associated with irregular pulse rate in general population


P4-083 Electrocardiographic voltage criteria for diagnosis of inappropriate left ventricular mass in Korean patients


P4-084 Prevalence and characteristic of J wave in patients with sarcoidosis

Naotaka HASHIGUCHI (Japan)

P4-085 P-QRS complex duration of manifest WPW syndrome correlates with the PQ interval after catheter ablation

Takatsugu KAJIYAMA (Japan)

P4-086 Electrocardiographic findings in takotsubo cardiomyopathy: ECG evolution and difference from ECG of acute coronary syndrome

June NAMGUNG (Korea)

P4-087 Markers of susceptibility to heart rhythm disturbances in adolescents with arterial hypertension

Vladimir DOLGIKH (Russia)

P4-088 Prediction of clinical courses of patients with acute myocarditis by electrocardiographic parameters on admission

Ami ISSHIKI (Japan)

P4-089 Delayed atrioventricular conduction in type 2 diabetic patients with vitamin D deficiency

Yap-Hang CHAN (Hong Kong)

P4-090 The usefulness of quantitative analysis of late potential after Pilsicainide challenge test in diagnosis of Brugada syndrome

Mayuko YAGAWA (Japan)

P4-091 Evaluation of continuous analysis of ventricular late potentials detected with a holter-based signal-averaged ECG system in obstructive sleep apnea syndrome patients

Toshio KINOSHITA (Japan)

130


FR

IDA

Y

P4-092 Evaluation of a holter based methodology for screening of sleep apnea syndrome

Rachel Xiao Shi NG (Singapore)

P4-093 A potential pitfall of modified 12-lead ECG (mason-likar modification) in catheter ablation of idiopathic ventricular arrhythmia originating the outflow tract

Suguru NISHIUCHI (Japan)

P4-094 Incidence and related factors of junctional ectopic tachycardia in infants after cardiac surgery for congenital heart disease

Nam Kyun KIM (Korea)

P4-095 Replication study for association between electrocardiographic voltage criteria and candidate single nucleotide polymorphisms associated with left ventricular hypertrophy from HyperGEN study in a Korean population


P4-096 Focal atrial tachycardia with polarity change from small positive or flat to negative of P wave in inferior leads in the surface electrocardiogram has a possibility to be ablated successfully in non-coronary aortic sinus

Reiko MATSUOKA (Japan)

P4-097 Long term prognosis of intraventricular conduction delay in patients with structurally normal heart

Young Woo JANG (Korea)

P4-098 Structure-preserving epicardial potentials reconstruction from multiple channel ECG data via an iterative reweighted regularization scheme

Liansheng WANG (China)

P4-099 The clinical correlates and prognostic impact of QRS prolongation in patients with dilated cardiomyopathy

Xiaoping LI (China)

P4-100 Evaluation of spontaneous variability in the frequency of premature ventricular complexes using 7-day holter monitor

Mingfang LI (China)

130 131


FR

IDA

Y

P4-101 Early repolarization is associated with atrial and ventricular tachyarrhythmia in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention


P4-102 Impact of autonomic nerve systems to atrial and ventricular ectopic beats: comparison study using 24hr holter monitoring

In-Cheol KIM (Korea)

P4-103 Clinical implication of amiodarone induced QT prolongation in patients underwent cardiac surgery

Myung Hwan BAE (Korea)

P4-104 Correlation between the obstructive sleep apnea and QT interval, QTc interval

Sun Ok KANG (Korea)

P4-105 Incidence and midterm outcome of arrhythmia in patients with atrial septal defect treated with percutaneous septal occluder

Myeong Ki YOON (Korea)

P4-106 The association between pulmonary dysfunction and the presence of electrocardiographic left ventricular hypertrophy in healthy middle aged

Chi Hyuk OH (Korea)

P4-107 The long-term effect of remote ischemic preconditioning induced by repetitive transient limb ischemia on ventricular premature contractions and heart rate variability

Xin-Chun YANG (China)

P4-108 STUDY QT changes IN hemodialysis in the fourth stage renal failure

Anh PHAM XUAN (Vietnam)

P4-109 QTc prolongation after ventricular septal defect repair in infants

Chang Woo HAN (Korea)

P4-110 Electrocardiographic features of therapeutic hypothermia

Woo Seok LEE (Korea)

132


FR

IDA

Y

P4-111 Seismic waves in the heart? – a novel understanding on the origin of torsades de pointes and U wave: physical, electrophysiological and beyond

Haiying SHEN (Korea)

P4-112 Spontaneous high-frequency action potential Haiying SHEN (Korea)

Room S421

[120] Bard Symposium - The BARD Unknown EP Tracing Course18:00 – 20:00 Chair: Eric Prystowsky (USA) Panelists: Jonathan Kalman (Australia) George Klein (Canada) Chu-Pak Lau (Hong Kong) Hui-Nam Pak (Korea)

Room 424

[121] St. Jude Medical China Heart Failure Forum (by invitation)18:00 – 19:30 Chairs: De-Jia Huang (China) Shu Zhang (China)

18:00 Present & Future: Device-based Therapy for HF in China

Wei Hua (China)

18:20 Expansion of CRT Therapy to Patients with Pacing Indications

Wei Xu (China)

18:40 CRT & Ablation Therapies in HF Patients with AF

Ji Yan (China)

19:00 Clinical Evidence for Basal Pacing in Left Ventricle

Liang-Rong Zheng (China)

Saturday, 5 October 2013

08:30-10:10 Main Sessions on Atrial Fibrillation (Ablation), VT Ablation, Tachycardia Therapy Device

Certificate CRM Course Basic Research Workshop Best Abstract Award Session Oral Abstract Session Joint Session with HRS/APHRS TTS Joint Symposium APHRS Guideline Session CSPE Session (Device)

10:10-10:40 Coffee Break & Chaired Poster Session – Challenging Case

10:40-12:20 Main Sessions on Atrial Fibrillation (Drug), Syncope Certificate CRM Course Basic Research Focus Session Workshop Young Investigator Award Session Oral Abstract Session APHRS Clinical Research Session CSPE Session (EP) Joint Session on Surgery and Catheter Ablation Industry Supported Session - Home Monitoring® of Cardiac

Devices (Biotronik)

12:20-13:50 Luncheon Symposium (Medtronic) Luncheon Symposium (Boston Scientific) Luncheon Symposium (St. Jude Medical) Luncheon Symposium (Boehringer Ingelheim)

13:50-15:30 Main Sessions on Atrial Fibrillation (Drug), SVT Ablation, Heart Failure & Remote Patient Monitoring

Certificate CRM Course Workshop Debate Oral Abstract Session Joint Session with SOLAECE & HRS/APHRS APHRS Basic Research Session CSPE Session (Device) Industry Supported Session – First Asia Pacific Women in EP

Forum (Medtronic)

15:30-16:00 Coffee Break & Chaired Poster Session – Device

16:00-17:40 Main Sessions on Atrial Fibrillation (Ablation), Sudden Cardiac Death, Genetic & Inherited Syndrome, Heart Failure & Remote Patient Monitoring

Certificate CRM Course Workshop Debate Basic Research Focus Session Oral Abstract Session APHRS CIED Session CSPE Session (EP) Industry Supported Session – Sudden Cardiac Arrest (Medtronic)

134


SA

TU

RD

AY

Hall 5G, Room A

[122] Atrial Fibrillation (Ablation) 5 - Anticoagulation/Stroke Prevention and Ablation08:30 – 10:10 Chairs: Sirin Apiyasawat (Thailand) Kam-Tim Chan (Hong Kong) Kan Takayanagi (Japan)

08:30 Novel Anticoagulants and Ablation Anil Saxena (India)

08:50 Anticoagulation Before and Immediately After Ablation

Luigi Di Biase (USA)

09:10 Safety of Stopping Anticoagulation After Successful Ablation

Jian Chen (Norway)

09:30 Left Atrial Appendage Exclusion as an Adjunct to Ablation

Yat-Yin Lam (Hong Kong)

09:50 Ablation as Stroke Prevention To be announced

Hall 5G, Room B

[123] VT Ablation 4 - Contemporary Topics in Idiopathic VT Ablation 08:30 – 10:10 Chairs: Shu-Kin Li (Hong Kong) Takanao Mine (Japan) Narayanan Namboodiri (India)

08:30 Catheter Ablation of Idiopathic Fascicular VT - New Insights

Mohan Nair (India)

08:50 Papillary Muscle Ventricular Arrhythmia Ablation: Overcoming the Challenges

Ming-Shien Wen (Taiwan)

09:10 Multiple Premature Ventricular Beats: What to Do?

Eli Ovsyshcher (Israel)

09:30 Ectopy-Mediated Cardiomyopathy: Mechanisms and Management

Brian Olshansky (USA)

09:50 Ablation of Mitral and Tricuspid Annular VT: The Ventricular Rings of Fire

Hiroshi Tada (Japan)

134 135


SA

TU

RD

AY

Hall 5G, Room C

[124] Tachycardia Therapy Device 3 - TOPICS IN CRT: Session II08:30 – 10:10 Chairs: Akira Fujiki (Japan) Bambang Budi Siswanto (Indonesia)

08:30 Critical Issues in Designing a Heart Failure Trial in Asia

Carolyn Lam (Singapore)

08:50 The Importance of QRS Duration in a Heart Failure Trial Using CRT

Angelo Auricchio (Switzerland)

09:10 Possible Endpoints for a CRT Trial in Patients with Ejection Fraction 35-50%

Michael Gold (USA)

09:30 The MADIT Asia Trial 2013 Arthur Moss (USA)

09:50 It is Safe to Implant a CRT Device with No Backup ICD in Patients with an EF 35-50%

Shu Zhang (China)

Room S421

[125] Joint Session with HRS / APHRS 1 - Stroke Prevention in Atrial Fibrillation08:30 – 10:10 Chairs: Chu-Pak Lau (Hong Kong) Anne Gillis (Canada)

08:30 Is There an Optimal Risk Prediction Algorithm: CHADS2, CHA2DS2-Vasc or Other?

Gregory Lip (UK)

08:50 Comparing the Novel Anticoagulants – Optimal Use in Clinical Practice


09:10 Oral Anticoagulant Safety and Efficacy - Effect Ethnic Background

Chern-En Chiang (Taiwan)

09:30 Role of Atrial Occlusion Devices Vivek Reddy (USA)

09:50 Quality Measures in AF Management in 2013 Anne Gillis (Canada)

136


SA

TU

RD

AY

Room S423

[126] CSPE Session (Device) 2 - Rotor and Arrhythmia08:30 – 10:10 Chairs: Ke-Jiang Cao (China) Hui-Min Chu (China) Bo Yang (China) Xin-Chun Yang (China)

08:30 Rotor Modulation – New Threshold for Atrial Fibrillation Ablation?

Jian-Zeng Dong (China)

08:50 Intracardiac Mapping with Basket Electrode Catheter and Rotor Modulation for Atrial Fibrillation

Hua Deng (China)

09:10 Simultaneous Multiple-lead Body Surface Potential Mapping and Rotor Modulation for Atrial Fibrillation

Xing-Peng Liu (China)

09:30 Rotor and Mechanism of Ventricular Fibrillation: Evidence from Multi-electrode Epicardial Mapping (Basic Research)

Jian Huang (China)

09:50 Rotor and Mechanism of Ventricular Fibrillation: Evidence from Multi-electrode Epicardial Mapping (Clinical Research)

Yi-Gang Li (China)

136 137


SA

TU

RD

AY

Room S424

[127] CRT Workshop 3 - Challenging Cases in Patient with CIED08:30 – 10:10 Chairs: Ashish Nabar (India) Kheng-Siang Ng (Singapore)

08:30 Case Based - Venous Anomalies during CRT Implant

Anoop Gupta (India)

08:50 Case Based - ICD Implant in ARVD Patient with Severe RV Dilatation and Myocardial Dysfunction

Ajay Naik (India)

09:10 Case Based - Adaptive CRT Vanita Arora (India)

09:30 Case Based - Simultaneous Contrast Medium Injection via Collateral Cardiac Vein to Facilitate LV Lead Implantation

Kuan-Hung Yeh (Taiwan)

09:50 Case Based – Topic to be announced Ryan Ko (Hong Kong)

138


SA

TU

RD

AY

Room S425

[128] Atrial Fibrillation (Ablation) Workshop 8 - Practical Application of Antithrombotic Therapy08:30 – 10:10 Chairs: Jiunn-Lee Lin (Taiwan) Hyung-Wook Park (Korea)

08:30 CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation: A Nationwide Population-Based Cohort Study

Tsu-Juey Wu (Taiwan)

08:46 Incidence of Silent AF after Catheter Ablation Kazutaka Aonuma (Japan)

09:02 Anticoagulation in Patients Receiving Cardioversion

Johannes Brachmann (Germany)

09:18 Anticoagulation in Patients with Renal Dysfunction

Edmund Ang (Philippines)

09:34 Secondary Stroke Prevention in Atrial Fibrillation

Jyh-Hong Chen (Taiwan)

09:50 Overview of Anticoagulation Usage for Stroke Prevention in Asia

Kang-Ling Wang (Taiwan)

138 139


SA

TU

RD

AY

Room S426

[129] Oral Abstract Session08:30 – 10:10 Best Abstract Award Judges: David Hayes (USA) Bruce Wilkoff (USA)

08:30 BA - 1 Role of the defibrillator vest as bridging therapy before ICD implantation


08:46 BA - 2 A randomized controlled trial of a minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: medium term follow-up (the minimax trial)


09:02 BA - 3 Electrophysiology of the PV-LA junction during acute stretch in humans: conduction slowing and complex fractionated electrograms

Tomos WALTERS (Australia)

09:18 BA - 4 Promising outcome by high-dense ganglionated plexi ablation for patients with paroxysmal atrial fibrillation: two years follow-up study.

Norishige MORITA (Japan)

09:34 BA - 5 Alpha B-crystallin prevents the arrhythmogenic effects of myocarditis by attenuating oxidative stress

Hyewon PARK (Korea)

09:50 BA - 6 Obesity and AF: reversal of obesity related pro-fibrotic factors expression, fibrosis regression and electro-structural reverse remodelling with weight reduction


140


SA

TU

RD

AY

Room S427

[130] Basic Research 7 - New Insights into the Mechanism of Ventricular Fibrillation08:30 – 10:10 Chairs: Kok-Han Chee (Malaysia) Yoshio Kosakai (Japan)

08:30 Systems Biology of Sudden Cardiac Death Andrew Grace (UK)

08:50 Alcohol and Cardiac Arrhythmias Chung-Lieh Hung (Taiwan)

09:10 Ryanodine Receptor as a New Target for Antiarrhythmic Drug Therapy

Peter Jones (New Zealand)

09:30 Small Conductance Calcium Activated K (SK) Channel and Cardiac Electrophysiology

Yu-Cheng Hsieh (Taiwan)

09:50 Proarrhythmic Consequences of SK Channel Inhibition


Room S429

[131] SVT Workshop 3 - Challenging SVT Ablation08:30 – 10:10 Chairs: Raymond HW Chan (Hong Kong) Shoei K. Stephen Huang (USA) Xun-Zhang Wang (USA)

08:30 Ablation of Difficult Focal AT Gregory K. Feld (USA)

08:50 Ablation of Focal AT Originating from Aortic Coronary Cusp

Hyoung-Seob Park (Korea)

09:10 Ablation of Arrhythmias Originating from the AV Node Area

Jian-Ming Li (USA)

09:30 Ablation of SVT in Congenital Heart Diseases Kai Lau (Australia)

09:50 Inappropriate Sinus Tachycardia and POTS: Ablative and Non-Ablative Therapies

Win-Kuang Shen (USA)

140 141


SA

TU

RD

AY

Room S430

[132] Oral Abstract Session08:30 – 10:10 Oral Presentation: Tachycardia Therapy Device

(ICD) Chairs: Ping-Ching Fong (Hong Kong) Jie-Fu Yang (China) Xiang-Jun Yang (China)

08:30 OP 17-1 Evidence-based shock reduction programming in asia-pacific ICD patients: sub-group results from the Shock-Less trial

Vanita ARORA (India)

08:46 OP 17-2 Incidence of antitachycardia therapy in patients undergoing AICD implantation for primary prevention


09:02 OP 17-3 Reuse of explanted ICDs for indigent patients Soumen DEVIDUTTA (India)

09:18 OP 17-4 Efficacy of antitachycardia pacing for terminating fast ventricular tachycardia in a japanese ICD population: primary results of the SATISFACTION study

Tetsuya WATANABE (Japan)

09:34 OP 17-5 Clinical application of novel non-invasive parameter for potential arrhythmogenicity in patients with implantable cardioverter defibrillator: e-Reynolds number (eRe#)

Minki HWANG (Korea)

09:50 OP 17-6 How well do results from large randomized clinical trials evaluating device function diffuse into clinical practice? assessment of impact of the INTRINSIC compared to MADIT-RIT trials in a large cohort of implantable cardioverter defibrillator patients (A)

Niraj VARMA (USA)

142


SA

TU

RD

AY

Room S221

[133] Certificate CRM Course 9 - Cardiac Imaging and Catheter Ablation in EP08:30 – 10:10 Chairs: Philip Chang (USA) Kam-Wai Lai (Hong Kong)

08:30 Essentials of CT, Cardiac MRI, 3D-RA and ICE Techniques in EP

Akiko Ueda (Japan)

08:55 3D Mapping: Principles, Tips and Tricks Luc Soucie (Canada)

09:20 Biophysics of Ablation Lesions Neil Seller (Saudi Arabia)

09:45 Emerging Technologies in AF Ablation Werner Jung (Germany)

Room S226

[134] Tokyo-Taipei-Seoul (TTS) Joint Symposium - Gender Differences in Cardiac Arrhythmias09:00 Opening Remarks Masayasu Hiraoka (Japan) Wen-Ter Lai (Taiwan) Dong-Jin Oh (Korea)

09:10 – 09:50 Session 1: Effects of Sex Hormones on Electrophysiological Parameters

Chair: Yi-Jen Chen (Taiwan)

09:10 Sex Hormone on Atrial Electrophysiology Wen-Chin Tsai (Taiwan)

09:30 Regulation of Cardiac Repolarization by Sex Hormones

Katsushige Ono (Japan)

09:50 – 11:20 Session 2: Gender Differences in Atrial Arrhythmia

Chairs: Hirotsugu Atarashi (Japan) Chen-Chuan Cheng (Taiwan) Tai-Ho Rho (Korea)

142 143


SA

TU

RD

AY

09:50 Gender Differences in Left Atrial Electroanatomical Remodeling and Mechanical Linkage to LV Diastolic Function in Patients with AF

Hui-Nam Pak (Korea)

10:10 Gender Differences of P Wave Signal Averaged Electrocardiograms: Based on the Risk of AF

Kyoungim Cho (Korea)

10:30 Gender Differences in Risk and Management of Atrial Arrhythmia

Tze-Fan Chao (Taiwan)

10:50 Gender Differences in Risk Factors of Atrial Fibrillation


11:20 – 12:05 Session 3: Gender Differences in Ventricular Arrhythmias

Chairs: Kazutaka Aonuma (Japan) You-Ho Kim (Korea)

11:20 Gender Difference of ST-segment and Role of Sex Hormone

Mikiko Nakagawa (Japan)

11:40 Gender Difference in Ventricular Tachycardia Jo-Nan Liao (Taiwan)

12:00 Closing Remarks Hirotsugu Atarashi (Japan) Young-Hoon Kim (Korea) Chi-Tai Kuo (Taiwan)

144


SA

TU

RD

AY

Room S227

[135] APHRS Guideline Session - The Launch of the APHRS’s 2013 Statement on Antithrombotic Therapy of Patients with NVAF08:30 – 10:10 Chairs: Jonathan Kalman (Australia) Swee-Chong Seow (Singapore)

08:30 To Unify and Promote Appropriate Antithrombotic Therapies in Asia-Pacific Countries

Satoshi Ogawa (Japan)

08:50 How to Use Warfarin, NOAC and ASA for Different Indications

Hung-Fat Tse (Hong Kong)

09:10 Racial Difference in Anticoagulant Effect. Fact or False?

De-Jia Huang (China)

09:30 NOAC, a Saviour of Stroke Prevention in NVAF for Asia-Pacific Population?

Martin Stiles (New Zealand)

09:50 Warfarin-Underuse and ASA-Overuse: Results of the APHRS Survey

Mohan Nair (India)

144 145


SA

TU

RD

AY

Hall 5G, Level 5

[136] Poster Session 510:10 – 10:40 Chaired Poster Session – Challenging Case Judge: Steve Lai (Hong Kong) P5-001 Facilitation in implantable cardioverter-

defibrillator (ICD) lead through a persistent left superior vena cava (LSVC) utilizing a left ventricular (LV) lead delivery system

L. Bing LIEM (USA)

P5-002 Radiofrequency ablation for incessant atrial tachycardia in a patient with repaired tetralogy of fallot

Cyril Yiu-Kwan KO (Hong Kong)

P5-003 Successful catheter ablation for interfascicular ventricular tachycardia in a case with electrical storm

Takeshi KITAMURA (Japan)

P5-004 AF ablation with a case complicated with giant coronary arteriovenous fistula running between LSPV and LAA


P5-005 Arrhythmic sequelae of the fontan procedure: impact of fontan type on pattern and prevalence of arrhythmias

Ashley NISBET (Australia)

P5-006 Para-hisian atrial tachycardia ablated from non coronary aortic sinus


146


SA

TU

RD

AY

Hall 5G, Room A

[137] Atrial Fibrillation (Drug) 3 - How to Use the New Oral Anticoagulants for Stroke Prevention10:40 – 12:20 Chairs: Mario Evora (Macau) Suet-Ting Lau (Hong Kong) Surapun Sitthisook (Thailand)

10:40 The Global Burden of AF – Focus on the Asian Perspective


11:00 An Overview of the New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Ken Okumura (Japan)

11:20 What Do the Guidelines Currently Say... and What Should Future Updates Modify?

John Camm (UK)

11:40 Management Peri-procedure (Surgery, Devices) and Ablation

Antonio Raviele (Italy)

12:00 Special Situations - Ischemic Stroke and Thrombolytic, Acute Coronary Syndrome, PCI/Stent, Bridging, Cardioversion etc.

Gregory Lip (UK)

146 147


SA

TU

RD

AY

Hall 5G, Room B

[138] Syncope 2 - Hot Topics in Syncope10:40 – 12:20 Chairs: Kin-Wing Chan (Hong Kong) Teruhisa Tanabe (Japan)

10:40 Causes of Transient Loss of Consciousness and Assessment of Need for Hospitalization

David Benditt (USA)

11:00 Syncope Unit: Impact on Patient Care and Health Related Costs

Win-Kuang Shen (USA)

11:20 Recent Advances in the Technology of Wearable and Insertable Cardiac Monitors and Their Clinical Outcomes in Evaluating the Collapse Patient

Laurence M. Epstein (USA)

11:40 Orthostatic Hypotension as a Cause of Syncope in the Elderly: How Important? And How Should We Diagnose and Manage It?

Imran Zainal Abidin (Malaysia)

12:00 Does Syncope Increase Risk in Patients with Suspected Channelopathy?

Philip Chang (USA)

148


SA

TU

RD

AY

Hall 5G, Room C

[139] BIOTRONIK Symposium - Home Monitoring® of Cardiac Devices: Curse or Cure? – A Review of Practical Issues Related to Integrating Remote Monitoring into Daily Clinical Practice10:40 – 12:20 Chairs: Niraj Varma (USA) Shu Zhang (China)

10:40 Introduction Niraj Varma (USA) Shu Zhang (China)

10:50 The Importance of Remote Monitoring and the Implication of Trial Results on Daily Clinical Application

Niraj Verma (USA)

11:10 How to Overcome Challenges Related to Integrating Home Monitoring into Clinical Practice

Vince Paul (Australia)

11:30 Evaluation of an Appropriate BIOTRONIK Home Monitoring® Clinical Workflow – A Real Life Example

Ke-Ping Chen (China)

11:50 Outpatient Clinic Improvement with BIOTRONIK Home Monitoring® and Results of the J-Home ICD Study

Eiichi Watanabe (Japan)

12:10 Discussion and Summary Niraj Varma (USA) Shu Zhang (China)

148 149


SA

TU

RD

AY

Room S421

[140] Focus Session 3 - AF Ablation Complications: A Case Based Approach 10:40 – 12:20 Chair: Hugh Calkins (USA)

10:40 Case Based: Atrial Flutter Following AF Ablation (Differential Diagnosis and Management)

Hiroshi Nakagawa (USA)

10:13 Case Based: A Case with PV Stenosis and PV Intervention - Diagnosis and Management of PV Stenosis

Kazuhiro Satomi (Japan)

10:46 Case Based: TEE Immediately Prior to AF Ablation Revels a LA Thrombus Despite Anticoagulation with Warfarin (Anticoagulation Strategies at the Time of AF Ablation)

John Day (USA)

Room S423

[141] CSPE Session (EP) 3 - New Technologies and New Methods10:40 – 12:20 Chairs: Yan-Sheng Ding (China) Yi-Gang Li (China) Guo-Dong Niu (China) Yun-Long Xia (China)

10:40 Radiofrequency Catheter with Contact Force Monitoring and Its Application in Ablation for Atrial Fibrillation

Shao-Wen Liu (China)

11:00 The Progress in Implantable Medical Devices Xiao-Hong Zhou (China)

11:20 Application of Magnetic Resonance Imaging in Radiofrequency Catheter Ablation: State-of-the-Art

He Huang (China)

11:40 Renal Artery Ablation in Arrhythmia Management

Qi-Jun Shan (China)

12:00 Totally Thoracoscopic Surgery for Isolated Atrial Fibrillation

Zhe Zheng (China)

150


SA

TU

RD

AY

Room S424

[142] SCD Workshop 2 - Brugada Syndrome10:40 – 12:20 Chairs: Chi-Ming Wong (Hong Kong) Iain Melton (New Zealand) Ajit Kumar Valaparambil (India)

10:40 Genetic and Molecular Basis of Brugada Syndrome

Kui Hong (China)

11:00 How to Distinguish the Real Brugada Syndrome from J Wave Syndrome

Gi-Byoung Nam (Korea)

11:20 Clinical and Electrocardiographic Features for Risk Assessment in Brugada Syndrome

Masahiko Takagi (Japan)

11:40 Mapping and Ablation of the Brugada Syndrome


12:00 Could Brugada Syndrome be Treated without ICD?

Shiro Kamakura (Japan)

Room S425

[143] Lead Extraction Workshop 3: Lead Extraction Techniques and Tools10:40 – 12:20 Chairs: Kwok-Fai Leung (Hong Kong) Nigel Lever (New Zealand)

10:40 Imaging (Duplex, CXR, 2D Echo, TEE, Cath, CT, Intravascular Ultrasound, Fluoroscopy)


11:00 Controlling the Lead Body (locking styles, sutures, Bulldogs, compression coils, deactivating active fixation)

Robert Giles (USA)

11:20 Snaring Leads: Why, Why Not and How Peter Belott (USA)

11:40 Choosing Laser, Evolution, Mechanical and When to Change or Stop

Xue-Bin Li (China)

12:00 Putting Together an Effective Team (Operator, RN, Radiology, Anesthesia, Surgeon)

Bruce Wilkoff (USA)

150 151


SA

TU

RD

AY

Room S426

[144] Oral Abstract Session10:40 – 12:20 Young Investigator Award Chairs: Chin-Pang Chan (Hong Kong) Narasimhan Calambur (India)

10:40 YIA - 1 Characteristics and clinical correlates of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in indian patients with hypertrophic cardiomyopathy

Harikrishnan G (India)

10:56 YIA - 2 Does termination of atrial fibrillation during ablation of long standing persistent atrial fibrillation predict the outcome at follow-up? Results from a prospective randomized study


11:12 YIA - 3 A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: acute outcomes in a prospective multi-centre randomised controlled trial (the minimax study)


11:28 YIA - 4 Usefulness of NOAC for perioperative period in atrial fibrillation ablation

Kenichi HIROSHIMA (Japan)

11:44 YIA - 5 Diffuse ventricular fibrosis measured by T1 mapping on cardiac MRI predicts success of atrial fibrillation ablation


12:00 YIA - 6 Causes of sudden cardiac death among young victims – a five-year review of autopsies done in Hong Kong


152


SA

TU

RD

AY

Room S427

[145] Basic Research 8 - New Insights into the Mechanism and Management of Atrial Arrhythmias10:40 – 12:20 Chairs: Chun-Ho Cheng (Hong Kong) Azlan Hussin (Malaysia)

10:40 Atrial Fibrosis: A New Paradigm in AF Development and Impact on Transcatheter Ablation

Ali Oto (Turkey)

11:00 Electrophysiology of Omega-3 Fatty Acid to PV Cardiomyocytes

Kazuyoshi Suenari (Japan)

11:20 Role of Adipocytokines on Atrial Arrhythmogenesis

Yi-Jen Chen (Taiwan)

11:40 Obesity and Atrial Electrostructural Remodeling

Yong-Mei Cha (USA)

12:00 Electrical Remodeling Induced by Primary Oxidative Stress - Studies in Primary Hyperoxidative Mice Model

Shinichi Niwano (Japan)

Room S429

[146] Joint Session: Surgery and Catheter Ablation - Long-term Outcomes after AF Ablation: Catheter vs. Surgery10:40 – 12:20 Chairs: Wing-Kuk Au (Hong Kong) Masataka Mitsuno (Japan)

10:40 Concomitant Surgical AF Ablation in Patients with High Surgical Risks Undergoing Open Heart Surgery: Risks vs. Benefits

Jae-Won Lee (Korea)

11:00 Anticonaglant Therapy after AF Surgery James Wong (Singapore)

11:20 Long-Term Outcomes after AF Surgery Yosuke Ishii (Japan)

152 153


SA

TU

RD

AY

11:40 Outcome after AF Ablation (Cardiologists) Hui-Nam Pak (Korea)

12:00 Outcome after AF Ablation (Cardiologists) Teiichi Yamane (Japan)

Room S430

[147] Oral Abstract Session10:40 – 12:20 Oral Presentation: SVT Ablation Chairs: Wei-Ze Zhang (China) Zheng Zhang (China)

10:40 OP 18-1 Catheter ablation of epicardial accessory pathway associated with coronary sinus musculature: single-center clinical experience

Weizhu JU (China)

10:56 OP 18-2 Electrophysiologic characteristics of supraventricular tachycardias with Ebstein's anomaly

Wei WEI (China)

11:12 OP 18-3 “Near-Zero” radiation exposure in catheter ablation of cardiac arrhythmias using electroanatomic mapping system

Man-Chun CHOI (Hong Kong)

11:28 OP 18-4 Waiting times after catheter ablation for supraventricular tachycardias: do we really need them?

Simran SINHA (UK)

11:44 OP 18-5 Left accessory pathway ablation-safety and superiority of antegrade vs retrograde approaches

Prakash V S (India)

12:00 OP 18-6 Electrophysiologic testing and catheter ablation in young asymptomatic subjects with ventricular pre-excitation

Roberto DE PONTI (Italy)

154


SA

TU

RD

AY

Room S221

[148] CRM Course 10 - Advanced Cardiac Resynchronization Therapy10:40 – 12:20 Chairs: Jungwae Park (Korea) Neil Seller (Saudi Arabia)

10:40 CRT Implantation Techniques: Tips and Tricks to Improve Successful Implant

Kheng-Siang Ng (Singapore)

11:13 CRT Follow-Up Complications and Management Elizabeth Stephenson (Canada)

11:46 Workshop: Case-Based Approach to CRT Troubleshooting


Room S227

[149] APHRS Clinical Research Session10:40 – 12:20 Chairs: Mitsunori Maruyama (Japan) Joy Maliackal Thomas (India)

10:40 AF (CFE and DF Mapping) Shiro Nakahara (Japan)

11:00 Signal Characteristics of Fractionated Electrograms in Paroxysmal, Persistent, and Long-Lasting Persistent AF

Yenn-Jiang Lin (Taiwan)

11:20 Redo and Multiple Procedure after Catheter Ablation of AF

Li-Wei Lo (Taiwan)

11:40 The Impact of Heterogeneous Pulmonary Vein Anatomy in Catheter Ablation of Atrial Fibrillation

Shih-Lin Chang (Taiwan)

12:00 Risk Factors and Predictors of New Occurrence of Atrial Fibrillation


154 155


SA

TU

RD

AY

Hall 5G, Level 5

Poster Session 508:30 – 12:20 Poster Display - Case Abstract


P5-007 Atrial lead location plays an important role to avoid unnecessary ventricular pacing during both atrial pacing and atrial sensing

Chikashi SUGA (Japan)

P5-008 Termination of persistent atrial fibrillation refractory to pulmonary vein isolation using very low-dose ibutilide and individualized atrial ablation

Xian-dong YIN (China)

P5-009 Unusual ratchet syndrome: spontaneous lead retraction after a generator exchange

Satoshi HIGUCHI (Japan)

P5-010 Unusual presentation of subclavian crush syndrome

Ho-Chuen YUEN (Hong Kong)

P5-011 Aconitine induced bidirectional ventricular tachycardia successfully supported by ECMO


P5-012 ICD lead fracture caused by subclavian venoplasty during CRT upgrade


P5-013 The effect of the initial ratio of left atrial appendage cycle length (LAACL) /pulmonary vein cycle length (PVCL) on the AF termination in persistent atrial fibrillation (PsAF) catheter ablation

Ying TIAN (China)

P5-014 Utility of unipolar electrogram morphologies in the pulmonary vein isolation with radiofrequency ablation

Xiao-Qing LIU (China)

P5-015 To identify the recurrence patients with persistent atrial fibrillation after catheter ablation: value of a pre-procedural ibutilide test

Ying TIAN (China)

156


SA

TU

RD

AY

P5-016 A novel approach to ablate paroxysmal atrial fibrillation refractory to pulmonary vein isolation: value of low dose ibutilide

Ying TIAN (China)

P5-017 The effects of cilostazol on the ion channels in rat right ventricular myocyte

Rong HE (China)

P5-018 NA Ms WEK (China)

P5-019 Pulmonic valve endocarditis with an underlying ventricular septal defect a report on three cases at the Philippine General Hospital

Jaime AHERRERA (Philippines)

P5-020 Recurrent transient ischemic attacks in a female with an atrial septal aneurysm and an atrial septal defect: a case report


P5-021 Cardiac tamponade as a rare manifestation of systemic lupus erythematosus a report on three cases in the Philippine General Hospital


P5-022 The case presentation of concealed WPW with the pseudo myocardial infarction (MI)

Nongnooch POOWANAWITTAYAKOM (USA)

P5-023 Supraventricular tachycardia with hydrops in a 20-year old primigravid

Arvisminda Luz FERNANDEZ (Philippines)

P5-024 Third degree atrioventricular block and pericarditis complicating hyperthyroidism and persistent left superior vena cava

Mark VICENTE (Philippines)

P5-025 Evaluation of an algorithm for identification of the origin of atrial tachycardia by the detailed analysis of P wave

Mitsumi YAMASHITA (Japan)

P5-026 A case of catecholaminergic polymorphic ventricular tachycardia with de novo mutation in ryanodine receptor 2 misdiagnosed as epilepsy

Xin LIU (China)

156 157


SA

TU

RD

AY

P5-027 Arrhythmogenic right ventricular tachycardia with total AV block manifestation

Aprilianasary UTAMI (Indonesia)

P5-028 Interpulmonary vein electrical connection and pulmonary vein tachycardia in a patient with paroxysmal atrial fibrillation: the important role of pulmonary vein carina

Eiji SATO (Japan)

P5-029 Transeptal, transmitral left ventricular lead positioning during CRT device implantation is safe

Aref ARJOMAND (Australia)

P5-030 Clinical effects of chemical ablation for the vein of Marshall in terms of pulmonary vein isolation in patients with atrial fibrillation

Tomoaki HASEGAWA (Japan)

P5-031 Successful catheter ablation against purkinje related reentrant ventricular tachycardia associated with myotonic dystrophy - a case report

Mayumi KANEDA (Japan)

P5-032 Successful radiofrequency catheter ablation for atrial tachycardia with specific activation mapping in a limited area after sequential linear defragmentation approach

Jin IWASAWA (Japan)

P5-033 Ventricular tachycardia storm in left dominant arrythmogenic cardiomyopathy

Surendra CHUTANI (India)

P5-034 A case of ventricular tachycardia originated from right purkinje system

Sung-Won JANG (Korea)

P5-035 Thrombus formation in the left atrial appendage during catheter ablation for persistent atrial fibrillation

Shin KASHIMURA (Japan)

P5-036 A case with much lower and varying basic rate induced by noncompetitive atrial pacing


P5-037 An unusual case of torsades de pointes: look before you treat!

Vivek CHATURVEDI (India)

158


SA

TU

RD

AY

P5-038 Lone atrial fibrillation in an adolescent girl Sit-Yee KWOK (Hong Kong)

P5-039 Case of late perforation of right ventricular caused by electrode

Sit-Yee LIANG (China)

P5-040 Successful catheter ablation of para-hisian atrial tachycardia from the noncoronary cusp of aortic valve

Li-Li CHEUNG (Hong Kong)

P5-041 Moxifloxacin-induced torsade de pointes, after the cardiac surgery

Fatih ADA (Turkey)

P5-042 Cardiac tamponade complicating disseminated non-tuberculous mycobacterial infection involving the pericardium: a case report


P5-043 A case of retained broken wire in coronary sinus during biventricular pacemaker implant

Tit-Kei NG (Hong Kong)

08:30 – 12:20 Poster Display - Case Reports II


P5-045 Case report: An 84-year-old man reported several episodes of palpitations over the previous 6 months


P5-046 Two cases of right atrial thrombi complicated by tachycardia induced cardiomyopathy

Haruka FUJIMAKI (Japan)

P5-047 Successful catheter ablation of junctional tachycardia in a heterotaxy patient with twin atrioventricular nodes

Tomomi NISHIMURA (Japan)

P5-048 Extremely rapid electrical activity persisting in the isolated pulmonary vein in patients with paroxysmal atrial fibrillation: a case series

Kotaro FUKUMOTO (Japan)

P5-049 Effectiveness of ASV and catheter ablation for the refractory electrical storm associated with SAS in patient with cardiac sarcoidosis

Koji YOSHIE (Japan)

P5-050 Usefulness of ivabradine in treatment of atrial tachycardia and predictors of its response


158 159


SA

TU

RD

AY

P5-051 Takotsubo cardiomyopathy complicating permanent complete AV-block

Takashi KANDA (Japan)

P5-052 Right ventricular papillary muscle tachycardia in a patient with Ehlers-Danlos syndrome

Alejandro JIMENEZ RESTREPO (New Zealand)

P5-053 Extracardiac structures are frequently present within close proximity to the mitral annulus: relevance to catheter ablation for the left mitral isthmus in 28 cases

Nobuhiro NISHIYAMA (Japan)

P5-054 Successful catheter ablation of para-hisian accessory pathway targeted the accessory pathway potential

Akemi ASO (Japan)

P5-055 The combination of post coronary vasospasm QT prolongation and right ventricular premature contractions is at risk for lethal ventricular arrhythmia in the patient with vasospastic angina

Sae MORITA (Japan)

P5-056 Ablation of right ventricular outflow tract VT/PVC from left ventricular side

Nwe NWE (Myanmar)

P5-057 Three cases of pacemaker implantation via persistent left superior vena cava

Sang Hyun LEE (Korea)

P5-058 Usefulness of surgical intervention for refractory ventricular tachycardia in patients with structural heart disease - lessons from two cases

Yasuhito KOTAKE (Japan)

P5-059 Successful catheter ablation for focal atrial tachycardia developed a macro-reentrant circuit around the mitral annulus in patient with dialysis: a case report

Hideki KOIKE (Japan)

P5-060 Focal atrial tachycardia - demographics, characteristics and outcomes post ablation in a south australian population


P5-061 Focal atrial tachycardia arising from crista terminalis – clinical and electrophysiological characteristics and ablation outcomes


160


SA

TU

RD

AY

P5-062 Paroxysmal supravetricular tachycardia with relative slow heart rate - a case report

Shan REN (China)

P5-063 PVCs and LV false tendon Aasit SHAH (India)

P5-064 Effect of routine bilateral circumferential pulmonary vein isolation for atrial fibrillation in patient with Ebstein's anomaly

Takehito KONDO (Japan)

P5-065 Failure of mode switch in 2:1 atrial flutter Wenheng LIU (China)

P5-066 Successful ablation of epicardial VT cases from great cardiac vein and endocardium

Shozo KONISHI (Japan)

P5-067 A delayed complication of simple and superficial pacemaker pocket infection

Weng-Chio TAM (Taiwan)

P5-068 An unusual presentation of ICD lead perforation

Weng-Chio TAM (Taiwan)

P5-069 Renal infarction due to atrial fibrillation after ICD implantation

Yingshuo HUANG (China)

P5-070 The cases of the complication with complete atrioventricular block and right bundle-branch block due to catheterization in right ventricle

Masayuki ISHIMURA (Japan)

P5-071 Temporary pacemaker lead perforation into pericardium: potential risk after Bentall’s surgery

Yen-Chang HUANG (Taiwan)

P5-072 Sawtooth electrocardiographic pattern with blocked cavotricuspid isthmus - what is the mechanism?

Weita CHEN (Taiwan)

P5-073 Late positive flecainide test for Brugada syndrome

Belinda GRAY (Australia)

P5-074 Radiofrequency catheter ablation at ventricular insertion site of left anterolateral accessory pathway with trans-septal approach

Jae-Jin KWAK (Korea)

160 161


SA

TU

RD

AY

P5-075 Pacemaker prevents ventricular tachycardia in the patient with intermittent complete atrioventricular block


P5-076 A pseudo-decremental accessory pathway: where did it block?

Yu QIAO (China)

P5-077 The SCN5A mutation in the patient with the progressive cardiac conduction defect - case report

Kohei MATSUSHITA (Japan)

P5-078 Delayed disappearance of premature ventricular complex after radiofrequency catheter ablation


P5-079 Ventricular tachycardia complicated with chronic pressure or volume overloading at right ventricular outflow tract in a patient who underwent device closure for patent ductus arteriosus: a case report


P5-080 Prinzmetal's angina with ventricular arrhythmia presented as seizure and incontinence during sleep in a young woman

Ming-Chih LIN (Taiwan)

P5-081 Voltage mapping guided ablation in patients with macroreentrant tachycardia developed after prior atrial fibrillation ablation

Dae In LEE (Korea)

P5-082 Case report: brugada syndrome: 10-year follow up of the first triplet family with Brugada syndrome in Hong Kong

Michael SH WAN (Australia)

P5-083 Successful upstream therapy with angiotensin receptor blockers for secondary prevention of paroxysmal atrial fibrillation: case reports

Patrick PAU (USA)

P5-084 Dramatic improvement of recurrent anemia due to intracardiac mechanical hemolysis in a patient with hypertrophic obstructive cardiomyopathy by dual chamber pacing

Yosuke MIWA (Japan)

162


SA

TU

RD

AY

P5-085 Evaluation of pulmonary vein stenosis following extensive encircling pulmonary vein isolation (EEPVI)

Yu MAKIHARA (Japan)

P5-086 Persistent focal atrial fibrillation in an isolated pulmonary vein: a case report


P5-087 The clinical application of home monitoring pacemaker in monitoring arrhythmia:a report of 14 cases

Xiao-Li LI (China)

P5-088 Radiofrequency catheter ablation of common atrial flutter via an anomalous IVC with azygos continuation and SVC by a femoral approach

Yasutaka HIRAYAMA (Japan)

P5-089 Successful isolation of arrhythmogenic area in a patient with focal atrial tachycardia originating from para-hisian region

Satoshi HIGA (Japan)

P5-090 Successful electrical disconnection of VT substrate in a patient with ARVC

Kazushige YAMAGUCHI (Japan)

P5-091 Entrainment pacing from coronary sinus ostium may support slow pathway as an antegrade limb of the reentry circuit in fast-slow atrioventricular nodal reentrant tachycardia

Yoshiaki KANEKO (Japan)

P5-092 Implantation of a transvenous right ventricular pacing lead via collateral veins in a nonagenerian with total occlusion of the subclavian vein

Max Olav SCHRAGE (Germany)

P5-093 Effect of hybrid approach including adaptive servo-ventilation and catheter ablation on reverse remodeling in long-standing atrial fibrillation with dilated cardiomyopathy

Asumi TAKEI (Japan)

P5-094 Interatrial electrical dissociation after radiofrequency catheter ablation for persistent atrial fibrillation

Jaemin SHIM (Korea)

162 163


SA

TU

RD

AY

P5-095 Self-terminating ventricular fibrillation - a case report

Joanna LEWEK (Poland)

P5-096 Pacemaker lead perforation at the right ventricular outflow pacing

Akihiro SUNAGA (Japan)

P5-097 Spontaneous Restoration of Sinus Rhythm after Deployment of a Left Atrial Appendage Occlusion Device in Patients with Persistent Atrial Fibrillation

Dae In Lee (Korea)

Hall 5G, Room A

[150] Medtronic Luncheon Symposium: New Technologies and Approaches in Arrhythmia Management12:20 – 13:50 Chairs: Imran Zainal Abidin (Malaysia) Joseph YS Chan (Hong Kong)

12:20 Maximising Benefit of CRT with LV Only Pacing Chu-Pak Lau (Hong Kong)

12:50 The Future of Lead Technology Bruce Wilkoff (USA)

13:20 Minimizing Shocks: Appropriate Device Selection and Programming


164


SA

TU

RD

AY

Hall 5G, Room B

[151] Boston Scientific Luncheon Symposium - The New Gold Standard in Mapping and Navigation Technology12:20 – 13:50 Chair: Young-Hoon Kim (Korea) Panelists: Yoshito Iesaka (Japan) Chang-Sheng Ma (China) Shu-Lin Wu (China)

12:20 Rhythmia™ - Next Generation 3D electroanotomical Mapping System

Hiroshi Nakagwa (USA)

13:05 Intellatip MiFi™ XP – Unparalleled Local Electrical Clarity in Real Time Ablation


Hall 5G, Room C

[152] St. Jude Medical Luncheon Symposium - Cardiac Pacing / Future Technologies12:20 – 13:50 Chairs: Kwok-Keung Chan (Hong Kong) Chun-Chieh Wang (Taiwan)

12:20 New Pacemaker Diagnostics to Improve Clinical Outcomes

Ashish Nabar (India)

12:50 MRI Conditional Pacemakers – Standard of Care?

Chee-Wan Lee (Singapore)

13:20 Leadless Pacemakers – The Future Today Johannes Sperzel (Germany)

164 165


SA

TU

RD

AY

Room S421

[153] Boehringer Ingelheim Luncheon Symposium - New Oral Anticoagulants for Stroke Prevention in Asia: Where Are We Now?12:20 – 13:50 Chairs: On-Hing Kwok (Hong Kong) Hung-Fat Tse (Hong Kong)

12:20 Current Status of Stroke Prevention in Asia Hung-Fat Tse (Hong Kong)

12:50 New Insights from Clinical Evidence and Real World Experience

Paul Dorian (Hong Kong)

13:20 Resolving Controversies and Maximizing Benefits of NOACs

Raymond SM Wong (Hong Kong)

Hall 5G, Room A

[154] Atrial Fibrillation (Drug) 4 - Antiarrhythmic Drugs in Atrial Fibrillation – Where are We Now?13:50 – 15:30 Chairs: Azlan Hussin (Malaysia) Choong-Hwan Kwak (Korea) Yuk-Kong Lau (Hong Kong)

13:50 Do We Have Outcomes Data for Rate-control Agents?


14:10 Should We Keep Digitalis in Rate Control Armamentarium?


14:30 Is the Rate Control vs Rhythm Control Argument Shifted to Early Onset AF – EAST, RACE-3

Isabelle van Gelder (The Netherlands)

14:50 Atrial Selective Anti-arrhythmia Agent: Hope or Hype?

John Camm (UK)

15:10 Holistic Management of AF – Looking Beyond Anti-arrhythmic Drugs

Paul Dorian (Canada)

166


SA

TU

RD

AY

Hall 5G, Room B

[155] SVT Ablation 3 - Diagnostic and Technical Considerations 13:50 – 15:30 Chairs: Liang Chow (Hong Kong) Rohan Gunawardena (Sri Lanka) U-Po Lam (Macau)

13:50 Supraventricular Tachycardia: Diagnostic Maneuvers

Bhargava Kartikeya (India)

14:10 AV Node Reentrant Tachycardia: The Typical and the Atypical

Shoei K. Stephen Huang (USA)

14:30 Paraseptal Focal Atrial Tachycardia Ablation: Resolving Adjacent Sites of Origin

Xing-Peng Liu (China)

14:50 Inappropriate Sinus Tachycardia: What Role of Ablation in the Ivabradine Era?

Brian Olshansky (USA)

15:10 Focal Atrial Tachycardias Arising from the Appendages

To be announced

Hall 5G, Room C

[156] Heart Failure & Remote Patient Monitoring 5 - Optimizing Benefit from CRT 13:50 – 15:30 Chairs: Yu-Ho Chan (Hong Kong) Chi-Tai Kuo (Taiwan)

13:50 Optimization Strategies in CRT Patients Cheuk-Man Yu (Hong Kong)

14:10 Novel Technologies for Targeting Left Ventricular Lead Placement

Daniel Gras (France)

14:30 Managing Phrenic Nerve Stimulation in CRT Patients

Tachapong Ngarmukos (Thailand)

166 167


SA

TU

RD

AY

14:50 Role of Acute Hemodynamic Indices to Predict Long-term Outcomes in Patients Receiving Cardiac Resynchronization Therapy


15:10 CRT Response in Patients Implanted with a Quadripolar LV Lead. Are 4 Poles Better than Two?

David O'Donnell (Australia)

Room S421

[157] Joint Session with HRS / APHRS 2 - Catheter Ablation of Atrial Fibrillation: State of the Art in 2013 13:50 – 15:30 Chair: Wee-Siong Teo (Singapore)

13:50 Catheter Ablation of Paroxysmal Atrial Fibrillation: Technique and Outcomes


14:10 Catheter Ablation of Long Standing Persistent Atrial Fibrillation: Is There a Consensus?

Hugh Calkins (USA)

14:30 Complications of AF Ablation: How Can We Avoid Them

John Day (USA)

14:50 Indications for AF Ablation: What Do The Guidelines Tell Us?


15:10 Managing Anticoagulation Peri Procedure Young-Hoon Kim (Korea)

168


SA

TU

RD

AY

Room S423

[158] CSPE Session (Device) 4 - Choices of CRT Indications13:50 – 15:30 Chairs: Yu-Gang Dong (China) Yan-Gang Su (China) Yu-Tang Wang (China)

13:50 CRT and Mild-to-Moderate Heart Failure Wei Hua (China)

14:10 Morphology (LBBB or non-LBBB) and Duration of QRS Complex and CRT

Fa-Rong Shen (China)

14:30 CRT and Pacemaker-Dependent Patients with Heart Failure - Interpretation of BLOCK HF Clinical Trial

Lin Chen (China)

14:50 Options of CRT and CRT-D: Risk and Benefit? Joseph YS Chan (Hong Kong)

Room S424

[159] Oral Abstract Session13:50 – 15:45 Case Based Oral Presentation: Device Chairs: Chun-Leung Lau (Hong Kong) Fang-Zheng Wang (China) Bao-Peng Tang (China)

13:50 OP 19-1 Mitraclip for cardiac resynchronization therapy nonresponder with cardiogenic shock

Andrew NG (Hong Kong)

14:04 OP 19-2 My difficult coronary sinus cannulation during biventricular pacemaker implantation

Manoj K ROHIT (India)

14:18 OP 19-3 Case of implanting ICD by hybrid operation Zhaoguang LIANG (China)

14:32 OP 19-4 Renal artery embolism after biventricular pacemaker implantation: a case report and literature review

Xin ZHAO (China)

168 169


SA

TU

RD

AY

14:46 OP 19-5 Two unusual cases of acute transient non-physiological oversensing in the ventricle with a DF4 lead

Paul GOULD (Australia)

15:00 OP 19-6 Peroperative epicardial left ventricular (LV) lead placement in severe aortic valve disease and LV dysfunction undergoing valve replacement -report of three cases

S P ABHILASH (India)

15:16 OP 19-7 Percutaneous mitral valve repair system (MitraClip) in CRT non-responders or CRT ineligible patients with severe functional mitral regurgitation

Ryan KO (Hong Kong)

Room S425

[160] VT Ablation Debate13:50 – 15:30 Chair: Yash Yahya Lokandwala (India)

13:50 Multipolar Mapping Catheters, Multiple Access Routes, and Complete Scar Homogenization are Necessary for Successful Catheter Ablation of Post-infarct Ventricular Tachycardia

Pro: Edward P. Gerstenfeld (USA) Con: Karl-Heinz Kuck (Germany)

14:40 Asymptomatic Patients with Very Frequent Ventricular Ectopy should Undergo Prophylactic Catheter Ablation to Prevent the Development of Cardiomyopathy

Pro: Akihiko Nogami (Japan) Con: Haris Haqqani (Australia)

170


SA

TU

RD

AY

Room S426

[161] Atrial Fibrillation (Ablation) Workshop 9 - Novel Insight13:50 – 15:30 Chairs: Gary CP Chan (Hong Kong) Calambur Narasimhan (India)

13:50 How to Improve the Durability of PV Isolation in AF-Ablation: Advantage of Repeat ATP-Method

Teiichi Yamane (Japan)

14:10 Surrogating Biomarker to Predict Outcome after AF Ablation

Tae-Joon Cha (Korea)

14:30 Low Voltage Zone Ablation is an Effective Adjunctive Therapy after Pulmonary Vein Antrum Isolation in Patients with Electrically Damaged Left Atrium

Takeshi Tsuchiya (Japan)

14:50 Relationship between Epicardial Fat Location by MSCT and CFAE Ablation

Ichiro Watanabe (Japan)

15:10 Ganglionated Plexi Ablation Plus Antral PV Isolation for AF

Kohei Yamashiro (Japan)

170 171


SA

TU

RD

AY

Room S427

[162] Medtronic - First Asia Pacific Women in EP Forum13:50 – 15:30 Chairs: Anne Gillis (Canada) Kathy Lee (Hong Kong) Panelists: Vanita Arora (India) Ke-Ping Chen (China) Margaret Hood (New Zealand) Ruth Kam (Singapore) Surinder Kaur (Malaysia) Asumi Takei (Japan)

13:50 Opening Kathy Lee (Hong Kong)

13:53 The Opportunities and Challenges for Women in Electrophysiology

Anne Gills (Canada)

14:08 Panel Discussion

14:48 Epicardial Catheter Ablation Kyoko Soejima (Japan)

15:03 Case Study Eun-Sun Jin (Korea)

15:15 T-Wave Oversensing and Inappropriate Shocks Li-Ting Ho (Taiwan)

15:27 Closing Kathy Lee (Hong Kong)

172


SA

TU

RD

AY

Room S429

[163] SVT Workshop 4 - Challenging SVT Ablation13:50 – 15:30 Chairs: Godwin TC Leung (Hong Kong) Hong Liu (Macau)

13:50 Catheter Ablation of SVT Patients Guided by 3D Mapping System to Minimize X-ray Exposure

Yan Yao (China)

14:10 Ablation of Difficult WPW George Klein (Canada)

14:30 Difficult Atrial Flutter Henry Hsia (USA)

14:50 Catheter Ablation of Atrial Fibrillation Koichiro Kumagai (Japan)

15:10 Macro Re-Entry AT Shih-Lin Chang (Taiwan)

Room S430

[164] Oral Abstract Session13:50 – 15:30 Oral Presentation: Basic and Translational

Science 2 Chairs: Man-Ling Chiu (Macau) Patricia HT Hon (Hong Kong) Dora ML Wong (Hong Kong)

13:50 OP 20-1 TRPC3 channel-dependent regulation of fibroblast proliferation/differentiation in atrial fibrillation

Masahide HARADA (Canada)

14:06 OP 20-2 Receptor for advanced glycation endproducts suppressed arrhythmia by reducing infarct size and apoptosis in myocardial infarction

Hyelim PARK (Korea)

14:22 OP 20-3 Blockade of NaV1.8 channels in ganglionated plexi influences cardiac conduction and atrial fibrillation inducibility

Baozhen QI (China)

172 173


SA

TU

RD

AY

14:38 OP 20-4 An innovative mathematical model with quantum number for rhythm phenomenon and its computer simulation

Mingliang YANG (China)

14:54 OP 20-5 The role of gap junction in atrial fibrillation caused by atrial stretch

Norihiro UEDA (Japan)

15:10 OP 20-6 Apamin induces early afterdepolarizations and triggered activity from failing rabbit ventricular myocardium with secondary rise of intracellular calcium

Po-Cheng CHANG (Taiwan)

Room S221

[165] Certificate CRM Course 11 - Advanced ICD13:50 – 15:30 Chairs: Kam-Wai Lai (Hong Kong) Chun-Ja Yoo (Korea)

13:50 VT/VF: Advances in Programming ICDs to Reduce Shocks

Jason Wildschut (Canada)

14:15 ICD Lead Technology in Lead Advisories/Recalls David Hayes (USA)

14:40 Subcutaneous ICD (S-ICD): Exploring Benefits and Limitations

Michael Gold (USA)

15:05 Workshop: Case-Based Approach to ICD Troubleshooting

Dulce Obias-Manno (USA)

174


SA

TU

RD

AY

Room S226

[166] Joint Session with SOLAECE - Atrial Fibrillation Ablation13:50 – 15:30 Chair: Victor KM Goh (Hong Kong)

13:50 Who Is a Candidate for Ablation for Atrial Fibrillation? A Guidelines-Based Approach

Guilherme Fenelon (Brazil)

14:10 Ablation for Atrial Fibrillation: State of the Art in 2013

Manuel Patete (Venezuela)

14:30 Outstanding Questions: Current Trials and Future Directions

Mauricio Abello (Argentina)

14:50 Ablate and Pace for Rate Control. State of the Art

Luis Molina (Mexico)

15:10 Anticoagulation in the Setting of Atrial Fibrillation Ablation

Luis Aguinaga (Argentina)

Room S227

[167] APHRS Basic Research Session - New Insights into the Mechanism and Management of Cardiac Arrhythmias13:50 – 15:30 Chair: Chi-Kin Chan (Hong Kong)

13:50 Animal Models for Ventricular Arrhythmia Research

Yukiomi Tsuji (Japan)

14:06 Neural Remodeling in Animal Models of Cardiac Arrhythmias


14:22 Calcium Dynamics and the Mechanisms of Ventricular Arrhythmia

Mitsunori Maruyama (Japan)

174 175


SA

TU

RD

AY

14:38 Sodium Calcium Exchanger as an Antiarrhythmic Target

Chung-Chuan Chou (Taiwan)

14:54 Targeting Intracellular Calcium Cycling in CPVT Ruey Sung (Taiwan)

15:10 Store-Overloaded-Induced Calcium Release in Ventricular Arrhythmias

Peter Jones (New Zealand)

Hall 5G, Level 5

[168] Poster Session 615:30 – 16:00 Chaired Poster Session – Device Judge: Jonathan Kalman (Anstralia)

P6-001 Successful CRT-D upgrade following subclavian venoplasty


P6-002 Riata implantable cardioverter-defibrillator lead failure removed via median sternotomy approach: a case beyond sudden death

Neil Wayne SALCES (Philippines)

P6-003 Normalization of left ventricular ejection fraction is associated with the absence of appropriate anti-tachycardia therapy in patients receiving implantable defibrillators for the primary prevention of sudden death

Dennis ZHU (USA)

P6-004 Late failure of left ventricular lead stabilized using the retained guidewire technique in a patient after cardiac resynchronization therapy

S P ABHILASH (India)

P6-005 Snare assisted left ventricular lead placement: results, safety and feasibility in 31 patients

Seth WORLEY (USA)

P6-006 Implant experience of percutaneous leadless pacemaker devices in swine

Keping CHEN (China)

176


SA

TU

RD

AY

Hall 5G, Room A

[169] Atrial Fibrillation (Ablation) 6 - Update in Complications 16:00 – 17:40 Chairs: Kwok-Keung Chan (Hong Kong) Jeong-Gwan Cho (Korea) Erika Maharani (Indonesia)

16:00 Pulmonary Vein Stenosis Hugh Calkins (USA)

16:20 Atrial Esophageal Fistula Davendra Mehta (USA)

16:40 Stroke Prevention Jian-Zeng Dong (China)

17:00 Phrenic Nerve Damage and Balloon Technologies

Wyn Davies (UK)

17:20 Perforation and Tamponade Michifumi Tokuda (Japan)

Hall 5G, Room B

[170] Sudden Cardiac Death 3 - Topics in Device Programming16:00 – 17:40 Chairs: Chi-Kin Chan (Hong Kong) Preecha Uerojanaungkul (Thailand) Tak-Fu Tse (Hong Kong)

16:00 The PREPARE Trial Bruce Wilkoff (USA)

16:20 The MADIT-RIT Trial: Trial Design and Results Arthur Moss (USA)

16:40 Critique of the MADIT-RIT Trial Jean-Jacques Blanc (France)

17:00 Implications of Recent Device Programming Trials for Asian Patients

Muhammad Munawar (Indonesia)

17:20 Implications of Recent Device Programming Trials for U.S. Patients

David Cannom (USA)

176 177


SA

TU

RD

AY

Hall 5G, Room C

[171] Genetic and Inherited Syndrome 2 - Clinical Management Cardiac Inherited Arrhythmic Syndrome 16:00 – 17:40 Chairs: Chung-Seung Chiang (Hong Kong) Nwe Nwe (Myanmar) Jitu Vohra (Australia)

16:00 Long QT Syndrome. From Clinical Management to New Genes

Peter J. Schwartz (Italy)

16:20 Management of Family Members with Sudden Cardiac Death

Kui Hong (China)

16:40 Heart Diseases with Sodium Channel Mutation Dao-Wu Wang (China)

17:00 Genetic in Cardiac Laminopathies Saurabh Kumar (Australia)

17:20 Idiopathic Ventricular Fibrillation or Early Repolarization Syndrome

Masayasu Hiraoka (Japan)

Room S421

[172] Focus Session 4 - Stroke Prevention in Atrial Fibrillation with New Anticoagulation Drugs – Practical Management Scenarios 16:00 – 17:40 Chairs: Gregory Lip (UK) Hung-Fat Tse (Hong Kong) Panelists: Jyh-Hong Chen (Taiwan) Satoshi Ogawa (Japan)

16:00 Case Based: The Patient at High Stroke Risk, Who Subsequently Presents with an Acute Coronary Syndrome Whilst on a New Oral Anticoagulant Drug

Jo Jo Hai (Hong Kong)

16:50 Case Based: The 50 Years Female Patient with Lone AF Who Undergoes Cardioversion and Subsequently, an Ablation Procedure

Tatjana Potpara (Serbia)

178


SA

TU

RD

AY

Room S423

[173] CSPE Session (EP) 5 - Considerations in ICD Implantation16:00 – 17:40 Chairs: De-Jia Huang (China) Quan Fang (China) Guang-Ping Li (China)

16:00 Device Selection in ICD Implantation: Single-Chamber vs. Dual-Chamber

Yan Dai (China)

16:20 Options of Venous Access and Pocket Position Si-Lin Chen (China)

16:40 How to Decide the Site of ICD Defibrillation Lead: Apex vs. Outflow?

Jie Fan (China)

17:00 Selection of ICD Defibrillation Lead: Single-Coil vs. Dual-Coil

Ming-Ho Wong (Hong Kong)

17:20 DFT Test in ICD Implantation: Necessary or Not?

Ta-Chuan Tuan (Taiwan)

Room S424

[174] VT Workshop 5 - Idiopathic VT16:00 – 17:40 Chair: Eli Ovsyshcher (Isreal)

16:00 Diagnosis and Assessment of Idiopathic VT Vadagenahalli S Prakashvs (India)

16:16 Outflow Tract VT Ablation and Long-Term Outcome

Hung-Ta Wo (Taiwan)

16:32 Atypical Idiopathic Ventricular Tachycardia Bobby John (India)

17:48 Aortic Cusp VT from Bench to Bedside Yash Yahya Lokhandwala (India)

17:04 Epicardial Ablation of Idiopathic VT Masaomi Chinushi (Japan)

17:20 Potentials in the Posterior Fascicle for Ventricular Tachycardia: Active Role or Passive Bystander

Xun-Zhang Wang (USA)

178 179


SA

TU

RD

AY

Room S425

[175] SCD Debate - Defibrillator Threshold Testing Should Be Done at the Time of ICD Implantation16:00 – 17:40 Chair: Katsushige Ono (Japan)

16:00 Protagonist Jeff Healey (Canada)

16:50 Antagonist Ali Oto (Turkey)

Room S426

[176] Heart Failure & Remote Patient Monitoring 6 - The Role of Devices’ Remote Monitoring in Heart Failure Patients16:00 – 17:40 Chairs: Chi-Keung AuYeong (Hong Kong) Carolyn SP Lam (Singapore)

16:00 Early Detection and Management of Heart Failure Worsening by Daily Remote Monitoring of Clinical Markers


16:20 Drug Therapy Optimization by Remote Monitoring

Masahiko Takagi (Japan)

16:40 Antiarrhythmic Electrical Therapy Optimization by Remote Monitoring of CRT Devices

Katherine Fan (Hong Kong)

17:00 Optimizing CRT Programming by Remote Monitoring

Wei Hua (China)

17:20 Social and Economical Sustainability of Remote Monitoring in HF: Is It Affordable to All Patients?

Niraj Varma (USA)

180


SA

TU

RD

AY

Room S427

[177] Medtronic Sudden Cardiac Arrest Symposia16:00 – 17:40 Chairs: Jiunn-Lee Lin (Taiwan) Anil Saxena (India) Shu Zhang (China)

16:00 What’s the Real NNT for Primary Prevention ICD Therapy?

David Cannom (USA)

16:33 The Role of Ambulatory ECG Monitoring to Determine SCA Risk in Post-MI Patients (REFINE ICD)

Bruce Wilkoff (USA)

17:06 SCA Prevention in Asia Pacific – The 1.5 Prevention Experiences in China and India

Calambur Narasimhan (India) Wei Hua (China)

Room S429

[178] Basic Research 9 - New Insights Into the Mechanism of Cardiac Arrhythmias16:00 – 17:40 Chair: Maria Belen O. Carisma (Philippines)

16:00 Basic Arrhythmia Mechanisms in Familial Hypertrophic Cardiomyopathy

Bjorn Knollmann (USA)

16:20 New Insights into the Steep Portion of the APD Restitution Curve

Yu-Cheng Hsieh (Taiwan)

16:40 Oxidative Stress, Glycolytic Inhibition, and Ventricular Fibrillation

Norishige Morita (Japan)

17:00 Protective Role of HO-1 in Atrial Fibrillation Yung-Hsin Yeh (Taiwan)

17:20 Apamin-Sensitive Calcium-Activated Potassium Currents in Rabbit Ventricles with Chronic Myocardial Infarction

Young-Soo Lee (Korea)

180 181


SA

TU

RD

AY

Room S430

[179] Oral Abstract Session 16:00 – 17:40 Oral Presentation: RVOT Ablation Chairs: Cathy Lam (Hong Kong) Qiang-Sun Zheng (China ) Guo-Qiang Zhong (China)

16:00 OP 21-2 Ablation of right ventricular outflow tract ventricular arrhythmias guided by non-contact mapping: techniques and long term clinical outcomes


16:16 OP 21-3 Relationship of the myocardial voltage map and successful ablation sites of idiopathic right ventricular outflow tract tachycardia

Jing WANG (China)

16:32 OP 21-4 Second coupling interval to distinguish “malignant” from “benign” ventricular tachycardia originating from right ventricular outflow tract

Chang Hee KWON (Korea)

16:48 OP 21-5 Ablation of idiopathic right ventricular outflow tract tachycardias under 3D mapping system: electrocardiographic and electrophysiological predictors of acute and short-term success

Dinesh CHOUDHARY (India)

17:04 OP 21-6 Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow tract ventricular arrhythmias: a randomized controlled study


182


SA

TU

RD

AY

Room S221

[180] Certificate CRM Course 12 - Advanced Pacemaker Programming16:00 – 17:40 Chairs: Marleen Irwin (Canada) Ying-Keung Lo (Hong Kong)

16:00 Special Features to Reduce Ventricular Pacing: Pitfalls and Pearls

Ta-Chuan Tuan (Taiwan)

16:33 Advanced Programming Features: One Size Fits All?

Chun-Ja Yoo (Korea)

17:06 Workshop: Case Studies of Complex Pacemaker Troubleshooting

Byron Lee (USA)

Room S226

[181] CRT Workshop 4 - Challenging Anatomies for Implantation16:00 – 17:40 Chair: Ping-Tim Tsui (Hong Kong)

16:00 Case Based - Congenital Complete Heart Block Deteriorating in Left Ventricular Function Soon (with in months) after Implantation of a Permanent Pacemaker and Requiring Upgrade to a CRT Device

Ashish Nabar (India)

16:25 Case Based - Options When Target Vein is Non-Usable

Shomu Bohora (India)

16:50 Case Based - Coronary Sinus Ostium Obstruction

Jen-Che Hsieh (Taiwan)

17:15 Case Based - Use of Snares for Difficult LV Lead Implantation

Seth Worley (USA)

182 183


SA

TU

RD

AY

Room S227

[182] APHRS CIED Session - Global Trends in ICD and Pacemaker Implant16:00 – 17:40 Chairs: Victor KM Goh (Hong Kong) Kohei Yamashiro (Japan)

16:00 China Shu Zhang (China))

16:12 Japan Kazuo Matsumoto (Japan)

16:24 Korea Tai-Ho Rho (Korea)

16:36 Taiwan Yen-Bin Liu (Taiwan)

16:48 Australia Harry Mond (Australia)

17:00 Malaysia Imran Zainal Abidin (Malaysia)

17:12 Hong Kong David CW Siu (Hong Kong)

17:24 Singapore Wee-Siong Teo (Singapore)

184


SA

TU

RD

AY

Hall 5G, Level 5

Poster Session 613:50 – 17:20 Poster Display - Atrial Fibrillation (Drug &

Device)


P6-007 AF surveillance post AF ablation using implantable cardiac monitor

John IP (USA)

P6-008 Intracardiac echocardiography in steerable sheath: noble tool for safe transseptal intervention

Shinji ISHIMARU (Japan)

P6-009 Echoguided venopuncture: safe and reliable method in patient with anticoagulation

Shinji ISHIMARU (Japan)

P6-010 Evaluation of electrophysiological and antiarrhythmic effects of niferidile, investigational potassium channel blocker, in patients with supraventricular tachycardia

Nikolai MIRONOV (Russia)

P6-011 In hospital registry of atrial fibrillation and multivariant analysis

Vijaya Chaitanya BORRA (India)

P6-012 Omega-3 polyunsaturated fatty acids may decrease the incidence of clinical postoperative atrial fibrillation

Xue-Yuan GUO (China)

P6-013 CHADS2 and CHA2DS2-VASc Scores in the prediction of mortalities in patients without atrial fibrillation after acute myocardial infarction (from the KAMIR)


P6-014 Are Asian patients more susceptible to intracranial bleeding with new oral anticoagulants for stroke prevention in atrial fibrillation? Insights from a meta-analysis of randomized controlled trials

Joey KWONG (Hong Kong)

P6-015 Safety and efficacy of short-time compression with a kaolin filled pad after catheter ablation of atrial fibrillation

Yuji MATSUDO (Japan)

184 185


SA

TU

RD

AY

P6-016 Clinical usefulness of the blood bepridil concentration measurement and validity of the dose adjustment by creatinine crearance in atrial fibrillation patients

Shunichiro HONDO (Japan)

P6-017 Time in therapeutic range during warfarin therapy in Korean patients with non-valvular atrial fibrillation and its clinical implications

Myung Hwan BAE (Korea)

P6-018 Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode

Zainul ABEDIN (USA)

P6-019 Atrial fibrillation reduces the functional REServe of the heart by a fifth

Nigel LEWIS (Australia)

P6-020 Left atrial thrombi is associated with left atrial appendage flow velocity rather than left atrial diameter in patients with atrial tachyarrhythmia

Hideyuki KISHIMA (Japan)

P6-021 Apixaban versus warfarin in patients with atrial fibrillation and valvular heart disease: findings from the ARISTOTLE study

Kathy LEE (Hong Kong)

P6-022 Apixaban reduces hospitalization in patients with atrial fibrillation: an analysis of the effect of apixaban therapy on resource use in the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation trial


P6-023 Apixaban is efficacious and safe in patients with atrial fibrillation using concomitant amiodarone: insights from the ARISTOTLE trial


P6-024 Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation


P6-025 Efficacy and safety of low dose amiodarone for preventing recurrence of persistent atrial fibrillation after direct current cardioversion

Satoshi KAWADA (Japan)

186


SA

TU

RD

AY

P6-026 Short stature and ischemic stroke in patients with nonvalvular atrial fibrillation: new insight into the old observation

Jeonggeun MOON (Korea)

P6-027 The role of renin-angiotensin system gene on the atrial flutter/fibrillation in patients after transcatheter closure of atrial septal defect

Shuenn-Nan CHIU (Taiwan)

P6-028 The association of intra-atrial coagulation factor IX and new-onset atrial fibrillation after cardiac surgery

Ching-Hui WENG (Taiwan)

P6-029 Feasibility of a novel ejection index derived from blood pressure in detecting atrial fibrillation – a pilot study

Chaoshun CHAN (Taiwan)

P6-030 Comparison of pulse amplitudeand time interval irregularity index in differentiation of atrial fibrillation and sinus rhythm – a pilot study

Po Ching CHI (Taiwan)

P6-031 Lenient vs. strict rate control in patients with atrial fibrillation and left ventricular hypertrophy

Peeyush GROVER (USA)

P6-032 SCN5A mutations associated with familial atrial fibrillation without structural heart diseases

Takeshi HARITA (Japan)

P6-033 The role of macrophage migration inhibitory factor in the regulation of connexin 43 in atrial myocytes

Fang RAO (China)

P6-034 Clinical outecomes of cardiac resynchronization therapy in patients with atrial fibrillation: a single center study including 111 patients with 3 years’ median follow-up

Suehiro HIDEYA (Japan)

P6-035 Catheter-tissue contact force determines atrial electrogram characteristics before and after ablation in patients with atrial fibrillation


186 187


SA

TU

RD

AY

P6-036 Effect of respiration on catheter-tissue contact force during pulmonary vein isolation for atrial fibrillation


P6-037 Marked growth of catheter ablation procedures for atrial fibrillation over the past decade: a nationwide study with implications for health care policy, infrastructure and spending


P6-038 Usefulness of activated partial thromboplastin time check in clinical use of dabigatran for patients with atrial fibrillation

Hiroshi TASAKA (Japan)

P6-039 Integrated chronic care management in patients with atrial fibrillation: a (cost-)effective treatment strategy

Jeroen HENDRIKS (The Netherlands)

P6-040 The atrial fibrillation registry in China: baseline characteristics and patient management

Zhang HAN (China)

P6-041 Patients with atrial fibrillation and other primary diagnosis in the emergency department: baseline characteristics and outcomes

Zhang HAN (China)

P6-042 Digoxin and mortality in patients with atrial fibrillation

Zhang HAN (China)

P6-043 Is the CHADS2 score predicts prognosis in atrial fibrillation patients concomitant with valvular atrial fibrillation

Zhang HAN (China)

P6-044 Effects of pericardial fat on P wave duration Shih-Jie Jhuo JHUO (Taiwan)

P6-045 CHADS2 score predicted new-onset dementia in the absence of atrial fibrillation: a nationwide cohort study

Min-Tsun LIAO (Taiwan)

P6-046 Randomized comparison of intravenous sedatives during catheter ablation of atrial fibrillation; interim result of DDR (deep sedation with dexmedetomidine and remifentanil) trial: interim result of ongoing prospective study


188


SA

TU

RD

AY

P6-047 Randomized Comparison of Continuous and Intermittent Heparin Infusion during Catheter Ablation of Atrial Fibrillation; Interim Results of ongoing COHERE (COntinuous HEparin infusion REferring to ablation of atrial fibrillation) trial


P6-048 The Institut Jantung Negara (the national heart institute of Malaysia) left atrial appendage occluder registry

Zulkeflee MUHAMMAD (Malaysia)

P6-049 Incidence and characteristics of patients unsuitable for dabigatran in clinical practice - a report from the STACIN registry

Hitoshi MINAMIGUCHI (Japan)

P6-050 Reduced ventricular response rate variability was associated with high risk clinical conditions in patients with persistent atrial fibrillation

Jumsuk KO (Korea)

P6-051 Clinical association of atrial fibrillation and cognitive impairment

Guoqiang ZHONG (China)

P6-052 Omega-3 fatty acid attenuated vulnerability of atrial fibrillation in left arial pressure overload rat model

Jumsuk KO (Korea)

P6-053 Identification of left atrial thrombus after 3-week anticoagulation prior to elective cardioversion in high risk patients with persistent atrial fibrillation

Youngjin CHO (Korea)

P6-054 Measurement of arterial stiffness in patients with atrial fibrillation

Scott WILLOUGHBY (Australia)

P6-055 Complications associated with initiation of anticoagulation therapy using warfarin – an observational study

Seng Han LIM (Singapore)

P6-056 Correlation of CHADS2 and CHA2DS2-VASc scores with left atrial thrombus in Chinese patients with nonvalvular atrial fibrillation

Yumei XUE (China)

188 189


SA

TU

RD

AY

P6-057 Exogenous cell-penetrating (cp)-Gαi1/2 C-terminal peptide inhibits adenylate cyclase (AC)/ cAMP/ PKA pathway and reduces vagal-induced atrial fibrillation

Hua JIANG (China)

P6-058 Predictors of recurrence of atrial fibrillation after direct-current cardioversion in patients with non-valvular persistent atrial fibrillation

Chang Hee KWON (Korea)

P6-059 Role of C-reactive protein level in carotid atherosclerosis in patients with atrial fibrillation and elevated


P6-060 Body mass index and mortality in patients with atrial fibrillation

Zhang HAN (China)

P6-061 Analysis of risk factors for all cause-mortality in atrial fibrillation patients

Juan WANG (China)

P6-063 The impact of polyunsaturated fatty acid on the recurrence after ablative therapy in patients with persistent atrial fibrillation

Yoon-Jung CHOI (Korea)

P6-064 Clinical profile of atrial fibrillation in a tertiary hospital in Indian subcontinent

Bobby JOHN (India)

P6-065 The time course of paroxysmal atrial fibrillation and its implication: an analysis from a snapshot

Minoru TAGAWA (Japan)

P6-066 Detection of an irregular vein activity using a LED and its potential for patients with atrial fibrillation

Jinseok LEE (Korea)

P6-067 Combining aspirin and warfarin for stroke prevention in atrial fibrillation: an incidence-based population study in Taiwan

Chieh-Yu LIU (Taiwan)

P6-068 Data from the Indian Heart Rhyhtm Society Atrial Fibrillation Registry (IHRS-AF Registry)

Aditya KAPOOR (India)

P6-069 Electrogram characteristics during atrial fibillation using cool-flex vs. 4mm bipolar electrode mapping catheter

Ra Seung LIM (Korea)

190


SA

TU

RD

AY

P6-070 Efficacy and safety of dabigatran in the peri-procedural period of radiofrequency ablation for atrial fibrillation

Nobuaki TANAKA (Japan)

P6-071 Long term results of CRT in patients with permanent atrial fibrillation and sinus rhythm


P6-072 New onset atrial fibrillation in patient with pacemaker implantation for sinus node dysfunction and atrioventricular block and its effect on clinical outcome

Kyoung Jeong KO (Korea)

P6-073 Close monitoring of arterial blood gas analysis is of importance when intravenous propofol is used for sedation of the patients for catheter ablation of atrial fibrillation

Kyoung Jeong KO (Korea)

P6-074 Personal impedance measurement of the patient with AF in electrical cardioversion

Seung-Young ROH (Korea)

P6-075 Effects of proangiotensin-12 on atrial electronic remodeling in a canine atrial rapid stimulation model

Xudong XIE (China)

P6-076 DR Abdullah AL-QAHTANI (Saudi Arabia)

P6-077 The HAS-BLED score is an independent predictor of symptomatic intracranial haemorrhage following haemorrhagic transformation of acute ischemic stroke in non-anticoagulated patients with or without atrial fibrillation

Tatjana POTPARA (Republic of Serbia)

P6-078 An initiative to minimize amount of contrast media utilizing a novel rotational coronary sinus occlusive venography technique with ordinary cath-lab x–ray machine during CRT implantation

Abdullah AL-QAHTANI (Saudi Arabia)

P6-079 Left atrial appendage closure followed by six weeks antithrombotic therapy – a prospective single center experience

Julian CHUN (Germany)

P6-080 Optimal strategy for restoration and maintenance of sinus rhythm in patients with rheumatic mitral stenosis and atrial fibrillation. a prospective randomized study

Narayanan NAMBOODIRI (India)

Sunday, 6 October 2013

08:30-10:10 Certificate CRM Course Workshop Oral Abstract Session Arrhythmia Management for Clinicians - HRS/APHRS CRM

Update

10:10-10:40 Coffee Break

10:40-12:20 Certificate CRM Course Workshop Oral Abstract Session Arrhythmia Management for Clinicians - HRS/APHRS CRM

Update Industry Supported Session - MRI Conditional Devices

(Medtronic)

12:20-13:50 Luncheon Symposium (Boehringer Ingelheim)

13:50-15:30 Certificate CRM Course – Hands-on Workshop Workshop Oral Abstract Session Arrhythmia Management for Clinicians - HRS/APHRS CRM

Update

15:30-16:00 Coffee Break

16:00-17:40 Certificate CRM Course – Hands-on Workshop Arrhythmia Management for Clinicians - HRS/APHRS CRM

Update

192


SU

ND

AY

Room S421

[183] Arrhythmia Management for Clinicians - HRS/APHRS CRM Update 1 - Evaluation of the Patient with an Arrhythmia 08:30 – 10:10 Chairs: Patrick TH Ko (Hong Kong) Chu-Pak Lau (Hong Kong)

08:30 ECG Workshop I Kathy Lee (Hong Kong)

08:55 ECG Workshop II George Klein (Canada)

09:20 Approach to the Patient with Palpitation Hugh Calkins (USA)

09:45 How to Investigate the Patient with First Onset Atrial Fibrillation


Room S425

[184] CRT Workshop 5 - 2013 Novelties08:30 – 10:10 Chair: Yui-Chi So (Hong Kong)

08:30 What's New in the 2013 ESC/EHRA Guidelines? Angelo Auricchio (Switzerland)

08:50 Management of Infection and Lead Issues in CRT Patients

Robert Giles (Australia)

09:10 Atrial Fibrillation in CRT Patients: Rate or Rhythm Control?

Bo Yu (China)

09:30 Remote Management of Arrhythmias and Device in CRT Patients


09:50 Multi Site or Multipoint Pacing for CRT David O'Donnell (Australia)

192 193


SU

ND

AY

Room S426

[185] Atrial Fibrillation (Ablation) Workshop 10 - Challenging Cases in Catheter Ablation08:30 – 10:10 Chairs: Steven SL Li (Hong Kong) Anil Saxena (India)

08:30 Case Based - The Effect of PV Isolation on the Response of Ganglionated Plexi located inside the PV Area

Shigeru Ikeguchi (Japan)

08:55 Case Based - Complex Multi-Reentrant Atrial Arrhythmias in Post-Surgery Cardiomyopathy

Fa-Bo Chung (Taiwan)

09:20 Case Based - Cases with Complicated Atrial Tachycardia after PV Isolation, Mapping and Diagnosis

Kazuhiro Satomi (Japan)

09:45 Case Based - AF Radiofrequency Ablation Using Conventional Ablation Catheters

Joy Maliackal Thomas (India)

Room S429

[186] VT Workshop 6 - Future VT Ablation08:30 – 10:10 Chairs: Bobby John (India) Ming-Shien Wen (Taiwan)

08:30 Future Technology for VT Ablation Vivek Reddy (USA)

08:50 Advances in MRI Guided Ablation Ganesan Anand (Australia)

09:10 Remote Navigation System for VT Ablation Edward P. Gerstenfeld (USA)

09:30 Bundle Branch Reentry VT Dennis Zhu (USA)

09:50 Catheter Ablation of Ischemic and Non-Ischemic VT

Shiro Nakahara (Japan)

194


SU

ND

AY

Room S430

[187] Oral Abstract Session08:30 – 10:10 Oral Presentation: Alternative Site Pacing Chair: Peter CY Wong (Hong Kong)

08:30 OP 22-1 Getting RV lead at thinner part of interventricular septum tends to shorten paced QRS duration with less dyssynchrony

Dmytro VOLKOV (Ukraine)

08:46 OP 22-2 Is right ventricular outflow tract (RVOT) septal pacing better than right ventricular apical (RVA) septal pacing with regard to long term left ventricular function and mechanical synchrony?

Gaurav GANESHWALA (India)

09:02 OP 22-3 Paced QRS duration as a predictor for clinical heart-failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block

Shaojie CHEN (China)

09:18 OP 22-4 Acute haemodynamic and hormonal effects of right ventricular apical pacing compared to right ventricular outflow tract pacing in non-bradycardic patients with normal ventricular function

Paul GOULD (Australia)

09:34 OP 22-5 Left atrial responses to acute right ventricular apical pacing in patients with sick sinus syndrome


09:50 OP 22-6 Long-term effect of right ventricular outflow tract versus apical pacing on cardiac function and synchrony

Yan DAI (China)

194 195


SU

ND

AY

Room S226-S227

[188] Certificate CRM Course 13 - Preventing Complications in EP and Device Therapy08:30 – 10:10 Chairs: Ricardo Bernardo (Italy) Hyun-Soo Lee (Koera)

08:30 Recognition and Prevention of Complications in Ablation

Shih-Lin Chang (Taiwan)

09:03 Device Infection Prevention: Risk Factors, Outcomes, Management Options

Charles Love (USA)

09:36 Anticoagulation Pre and Post AF Ablation Oussama Wazni (USA)

Room S421

[189] Arrhythmia Management for Clinicians - HRS/APHRS CRM Update 2 - Management of Atrial Fibrillation 10:40 – 12:20 Chairs: John Day (USA) Paul Lam (Hong Kong)

10:40 Rate Control of AF – What the Guidelines Tell Us

Anne Gillis (Canada)

11:05 Rhythm Control Choices - Practical Tips on Anti Arrhythmic Drug Use and Goals of Therapy

Isabelle van Gelder (The Netherlands)

11:30 When Should I Recommend Novel Oral Anticoagulants

Chu-Pak Lau (Hong Kong)

11:55 Management of AF in 2013: Does Age Matter Win-Kuang Shen (USA)

196


SU

ND

AY

Room S425

[190] Case Based Lead Extraction Workshop 10:40 – 12:20 Chairs: Shui-Wah Chiu (Hong Kong) Amitabh Yaduvanshi (India)

10:40 Case Based - A Combined Approach Nigel Lever (New Zealand)

11:00 Case Based - Patients with 2 Infected Right Sided ICD Leads

Joseph YS Chan (Hong Kong)

11:20 Case Based - Hybrid Extraction in a Pacemaker Dependent Elderly Patient with 20 Years Old Lead

Xue-Bin Li (China)

11:40 Case Based - Extraction of Coronary Sinus Leads


12:00 Case Based - Riata Lead Extraction Yoji Okamoto (Japan)

Room S426

[191] Atrial Fibrillation (Ablation) Workshop 11 - What's New in AF Ablation10:40 – 12:20 Chair: Rohan Gunawardena (Sri Lanka)

10:40 Role of LAA Isolation to AF Ablation Jae-Min Shim (Korea)

11:00 Imaging Integration and 3-D Mapping for VT Roberto De Ponti (Italy)

11:20 Hansen Robotic System for AF Ablation Andrew McGavigan (Australia)

11:40 Ballon Catheter PV Isolation Boris Schmidt (Germany)

12:00 Remote Nagivation for AF Ablation Xu Chen (Denmark)

196 197


SU

ND

AY

Room S429

[192] Oral Abstract Session10:40 – 12:20 Case-based Oral Presentation: Ablation Chairs: Yau-Ting Tai (Hong Kong) Ho-Chuen Yuen (Hong Kong)

10:40 OP 23-1 Catheter ablation of accessory pathway between the right atrial appendage and the right ventricle: a case report

Daljeet SAGGU (India)

10:56 OP 23-2 Novel therapeutic approach for catheter ablation of incessant ventricular tachycardia associated with cardiac sarcoidosis: the usefulness of CARTO-SOUND® system

Shinya KOWASE (Japan)

11:12 OP 23-3 Successful cryoablation of symptomatic nonpost-operative junctional ectopic tachycardia resistant to multidrug regimens: a case report

Ayhan KILIC (Turkey)

11:28 OP 23-4 Ablation premature ventricular contractions in left coronary cusp with magnetic navigation catheter

Tian-You LING (China)

11:44 OP 23-5 Radiofrequency ablation of a left posteriolateral accessory pathway in a patient with machenical mitral valve

Thuy TO HUNG (Vietnam)

12:00 OP 23-6 Trans-subclavian vein approach plus trans-femoral vein approach improve the outcomes of catheter ablation of idiopathic ventricular arrhythmias originating from subtricuspid annulus

Li TENG (China)

198


SU

ND

AY

Room S430

[193] Oral Abstract Session10:40 – 12:20 Oral Presentation: VT Ablation 1 Chair: Leo CC Kum (Hong Kong)

10:40 OP 24-1 High density mapping of ventricular scar- a comparison of ventricular tachycardia supporting channels with channels that do not support VT


10:56 OP 24-2 Acute catheter ablation of electrical storm in patients with ischemic heart disease using a remote magnetic navigation system

Steen PEHRSON (Denmark)

11:12 OP 24-3 Significance of abnormal potentials for guiding successful target of catheter ablation from the aortic sinus cusp ventricular arrhythmia

Xiaoyan LIU (China)

11:28 OP 24-4 Radiofrequency catheter ablation of ventricular arrhythmias on the left papillary muscles

Wei WEI (China)

11:44 OP 24-5 Posterior fascicle to myocardial conduction block during ILVT ablation: an electrophysiological marker of long-term success


12:00 OP 24-6 Electrophysiologic characteristics of induced ventricular tachycardia over multiple ablation procedures

Michifumi TOKUDA (Japan)

198 199


SU

ND

AY

Room S225

[194] Medtronic Symposium - MR Scanning with Implanted MRI Compatible Pacing/Defibrillator Device10:40 – 12:30 Chairs: Carmen Chan (Hong Kong) Gladys MY Lo Goh (Hong Kong) 10:40 Clinical Indications for Pacemaker/ICD

Implantation Le-Peng Zeng (USA) 10:50 Fundamental Concept on Operation of

Pacemaker and ICD Devices Le-Peng Zeng (USA) 11:10 Design on MRI Conditional Leads and

Generator Sung-Min Park (USA) 11:40 Safety on MRI Scanning with Implanted MRI

Compatible Pacing Device: Experience Sharing from a Single Centre

Lawrance Yip (Hong Kong) 12:00 Clinical Data on Latest MRI Compatible Device

Scanning and Current Limitations Stephen CW Cheung (Hong Kong)

Room S226-S227

[195] Certificate CRM Course 14 - Atrial Fibrillation10:40 – 12:20 Chair: Yi-Lan Kou (Taiwan)

10:40 3D Mapping for AF Ablation Massimo Moltrasio (Italy)

11:13 Application in AF Ablation: Contact Force, Contact Sense

Atul Verma (Canada)

11:46 Atrial Tachycardias During AF Ablation Hyun-Soo Lee (Korea)

200


SU

ND

AY

Room S421

[196] Boehringer Ingelheim Luncheon Symposium - Prevention of Stroke in AF Patients in Asia12:30 – 13:50 Chairs: Jeffery WH Fung (Hong Kong) Yat-Yin Lam (Hong Kong)

12:30 Anticoagulants and Atrial Fibrillation: Clinical Guidelines and Real World Experience


13:10 Maximizing the Benefits of NOACs for Stroke Prevention in AF Patients

Gregory Lip (UK)

Room S421

[200] Arrhythmia Management for Clinicians - HRS/APHRS CRM Update 3 - A Clinician’s Challenge in an Asymptomatic Patient13:50 – 15:30 Chairs: Andy WK Chan (Hong Kong) Cynthia Huie (Hong Kong)

13:50 Silent Atrial Fibrillation David CW Siu (Hong Kong)

14:10 Brugada ECG Ngai-Shing Mok (Hong Kong)

14:30 Frequent Atrial or Ventricular Ectopics Kalyanam Shivkumar (USA)

14:50 Low Ejection Fraction and LBBB Swee-Chong Seow (Singapore)

15:10 A Patient with an Implantable Cardiac Device Going to Surgery, Endoscopy or MRI

John Fisher (USA)

200 201


SU

ND

AY

Room S425

[201] CRT Workshop 6 - Updates of CRT for Heart Failure13:50 – 15:30 Chair: Wilson WM Chan (Hong Kong)

13:50 New Indications for CRT Johannes Sperzel (Gernmany)

14:10 Management of AF in CRT Patients Maurizio Gasparini (Italy)

14:30 Remote Monitoring of CRT Patients To be announced

14:50 Long-Term Complications of CRT-D Maurizio Landolina (Italy)

15:10 Optimization of CRT Bülent Özin (Turkey)

202


SU

ND

AY

Room S430

[202] Oral Abstract Session13:50 – 15:30 Oral Presentation: VT Ablation 2 Chair: Sheng-Hua Zhou (China)

13:50 OP 25-2 Post infarction scar ventricular tachycardia (PISVT) ablation: superiority of substrate based mapping in sinus rhythm over entrainment mapping during ventricular tachycardia with reference to total procedural time and long term freedom from recurrence

Prakash V S (India)

14:06 OP 25-3 Ablation of ventricular tachycardia during a “VT storm”


14:22 OP 25-4 Role of catheter ablation in drug refractory VT of granulomatous myocarditis

Mandar SHAH (India)

14:38 OP 25-5 Efficacy and outcome of catheter ablation for sustained /nonsustained ventricular tachycardia - related electrical storm: a single center experience

Heng-Hsu LIN (Taiwan)

14:54 OP 25-6 A novel strategy for mapping in sinus rhythm to localize ventricular tachycardia channels in ischemic cardiomyopathy


202 203


SU

ND

AY

Room S421

[206] Arrhythmia Management for Clinicians - HRS/APHRS CRM Update 4 - What Was not Taught in Medical School but Got Increasingly asked by Patients16:00 – 17:40 Chairs: Wing-Hong Fung (Hong Kong) Chiu-On Pun (Hong Kong)

16:00 I Experience Heart Racing During Running, Am I Fit for Marathon?

André Ng (UK)

16:20 When Should I Undergo AF Ablation to Get a Cure?

Steve Lai (Hong Kong)

16:40 Practical Tips on Using Novel Oral Anticoagulation

Kai-Hang Yiu (Hong Kong)

17:00 Dizziness, Blackout, POTS, What’s the Best Approach?

Richard Sutton (Monaco)

17:20 Emerging Cardiac Rhythm Management Therapies, What does a Non-Electrophysiologist Need to Know?

David J. Callans (USA)

204

Thursday, 3 October 2013 10:10 – 10:40 Hall 5G, Corner A Medtronic - How Smart is SmartShock? Thoranis Chantrarat (Thailand)

Hall 5G, Corner B Boston Scientific - The BSC Longevity History

from a Product Designer’s View Jim Gilkerson

12:20 – 13:50 Hall 5G, Corner B Cook Medical 1. Cook Medical Advanced Platform Devices Louis Goode

2. Leader Database Barry Norlander

3. Teams and Tools Nigel Lever (New Zealand)

13:50 – 14:20 Hall 5G, Corner A St. Jude Medical - Case Discussion – Steerable

Introducer Technology for Complex Ablation (Agilis Experience)

Gerhard Hindricks (Germany)

15:30 – 16:00 Hall 5G, Corner A Medtronic - One-Year Experiences in

Implanting and Managing MR-Conditional Pacemakers


Hall 5G, Corner B Boston Scientific - Latest ICD Lead Technology

and Test Methods ShantanuReddy(USA)&DanCooke(USA)

Meet the Experts Corner

204 205

Friday, 4 October 201310:10 – 10:40 Hall 5G, Corner A Medtronic - The Unmet Needs for Effective AF

Treatment in Asia Region Kazuo Matsumoto (Japan)

Hall 5G, Corner B St. Jude Medical - Case Discussion – New LV

Lead Technologies to Improve CRT Clinical Outcomes (Quadra Experience)


12:20 – 13:50 Hall 5G, Corner B Boehringer Ingelheim - Pradaxa in Practice -

What Important Things You Need to Know? 1. Using in Different Patient Populations 2. Preparing My Patient for Surgery or Procedures? 3. Picking the Right Dose for Your AF Patients

13:50 – 14:20 Hall 5G, Corner A BMS/Pfizer post-Symposium Discussion

Hall 5G, Corner B Boston Scientific - Understanding the S-ICD RichSanders&RickSanghera

15:30 – 16:00 Hall 5G, Corner A Medtronic - Strategies for Monitoring the

Phrenic Nerve During Cryoablation Marcin Kowalski (USA)

Hall 5G, Corner B St. Jude Medical - Case Discussion – New

Ablation Catheter Tip Technologies to Improve Clinical Outcomes (Coolflex Experience)



206


Saturday, 5 October 201310:10 – 10:40 Hall 5G, Corner A St. Jude Medical - Case Discussion - MRI in the

Pacemaker Patient, Clinical Experience Rabin Chakraborty (India)

12:20 – 13:50 Hall 5G, Corner A Biosense Webster 1. Overview of Biosense Webster Alexander Wallstein

2. A New Measure of Success in Complex Cardiac Ablation: SmartTouch Catheter

Judith Ayalon

3. The First Irrigated, Fully Integrated Multi-Ablation Platform: nMARQ

Mike Zirkle

Hall 5G, Corner B Cook Medical 1. Setting up an EP Lab for Lead Extraction Nigel Lever (New Zealand)

2. Making Decisions in Lead Extractions Robert Giles (Australia)

3. Reducing Complications Related to Chronic Lead Extraction

Russell Deman (Australia)

13:50 – 14:20 Hall 5G, Corner A St. Jude Medical - Case Discussion – New

Technologies for Ablation of Complex Arrhythmias (Velocity & Hensen)

Swee-Chong Seow (Singapore)

Hall 5G, Corner B Boston Scientific - Intellatip MiFi™ XP Kenneth Stein

15:30 – 16:00 Hall 5G, Corner A St. Jude Medical - Case Discussion - Reduction

of Inappropriate ICD Therapy Luca Santini (Italy)

thursday, 3 october 20132013.cardiorhythm.com/download/detail-program-26-sep.pdf · mohit singla...

Documents